Sentence,class,file
"EQUIP study, 2009. http://www.gmc-uk.org/ FINAL_Report_prevalence_and_causes_of_prescribing_errors.pdf_28935150.pdf (Last accessed 10 Mar 2014).",Non-OADS,/arxiv_data1/oa_pdf/a2/3b/bmjopen-2014-005948.PMC4360808.pdf
2010. http://www.nmc-uk.org/Documents/NMC-Publications/NMC-Standards-for-medicines-management.pdf(Last accessed 14 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/a2/3b/bmjopen-2014-005948.PMC4360808.pdf
"John Wiley and Sons Ltd, 2010. http://onlinelibrary.wiley.com/doi/10.1002/9781444316568.",Non-OADS,/arxiv_data1/oa_pdf/a2/3b/bmjopen-2014-005948.PMC4360808.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006724).,Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
Cancer Research UK Statistical Information Team 2011: Cancer in the UK: April 2011. http://info.cancerresearchuk.org/cancerstats/incidence/ (accessed 12 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
http://info.cancerresearchuk.org/ cancerstats/mortality/cancerdeaths/ (accessed 12 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
"The Royal College of Surgeons of England, 2012. http://www.hscic.gov.uk/catalogue/PUB06331/clin-audi-supp-prog-oeso-gast-2012-rep.pdf(accessed 19 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
"The Royal College of Surgeons of England, 2013. http://www.hscic.gov.uk/catalogue/PUB11093/clin-audi-supp-prog-oeso-gast-2013-rep.pdf(accessed 19 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
http://info.cancerresearchuk.org/cancerstats/survival/latestrates/ (accessed 12 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
"The English Indices of Deprivation 2004: summary (revised) http://www.communities.gov.uk/documents/communities/pdf/131206.pdf, Neighbourhood renewal unit, 2004.",Non-OADS,/arxiv_data1/oa_pdf/92/93/bmjopen-2014-006724.PMC4360809.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2015- 000081).,Non-OADS,/arxiv_data1/oa_pdf/31/1c/bmjdrc-2015-000081.PMC4360821.pdf
2009. http://www.iotf.org16.,Non-OADS,/arxiv_data1/oa_pdf/31/1c/bmjdrc-2015-000081.PMC4360821.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007198).,Non-OADS,/arxiv_data1/oa_pdf/73/19/bmjopen-2014-007198.PMC4360822.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007020).,Non-OADS,/arxiv_data1/oa_pdf/81/3b/bmjopen-2014-007020.PMC4360823.pdf
Available from: http://aihw.gov.au/alcohol-and-other- drugs/ndshs/2013/tobacco/.,Non-OADS,/arxiv_data1/oa_pdf/81/3b/bmjopen-2014-007020.PMC4360823.pdf
http://www.cancerinstitute.org.au/publications/aboriginal-smoking-and-health-survey 15.,Non-OADS,/arxiv_data1/oa_pdf/81/3b/bmjopen-2014-007020.PMC4360823.pdf
http://www.itcproject.org/countries/australia/tats 21.,Non-OADS,/arxiv_data1/oa_pdf/81/3b/bmjopen-2014-007020.PMC4360823.pdf
http://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa2011 29.,Non-OADS,/arxiv_data1/oa_pdf/81/3b/bmjopen-2014-007020.PMC4360823.pdf
http://www.rewriteyourstory.com.au/ 54.,Non-OADS,/arxiv_data1/oa_pdf/81/3b/bmjopen-2014-007020.PMC4360823.pdf
http://www.health.nsw.gov.au/tobacco/pages/default.aspx 61.,Non-OADS,/arxiv_data1/oa_pdf/81/3b/bmjopen-2014-007020.PMC4360823.pdf
"Secondary adult weight, 2011. http://www.noo.org.uk/uploads/doc/vid_11515_Adult_Weight_Data_Briefing.pdf 50.",Non-OADS,/arxiv_data1/oa_pdf/72/a2/bmjopen-2014-006285.PMC4360824.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006218).,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/bmjopen-2014-006218.PMC4360825.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/bmjopen-2014-006218.PMC4360825.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/6c/ott-8-595.PMC4360827.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 595–600OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  595Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7931 6Transcatheter arterial chemoembolization  with gemcitabine and oxaliplatin for the treatment  of advanced biliary tract cancer Qing Zhao* sheng Qian* liang Zhu Xu-Dong Qu Wei Zhang Zhi-Ping Yan Jie-Min cheng Qing-Xin liu rong liu Jian-hua Wang Department of interventional  radiology, Zhongshan hospital, Fudan  University, shanghai, People’s republic  of china *These authors contributed equally  to this workBackground:  The aim of this study was to determine the therapeutic efficacy and safety of  transarterial chemoembolization (TACE) with gemcitabine and oxaliplatin in patients with  advanced biliary tract cancer (BTC).",Non-OADS,/arxiv_data1/oa_pdf/77/6c/ott-8-595.PMC4360827.pdf
"In recent years, studies of the efficacy of TACE in correspondence: rong liu; Jian-hua  Wang Department of interventional radiology,  Zhongshan hospital, Fudan University,  180 Fenglin road, Xuhui District,  shanghai 200032, People’s republic of  china Tel/fax +86 21 6404 1990 extension 3088 email fdzslr@163.co m; docwjh@126.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhao et al Running head recto: TACE with gemcitabine and oxaliplatin for advanced BTC DOI: http://dx.doi.org/10.2147/OTT.S79316",Non-OADS,/arxiv_data1/oa_pdf/77/6c/ott-8-595.PMC4360827.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/77/6c/ott-8-595.PMC4360827.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/6c/ott-8-595.PMC4360827.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/a4/bctt-7-081.PMC4360828.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 81–98Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  81Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S4701 2Methods to improve rehabilitation of patients  following breast cancer surgery: a review   of systematic reviews Siew Yim Loh Aisya Nadia Musa Department of Rehabilitation  Medicine, Faculty of Medicine,   University of Malaya, Kuala Lumpur,   Malaysia Correspondence: Siew Yim Loh   Department of Rehabilitation Medicine,  Faculty of Medicine, University of Malaya,  Kuala Lumpur, Malaysia.",Non-OADS,/arxiv_data1/oa_pdf/ec/a4/bctt-7-081.PMC4360828.pdf
Available from: http://www.cancer.org/research/cancerfacts figures/ cancerfacts figures/cancer-facts- figures-201 2.,Non-OADS,/arxiv_data1/oa_pdf/ec/a4/bctt-7-081.PMC4360828.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ec/a4/bctt-7-081.PMC4360828.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006681).,Non-OADS,/arxiv_data1/oa_pdf/05/aa/bmjopen-2014-006681.PMC4360829.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006340).,Non-OADS,/arxiv_data1/oa_pdf/fd/f1/bmjopen-2014-006340.PMC4360830.pdf
2004. http://www.who.int/rpc/summit/en/ 51.,Non-OADS,/arxiv_data1/oa_pdf/fd/f1/bmjopen-2014-006340.PMC4360830.pdf
2008. http://www.who.int/mediacentre/events/meetings/forum_rh/en/ 52.,Non-OADS,/arxiv_data1/oa_pdf/fd/f1/bmjopen-2014-006340.PMC4360830.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://www.mentalhealthcommission.ca/SiteCollectionDocuments/Key_Documents/en/2010/Issues_Options_FINAL_English%2012Nov09.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://mbc.metropolis.net/assets/uploads/files/wp/1998/WP98 –20.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://www.urban.org/uploadedpdf/411574_immigrant_integration.pdf14.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
222. http://publications.gc.ca/Collection/Statcan/11F0019MIE/11F0019MIE2004222.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://www.socwomen.org/wp-content/ uploads/swsfactsheet_intersectionality.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://www.crunch.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://ywcacanada.ca/data/research_docs/ 00000189.pdf 46.,OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://martinprosperity.org/2009/03/12/ recent-immigrants-are-the-most-educated-and-yet-underemployed-in-the-canadian-labour-force/2013 54.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
190. http://socserv.mcmaster.ca/sedap/p/sedap190.pdf 55.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://www1.toronto.ca/wps/portal/ contentonly?vgnextoid=31a64485d1210410VgnVCM10000071d60f89RCRD 66.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
Ontario Public Health Standards 2008. http://www.health.gov.on.ca/ en/pro/programs/publichealth/oph_standards/docs/ophs_2008.pdf 67.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
"http://www.cbc.ca/news/ canada/flight-to-canada-the-refugee-process-1.889045, 2014.",Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
http://www.health.gov.on.ca/en/public/ publications/ohip/ohip_waiting_pd.aspx 75.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
"http://digitalcommons.ryerson.ca/cgi/viewcontent.cgi?article=1001&context=ece, 2013 76.",Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
"http://digitalcommons.iwu.edu/cgi/viewcontent.cgi?article=1005&context=psych_scholarship Durbin A, et al.BMJ Open 2015; 5:e006690.",Non-OADS,/arxiv_data1/oa_pdf/95/5f/bmjopen-2014-006690.PMC4360831.pdf
Data on footpath network were obtained from the OpenStreetMap project (http://www.openstreetmap.,OADS,/arxiv_data1/oa_pdf/81/3a/bmjopen-2014-006481.PMC4360832.pdf
"R Foundation for Statistical Computing, Vienna, Austria, 2014. http://www.R-project.org/ 17.",Non-OADS,/arxiv_data1/oa_pdf/81/3a/bmjopen-2014-006481.PMC4360832.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/73/ccide-7-045.PMC4360835.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dentistry 2015:7 45–53Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  45OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S7858 9guided bone augmentation using ceramic   space-maintaining devices: the impact of chemistry Jonas anderud1,2 Peter abrahamsson2 ryo Jimbo1 sten Isaksson2 erik adolfsson3 Johan Malmström2 Y oshihito naito4 ann Wennerberg1 1Department of Prosthodontics,   Faculty of Odontology, Malmö  University, Malmö, sweden;   2Maxillofacial Unit halmstad, region  halland, halmstad, sweden;  3swedish  Ceramic Institute, IVF , Mölndal,   sweden;  4Department of Oral and  Maxillofacial Prosthodontics and  Oral Implantology, Institute of health  Biosciences, University of Tokushima  graduate school, T okushima, Japan Correspondence: Jonas anderud   Department of Prosthodontics,   Faculty of Odontology, Malmö   University,  20506 Malmö, sweden   Tel +46 706 212 961  email jonas.anderud@regionhalland.s eAbstract:  The purpose of the study was to evaluate histologically, whether vertical bone aug - mentation can be achieved using a hollow ceramic space maintaining device in a rabbit calvaria  model.",Non-OADS,/arxiv_data1/oa_pdf/54/73/ccide-7-045.PMC4360835.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/54/73/ccide-7-045.PMC4360835.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/54/73/ccide-7-045.PMC4360835.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007306).,Non-OADS,/arxiv_data1/oa_pdf/7f/c1/bmjopen-2014-007306.PMC4360837.pdf
"Faecal calprotectin Faecal calprotectin levels will be measured at the University Hospital Zurich by a novel ELISA-based calpro- tectin test named EliA calprotectin (Thermo Scienti ﬁc, for product description see http://www.phadia.com/ PageFiles/29347/Product% 20information%20EliA%20 Calprotectin.pdf).",Non-OADS,/arxiv_data1/oa_pdf/7f/c1/bmjopen-2014-007306.PMC4360837.pdf
"Author affiliations 1Institute of Primary Care, University Hospital of Zürich ,Zürich, Switzerland 2IBDnet (http://www.ibdnet.ch), Stadtspital Triemli, Zürich, Switzerland 3Division of Gastroenterology, Department of Internal Medicine, Triemli Hospital, Zürich, Switzerland 4Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland Contributors TR, SV and GR were the initiators of this study.",Non-OADS,/arxiv_data1/oa_pdf/7f/c1/bmjopen-2014-007306.PMC4360837.pdf
2009. http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/20_irritable_bowel_syndrome.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/7f/c1/bmjopen-2014-007306.PMC4360837.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006731).,Non-OADS,/arxiv_data1/oa_pdf/7c/f5/bmjopen-2014-006731.PMC4360838.pdf
2008. http://www.sum.dk/Aktuelt/Publikationer/~/media/Filer%20-%20Publikationer_i_pdf/2008/UK_Healthcare_in_dk/pdf.ashx(accessed 28 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/7c/f5/bmjopen-2014-006731.PMC4360838.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006976).,Non-OADS,/arxiv_data1/oa_pdf/57/b8/bmjopen-2014-006976.PMC4360839.pdf
http://www.ash.org.uk/files/documents/ASH_108.pdf (accessed 11 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/57/b8/bmjopen-2014-006976.PMC4360839.pdf
"TheCochrane Collaboration , 2011. http://www.cochrane-handbook.org 9.",OADS,/arxiv_data1/oa_pdf/57/b8/bmjopen-2014-006976.PMC4360839.pdf
http://www.dare.org/about-d-a-r-e/(accessed 30 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/57/b8/bmjopen-2014-006976.PMC4360839.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007227).,Non-OADS,/arxiv_data1/oa_pdf/21/bf/bmjopen-2014-007227.PMC4360840.pdf
August 2011. http://www.ncceh.ca/sites/default/files/Critical_Appraisal_Cross-Sectional_Studies_Aug_2011.pdf (accessed Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/21/bf/bmjopen-2014-007227.PMC4360840.pdf
31 May 2013. http://www.casp-uk.net/#!casp-tools-checklists/c18f8 (accessed Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/21/bf/bmjopen-2014-007227.PMC4360840.pdf
31 May 2013. http://www.casp-uk.net/#!casp-tools- checklists/c18f8 (accessed Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/21/bf/bmjopen-2014-007227.PMC4360840.pdf
13 June 2014. http://tech.cochrane.org/revman (accessed Nov 2014).,OADS,/arxiv_data1/oa_pdf/21/bf/bmjopen-2014-007227.PMC4360840.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006944).,Non-OADS,/arxiv_data1/oa_pdf/04/b7/bmjopen-2014-006944.PMC4360845.pdf
"Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iarc.fr (accessed Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/04/b7/bmjopen-2014-006944.PMC4360845.pdf
http://www.nhs.uk/ Livewell/Breastcancer/Pages/Breastcancersymptoms.aspx(accessed Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/04/b7/bmjopen-2014-006944.PMC4360845.pdf
"Cancer Research UK, England and Wales Survival (2010 –2011) Summary —April 2014. http://publications.cancerresearchuk.org/ cancerstats/statssurvival/surv-data-table.html (accessed Aug 2014).",Non-OADS,/arxiv_data1/oa_pdf/04/b7/bmjopen-2014-006944.PMC4360845.pdf
"Evaluation of a community-based prostate health clinic in London, 2012. https://www.kcl.ac.uk/nursing/research/programmes/PatientCarerExperience/Evalutation-of-a-Prostate-Health-Clinic---report.pdf (accessed Jun2014).",Non-OADS,/arxiv_data1/oa_pdf/04/b7/bmjopen-2014-006944.PMC4360845.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC4360913.pdf
"Consent N/A Sample source location La Jolla, CA, USA Direct link to deposited data The deposited data can be found at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE55269 .Experimental design, materials and methods Tissue culture Primary human neonatal keratinocytes were derived from newborn foreskin as previously described [1,2] .",OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC4360913.pdf
http://dx.doi.org/10.1016/j.gdata.2015.02.002 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC4360913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC4360913.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/f8/33/main.PMC4360913.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/48/main.PMC4360915.pdf
Tel./fax: +81 52 759 2165. http://dx.doi.org/10.1016/j.bbacli.2015.01.002 2214-6474/Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/b4/48/main.PMC4360915.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/48/main.PMC4360915.pdf
Contents lists available at ScienceDirect BBA Clinical journal homepage: http://www.journals.elsevier.com/bba-clinical/,Non-OADS,/arxiv_data1/oa_pdf/b4/48/main.PMC4360915.pdf
http://dx.doi.org/10.1111/jop.12238 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/b4/48/main.PMC4360915.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/50/eb-6-005.PMC4360995.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpEye and Brain 2014:6 (Suppl 1)5–18Eye and Brain Dove press submit your manuscript | www.dovepress.co m Dove press  5Original rESEarchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/EB.S5181 4histological features of layers and sublayers   in cortical visual areas V1 and V2 of chimpanzees,   macaque monkeys, and humans Pooja Balaram nicole a Y oung Jon h Kaas Department of Psychology,    Vanderbilt University, nashville,    Tn, USa correspondence: Pooja Balaram   Vanderbilt University, 301 Wilson   hall, 111 21st avenue South,   nashville, Tn 37203, USa   Tel +1 508 314 3030   Fax +1 615 343 8449   Email pooja.balaram@vanderbilt.ed uAbstract:  The layers and sublayers of primary visual cortex, or V1, in primates are easily   distinguishable compared to those in other cortical areas, and are especially distinct in anthropoid  primates – monkeys, apes, and humans – where they also vary in histological appearance.",Non-OADS,/arxiv_data1/oa_pdf/b0/50/eb-6-005.PMC4360995.pdf
"Eye and Brain Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/eye-and-brain-journal  Eye and Brain is an international, peer-reviewed, open access journal   focusing on clinical and experimental research in the field of  neuro-ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/50/eb-6-005.PMC4360995.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/50/eb-6-005.PMC4360995.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.1Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/ars.2014.6032.PMC4361008.pdf
(a) Secondary structure of the human 18S rRNA (http://apollo.chemistry.gatech.edu/RibosomeGallery/).,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/wrna0006-0225.PMC4361047.pdf
"FURTHER READING/RESOURCES HCVIVdb.org (http://www.hcvivdb.org/), a database of mutations within the IRES of the hepatitis C virus.",Non-OADS,/arxiv_data1/oa_pdf/cb/1a/wrna0006-0211.PMC4361049.pdf
"Drug use resistance was strongly associated with having  experienced a passive drug use opportunity (AOR=3.1, 95%CI=2.0, 4.9), the number of drugs  offered (AOR=0.7, 95% CI=0.6, 0.8) and family factors such as not having a drug-using first- *Supplementary material can be found by accessing the online version of this paper at http://dx.doi.org  and by entering doi….",Non-OADS,/arxiv_data1/oa_pdf/26/38/nihms661878.PMC4361287.pdf
9All the patientsFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
Severity Stages in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
Severity Stages in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"Mov Disord 2009;14:2033– 2041, doi: http://dx.doi.org/10.1002/mds.22755.",OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"Neurology 2000; 55:1547–1551, doi: http://dx.doi.org/10.1212/WNL.55.10.1547.",Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"J Neurol Neurosurg Psychiatry 2011;82:761–765, doi: http://dx.doi.org/10.1136/jnnp.2010.229740.6.Louis ED, Michalec M, Gillman A.",Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"Parkinsonism Rel Disord 2010;16:412–414, doi: http://dx.doi.org/10.1016/j.parkreldis.2010.04.",OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"Neurology 1967;17:427–442, doi: http://dx.doi.org/10.1212/WNL.17.5.427.",Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"J Clin Neurophysiol 2004;21:446–450, doi: http://dx.doi.org/ 10.1097/00004691-200411000-00009.",Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"Eur J Neurol 2013;20:949–954, doi: http://dx.doi.org/10.1111/ene.12123.",Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"Arch Neurol 2000;57:1194–1198, doi: http://dx.doi.org/10.1001/archneur.57.8.",Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
"Mov Disord 2001;16:320–324, doi: http://dx.doi.org/10.1002/mds.1040.Severity Stages in Essential Tremor Gironell A, Ribosa-Nogue ´ R, Gich I, et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/6d/49/tre-05-299-6609-1.PMC4361372.pdf
http://www.sages.org/publication/id/CSR1/.,Non-OADS,/arxiv_data1/oa_pdf/26/15/10.1177_1553350614526788.PMC4361451.pdf
http://www.cioms.ch/images/stories/ CIOMS/guidelines/guidelines_nov_2002_blurb.htm (26 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/1b/6a/10.1177_1753193413519926.PMC4361452.pdf
http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html (25 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/1b/6a/10.1177_1753193413519926.PMC4361452.pdf
http://www.wma.net/en/30publications/10policies/b3/  (26 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/1b/6a/10.1177_1753193413519926.PMC4361452.pdf
Available from: http://www.cdc.gov/vhf/ ebola/resources/outbreak-table.html 2.,OADS,/arxiv_data1/oa_pdf/e4/11/10.1177_0049475514564269.PMC4361454.pdf
Available from: http://www.politico.com/magazine/story/ 2014/09/the-ebola-epidemic-is-about-to-get-worse- 111493.html#ixzz3IZBQKz7V 3.,Non-OADS,/arxiv_data1/oa_pdf/e4/11/10.1177_0049475514564269.PMC4361454.pdf
Available from: http://www.msf.org/article/guinea-ebola-epidemic-declared-msf-launches-emergency-response4 Tropical Doctor 45(1),Non-OADS,/arxiv_data1/oa_pdf/e4/11/10.1177_0049475514564269.PMC4361454.pdf
16. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002677/human_med_001764.,Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
jsp&mid=WC0b01ac058001d124 (accessed 29 August 2014)  17. http://www.ema.europa.eu/ema/index.jsp?curl=pages/ medicines/human/medicines/002322/human_med_001546.jsp&mid=WC0b01ac058001d124 (accessed 29 August 2014)  18. http://www.ema.europa.eu/ema/index.jsp?curl=pages/ medicines/human/medicines/002649/human_med_001707.,Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
jsp&mid=WC0b01ac058001d124 (accessed 29 August 2014)  19. http://www.accessdata.fda.gov/drugsatfda_docs/ label/2014/204629s000lbl.pdf (accessed 20 September 2014)  20. http://www.accessdata.fda.gov/drugsatfda_docs/ label/2014/204042s002lbl.pdf (accessed 20 September 2014)  21. http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202293s003lbl.pdf (accessed 20 September 2014)  22.,Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
"Dapagliflozin tab - lets 5 and 10 mg, http://www.fda.gov/DOWNLOADS   /ADVISORYCOMMITTEES/COMMITTEESMEETING   MATERIALS/DRUGS/ENDOCRINOLOGICANDMETA-   BOLICDRUGSADVISORYCOMMITTEE/UCM262994.",Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
"FDA briefing material, http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334550.pdf (accessed 20 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
"2008, http://www.fda.gov/down-loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf (accessed 20 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
"CANVAS-R, http://www.clinicaltrials.gov/ ct2/show/NCT01989754?term=canvas-r&rank=1  85.",Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
"CREDENCE, http://www.clinicaltrials.gov/ ct2/show/NCT02065791?term=CREDENCE&rank=2  86.",Non-OADS,/arxiv_data1/oa_pdf/54/d7/10.1177_1479164114559852.PMC4361459.pdf
Retrieved from http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://www.healthlawyers.org/ hlresources/PI/InfoSeries/Documents/For%20the%20Health- care%20Executive/Minimizing%20EHRSSE.pdf Blumenthal, D., & Tavenner, M. (2010).",Non-OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://www.nap.edu/openbook.php?record_id=10781 Cook, R., & Rasmussen, J.",OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://healthit.ahrq.gov/sites/default/files/docs/page/Evaluation%20Toolkit%20Revised%20Version.pdf De Keyser, V ., & Woods, D. D. (1990).",OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://www.hhs.gov/ocr/ privacy/hipaa/understanding/srsummary.html Endsley, M. R. (1988).",OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from  http://www.healthit.gov/sites/default/files/pdf/0512_ONC- DataBrief2_JobPostings.pdf Greenhalgh, T., Potts, H., Wong, G., Bark, P., & Swinglehurst, D.  (2009).",OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pmc/issues/131751/ Han, Y ., Carcillo, J., Venkataraman, S., Clark, R., Watson, S.,  Nguyen, T., .",Non-OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pmc/issues/177327/ Hoffman, R. R., & Woods, D. D. (2011, May/June).",OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://www.nap.edu/open-book.php?record_id=13269 Jha, A. K., & Classen, D. C. (2011).",OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
"Retrieved from http://www.healthit.gov/sites/ default/files/safetyplanhhspubliccomment.pdf Pariès, J.",OADS,/arxiv_data1/oa_pdf/21/ec/10.1177_1555343414534242.PMC4361460.pdf
Reprints and permissions:   http://www.sagepub.co.uk/  journalsPermissions.nav 92 http://msj.sagepub.comMULTIPLE SCLEROSIS MSJJOURNAL Introduction Interest in falls in people with multiple sclerosis (PwMS) has increased significantly in the last dec-ade.,Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
"http://msj.sagepub.com 93falls data retrospectively, asking participants how  many times they have fallen in a specified period of the recent past.",Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
"Multiple Sclerosis Journal 21(1) 94 http://msj.sagepub.comtwo (US n = 54, AUS n = 210) or four (SE n = 49)  falls each month.",Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
"http://msj.sagepub.com 95MS subtype and higher EDSS scores, consistent with  previous studies.10,28,31  In contrast with previously  reported results, use of a walking aid was not signifi-cantly associated with higher fall risk.This meta-analysis provides further detail on the rela-tionship between fall risk in MS and disease severity as measured by the EDSS.",Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
Multiple Sclerosis Journal 21(1) 96 http://msj.sagepub.commobility limitations are first acknowledged) and 6.0  (when a walking aid is required).,Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
http://msj.sagepub.com 97 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
Multiple Sclerosis Journal 21(1) 98 http://msj.sagepub.compart of the world where MS is prevalent.,Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
http://msj.sagepub.com 99risk screening and recommend appropriate interven- tions to reduce the occurrence of falls in this high-risk group.,Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
Multiple Sclerosis Journal 21(1) 100 http://msj.sagepub.comA systematic review and meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/92/36/10.1177_1352458514538884.PMC4361466.pdf
suPPleMent Ary MA terIAl The online supplementary material is available at  http://edm.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/3b/5b/10.1177_1555343414554702.PMC4361467.pdf
"Reprints and permissions:  http://www.sagepub.co.uk/  journalsPermissions.navMULTIPLE SCLEROSIS MSJJOURNAL http://msj.sagepub.com 263Introduction Comorbidity is an area of increasing interest in multi-ple sclerosis (MS) as evidence emerges that comor - bidity is associated with diagnostic delays, disability progression, health-related quality of life, and pro-gression of lesion burden on magnetic resonance imaging (MRI).",Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
"Multiple Sclerosis Journal 21(3) 264 http://msj.sagepub.comMS cohorts, and to evaluate the quality of all included  studies.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
http://msj.sagepub.com 265based on a scoring system suggested by Boyle.18 We  based quality scores on the responses to the follow- ing questions where each affirmative answer was accorded one point: 1) Was the target population clearly described?,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Multiple Sclerosis Journal 21(3) 266 http://msj.sagepub.comTable 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
http://msj.sagepub.com 267Comorbidity No.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Multiple Sclerosis Journal 21(3) 268 http://msj.sagepub.comTable 2.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
"http://msj.sagepub.com 269Discussion We systematically reviewed the world literature regarding the incidence and prevalence of comorbid-ity in MS, evaluating a total of 249 unique manu-scripts.",OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
"Multiple Sclerosis Journal 21(3) 270 http://msj.sagepub.comDespite growing interest in the impact of comorbidity  on outcomes in MS,5,90 and the emergence of thera- pies that increase the risk of comorbidity or that may be relatively contraindicated in the presence of comorbidity, 273 relatively little high-quality informa- tion is available regarding the incidence or prevalence of comorbidity in MS at any point in the disease course.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
"http://msj.sagepub.com 271Gary Cutter has served on scientific advisory boards  for and/or received funding for travel from Innate Immunity, Klein-Buendel Incorporated, Genzyme, Medimmune, Novartis, Nuron Biotech, Spiniflex Pharmaceuticals, Somahlution, and Teva Pharma-ceuticals; receives royalties from publishing Evaluation of Health Promotion and Disease Prevention (The McGraw Hill Companies, 1984); has received hono-raria from GlaxoSmithKline, Novartis, Advanced Health Media Inc, Biogen Idec, EMD Serono Inc, EDJ Associates Inc, the National Heart, Lung, and Blood Institute, National Institute of Neurological Diseases and Stroke, National Marrow Donor Program, Consortium of Multiple Sclerosis Centers, Mt.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Multiple Sclerosis Journal 21(3) 272 http://msj.sagepub.com  14.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
http://msj.sagepub.com 273fatigue and depression.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Multiple Sclerosis Journal 21(3) 274 http://msj.sagepub.com  70.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
http://msj.sagepub.com 275  97.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Multiple Sclerosis Journal 21(3) 276 http://msj.sagepub.com 125.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
http://msj.sagepub.com 277 153.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Multiple Sclerosis Journal 21(3) 278 http://msj.sagepub.comof multiple sclerosis patients.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
http://msj.sagepub.com 279 208.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Multiple Sclerosis Journal 21(3) 280 http://msj.sagepub.com 236.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
http://msj.sagepub.com 281of adherence to interferon beta-1b in patients with  multiple sclerosis: Design and baseline results of an observational cohort study.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/cf/96/10.1177_1352458514564491.PMC4361468.pdf
"Retrieved from http://www.nhtsa.gov/Research/Human+Factors/Distraction Senders, J. W., Kristofferson, A.",OADS,/arxiv_data1/oa_pdf/61/c4/10.1177_0018720814542974.PMC4361471.pdf
Available at: http://dissertation.laerd.com/non-probability-sampling.,Non-OADS,/arxiv_data1/oa_pdf/3f/92/10.1177_0963662514525560.PMC4361474.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/  journalsPermissions.navMULTIPLE SCLEROSIS MSJJOURNAL http://msj.sagepub.com 1825Introduction A large body of evidence indicates that infection with the Epstein–Barr virus (EBV) plays a major role in the pathogenesis of multiple sclerosis (MS), although its exact role is incompletely understood.",Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
"Multiple Sclerosis Journal 20(14)1826 http://msj.sagepub.comre-expressing CD45RA (EMRA) (CD45RA+CCR7– CD62L–) cells.15,16 Naïve and CM CD8+ T cells  home to secondary lymphoid organs whereas EM  and EMRA CD8+ T cells traffic to inflamed non- lymphoid tissues and exhibit effector functions such as interferon-γ production and cytotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
http://msj.sagepub.com 1827have been presented as medians with interquartile  ranges.,Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
"Multiple Sclerosis Journal 20(14)1828 http://msj.sagepub.comrelationships between T cell frequencies and age,  disease duration, Expanded Disability Status Scale (EDSS) score and MS Severity Score (MSSS) we used Spearman rank correlation.",OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
http://msj.sagepub.com 1829 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
"Multiple Sclerosis Journal 20(14)1830 http://msj.sagepub.cominflamed CNS were to be incriminated as the cause of  the reduction in circulating CD8+ T cells it would also  be expected to cause a reduction in circulating CD4+ T cells, which is not the case.",Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
"http://msj.sagepub.com 1831decreased in PPMS in either our study or the previous  report despite a reduction in the thymic output of naïve CD4 + T cells.28 By reducing the number of  naïve CD8+ T cells available to generate effector T  cells in response to stimulation by antigen, the accel-erated age-related decline in naïve CD8 + T cells is  likely to contribute to the reduction of CD8+ EM and  EMRA T cells in PPMS, especially in older patients.",Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
Multiple Sclerosis Journal 20(14)1832 http://msj.sagepub.com 20.,Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/40/81/10.1177_1352458514536252.PMC4361480.pdf
Supplementary material for this article is available on the Journal of  Biomolecular Screening Web site at http://jbx.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/ca/5c/10.1177_1087057114559668.PMC4361481.pdf
"http://www.ismp-canada.org/download/reports/ FluorouracilIncidentMay2007.pdf (2007, accessed 9October 2014).",OADS,/arxiv_data1/oa_pdf/a6/3b/10.1177_1356262214556550.PMC4361486.pdf
http://www.fda.gov/MedicalDevices/Device RegulationandGuidance/GuidanceDocuments/ ucm259748.htm (accessed 9 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/a6/3b/10.1177_1356262214556550.PMC4361486.pdf
Epub ahead of print 20 June 2014. http://dx.doi.org/10.1016/ j.apergo.2014.05.012 16.,Non-OADS,/arxiv_data1/oa_pdf/a6/3b/10.1177_1356262214556550.PMC4361486.pdf
Using safety cases in industry and healthcare http://tinyurl.com/chwg3a3 (accessed 25 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/a6/3b/10.1177_1356262214556550.PMC4361486.pdf
"http://www.mhra.gov.uk/home/groups/dts-bs/ documents/publication/con007424.pdf (2014, accessed 25 August 2014).110 Clinical Risk 20(5)",Non-OADS,/arxiv_data1/oa_pdf/a6/3b/10.1177_1356262214556550.PMC4361486.pdf
"Retrieved from http://canceraustralia.gov.au/affected-can- cer/cancer-types/prostate-cancer/prostate-cancer-statistics Bottorff, J. L., Oliffe, J. L., Halpin, M., Phillips, M., McLean,  G., & Mroz, L. (2008).",Non-OADS,/arxiv_data1/oa_pdf/38/f8/10.1177_1557988314543510.PMC4361490.pdf
Retrieved from http://www.cancer-asian.com/images/news/Canadian_Can- cer%20Statistics_2011_English.pdf Canadian Cancer Society.,Non-OADS,/arxiv_data1/oa_pdf/38/f8/10.1177_1557988314543510.PMC4361490.pdf
Retrieved from http://www.cancer.ca/en/cancer-informa- tion/cancer-type/prostate/statistics/?region=bc Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/38/f8/10.1177_1557988314543510.PMC4361490.pdf
"Retrieved from http://www.cdc.gov-/can-cer/prostate/statistics Chapple, A., & Ziebland, S. (2002).",OADS,/arxiv_data1/oa_pdf/38/f8/10.1177_1557988314543510.PMC4361490.pdf
"Retrieved from http://research-bank.swinburne.edu.au/vital/access/services/Download/ swin:7543/SOURCE2 Wall, D., & Kristjanson, L. (2005).",OADS,/arxiv_data1/oa_pdf/38/f8/10.1177_1557988314543510.PMC4361490.pdf
/C211The Author(s) 2014 Reprints and permission: http://www.sagepub.com/journalsPermissions.nav DOI: 10.1177/0272989X14563081 MEDICAL DECISION MAKING/FEBRUARY 2015 143LETTER TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/dc/3b/10.1177_0272989X14563081.PMC4361492.pdf
Reprints and permissions:   http://www.sagepub.co.uk/  journalsPermissions.nav 22 http://msj.sagepub.comMULTIPLE SCLEROSIS MSJJOURNAL Introduction Multiple sclerosis is a chronic and degenerative auto-immune inflammatory disease leading to demyelina-tion and damage of axons in the brain and spinal cord.,Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"H Hartung, O Aktas et al.http://msj.sagepub.com 23 Table 1.",Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"Multiple Sclerosis Journal 21(1) 24 http://msj.sagepub.comstage that patient unblinding due to the distinct mode  of administration and established side effect profile of the two therapies was inevitable in practice, and there were expressed concerns about the ethics and practi-cality of maintaining patients, well aware they had the active infused therapy, on over two years of thrice weekly subcutaneous injections.",Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"H Hartung, O Aktas et al.http://msj.sagepub.com 25two years (Table 1).8,9 The mean EDSS score in alem- tuzumab-treated patients was significantly reduced  over two years, indicating an improvement in disabil-ity score, whereas the mean EDSS score for patients treated with SC IFNß-1a was significantly increased from baseline (alemtuzumab, –0.17 vs IFNβ-1a, +0.24; p < 0.0001).",Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
Multiple Sclerosis Journal 21(1) 26 http://msj.sagepub.comTable 2.,Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"H Hartung, O Aktas et al.http://msj.sagepub.com 27 Table 3.",Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
Multiple Sclerosis Journal 21(1) 28 http://msj.sagepub.com Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"H Hartung, O Aktas et al.http://msj.sagepub.com 29innate immune system, e.g.",OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
Multiple Sclerosis Journal 21(1) 30 http://msj.sagepub.comTable 4.,Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"H Hartung, O Aktas et al.http://msj.sagepub.com 31with methylprednisolone, antipyretics and antihista- mines (Table 4).",OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"Multiple Sclerosis Journal 21(1) 32 http://msj.sagepub.comthe CARE-MS program, between 14 and 36 months  after first exposure to alemtuzumab.7,8 The first case  of ITP, in the phase 2 CAMMS223 trial, went unrec-ognized and the patient died from intracerebral hem-orrhage.",Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"H Hartung, O Aktas et al.http://msj.sagepub.com 33Unlike other labeling classifications of RRMS such as  “highly active” or “rapidly evolving severe,” which require the presence of both clinical and imaging fea-tures with very specific criteria in each category, active RRMS in the alemtuzumab EU Summary of Product Characteristics (SmPC) is defined based on either clinical or imaging features.",Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"EU summary of product characteristics,  http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/003718/WC500150521.pdf (2013, accessed 20 January 2014).",Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
Multiple Sclerosis Journal 21(1) 34 http://msj.sagepub.comnext generation efficacy criteria.,Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/99/00/10.1177_1352458514549398.PMC4361497.pdf
"Accessed October 13 2013, http://jcr.sagepub.com/content/early/2013/01/02/0022002712468726.abstract.",Non-OADS,/arxiv_data1/oa_pdf/2b/e6/10.1177_0022002713508927.PMC4361499.pdf
http://www.rand.org/content/dam/rand/pubs/occasional_papers/2009/RAND_ OP257.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2b/e6/10.1177_0022002713508927.PMC4361499.pdf
Available from:  http://www.stoptb.org/assets/documents/global/awards/tbreach/Kyrgyztan%20NTP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/a2/2186-3326-77-0041.PMC4361506.pdf
This study was registered at http://www.clinicaltrials.gov (NCT01118572).,Non-OADS,/arxiv_data1/oa_pdf/75/40/2186-3326-77-0081.PMC4361510.pdf
"The Cochrane Library, 2010, Issue 12. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007357.pub2/pdf (accessed Jun 10, 2014) 23) Fujita M, Azuma T. Celecoxib (YM177) Tablet Pharmacokinetic Study (2) -Pharmacokinetics of Single Oral Dose Celecoxib-.",OADS,/arxiv_data1/oa_pdf/75/40/2186-3326-77-0081.PMC4361510.pdf
2014; “http://data.worldbank.org/indicator/SH.DYN.NMRT”.,Non-OADS,/arxiv_data1/oa_pdf/d8/19/2186-3326-77-0103.PMC4361512.pdf
"(in Japanese) http://www.ninjal.ac.jp/byoin/teian/ruikeibetu/teiango/index.html (accessed on Aug 21,  2014) 11) Yoshida Y , Zhang Y , Yoshida Y , Ma D & Wang P. Current situation of clinical trials in Beijing, China.",Non-OADS,/arxiv_data1/oa_pdf/87/9a/2186-3326-77-0123.PMC4361514.pdf
"J Neurosurg, 1986; 65(1): 22– 27.  http://dx.doi.org/10.3171/jns.1986.65.1.0022.",OADS,/arxiv_data1/oa_pdf/e5/35/2186-3326-77-0297.PMC4361532.pdf
http://dx.doi.org/10.3171/2009.3.PEDS0948.,Non-OADS,/arxiv_data1/oa_pdf/e5/35/2186-3326-77-0297.PMC4361532.pdf
http://dx.doi.org/10.3171/jns.1992.77.5.0804.,OADS,/arxiv_data1/oa_pdf/e5/35/2186-3326-77-0297.PMC4361532.pdf
Or listen to this and other JPEN podcasts at http://pen.sage-pub.com/site/misc/Index/Podcasts.xhtml.,Non-OADS,/arxiv_data1/oa_pdf/2c/69/10.1177_0148607114550189.PMC4361695.pdf
http://clinicaltrials.gov/show/NCT01419145.,Non-OADS,/arxiv_data1/oa_pdf/2c/69/10.1177_0148607114550189.PMC4361695.pdf
"In this article, we use the category ‘‘neglected tropical disease’’ (NTD) or ‘‘neglected diseases’’ to encompass malaria and tuberculosis, in addition to the seventeen diseases affecting populations in low-income countries identified by the World Health Organization in its official list of NTDs: http://www.who.int/ neglected_diseases/diseases/en/ (accessed December 15, 2013).",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"See https://www.collaborativedrug.com/pages/public_access (accessed May 25, 2014).24 Science, Technology, & Human Values 40(1)",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"‘‘Toward a New Approach to Product Develop- ment Partnership Performance Measurement.’’ Accessed February 21, 2013, http://www.fsg.org/Portals/0/Uploads/Documents/PDF/New_Approach_to_PDP_ Performance_Measurement.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"Accessed July 2, 2014 http://www.imshealth.com/ims/Global/Content/Insights/Featured %20Topics/ Emerging %20Markets/IMS_Africa_Oppor tunity_Whitepaper.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"Accessed December 29, 2013, http://www.druid.dk/uploads/tx_picturedb/wp05-02.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"Accessed July 2, 2014: http://www.pharmexec.com/pharmexec/ article/articleDetail.jsp?id=739264.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"Accessed July 2, 2014, http://www.policycures.org/downloads/g-finder_2010.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"Accessed July 2, 2014, http://www.ipwatchdog.com/2011/03/06/erik-iverson- gates-foundation-interview-part-2/id=15676/.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"Accessed December 29, 2013, http://pdpfundersgroup.org/PFG_Website/PFG_Briefing_ Papers.html.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"Accessed December 29, 2013, http://pdpfundersgroup.org/PFG_Web- site/PFG_Briefing_Papers.html.28 Science, Technology, & Human Values 40(1)",Non-OADS,/arxiv_data1/oa_pdf/3e/10/10.1177_0162243914542349.PMC4361701.pdf
"A 17-question questionnaire was mailed along with a  summary letter of explanation and a letter inviting the patients to participate in the study (Appendix A, http://clp.sagepub.com/content/by/supplemental-data).",Non-OADS,/arxiv_data1/oa_pdf/33/49/10.1177_0009922814550396.PMC4361703.pdf
"http://oacu.od.nih.gov/disaster/ShelterGuide.pdf (2010, accessed February 26, 2014).<Dermatophytosis is a treatable and curable disease.",Non-OADS,/arxiv_data1/oa_pdf/28/5a/10.1177_1098612X14530215.PMC4361704.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 1Special Article  Bioethics, neurosurgery, and integral healing Atul Goel, Sehdev Kumar1 Department of Neurosurgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra, I ndia,  1Professor Emeritus of Bioethics and Environmental Studies at the University of Waterloo, Canada Corresponding author: Prof. Atul Goel, Department of Neurosurgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Parel,  Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"HYPERLINK ""http://books.google.com/ books?id=mERfunMVv_oC""The Ethics of Biomedical Research: An international perspective.",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"HYPERLINK ""http://books.google.com/ books?id=mERfunMVv_oC""The Ethics of Biomedical Research: An  international perspective.",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"HYPERLINK ""http://www.guardian.co.uk/ world/2010/oct/01/us-apology-guatemala-syphilis-tests""""US says sorry for 'outrageous and abhorrent' Guatemalan syphilis tests Experiments in 1940s saw hundreds of Guatemalan prisoners and soldiers deliberately infected to test effects of penicillin"".",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"HYPERLINK ""http://books.google.com/ books?id=MlpEAAAAMAAJ""Obedience to Authority; An Experimental View.",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"HYPERLINK ""http://www.nytimes.com/2003/03/16/ magazine/the-stuttering-doctor-s-monster-study.html""""The Stuttering  Doctor's 'Monster Study'"".",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"HYPERLINK ""http://human-nature.com/rmyoung/papers/pap102h.html""Companion to the History of Modern  How to cite this article:  Goel A, Kumar S. Bioethics, neurosurgery,  and integral healing.",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"HYPERLINK ""http://books.google.com/books?id=3Zpr6N Oy5tsC&printsec=frontcover""The Synaptic Self: How Our Brains Become Who We Are.",Non-OADS,/arxiv_data1/oa_pdf/40/f9/JCVJS-6-1.PMC4361830.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 10Editorial C2 ganglion resection for lateral mass fixation  techniques Atul Goel Department of Neurosurgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Parel, Mumbai, India Corresponding author: Prof. Atul Goel, Department of Neurosurgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College Medical College,  Parel, Mumbai - 400 012, Maharashtra, India E-mail: atulgoel62@hotmail.com Journal of Craniovertebral Junction and Spine 2015, 6:4  Goel and Laheri fi  rst desc ribed the possibility of safe  resection of C2 ganglion for lateral mass atlantoaxial fi  xation in 1988.",Non-OADS,/arxiv_data1/oa_pdf/28/e9/JCVJS-6-10.PMC4361831.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 12Original Article  Additional merit of coronal STIR imaging for MR  imaging of lumbar spine Ranjana Gupta, Puneet Mittal, Amit Mittal, Kapish Mittal, Sharad Gupta, Ravleen Kaur Department of Radiodiagnosis, Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana, Ambala, Haryana, Ind ia Corresponding author: Dr. Puneet Mittal, 448, Prem Basti, Sangrur - 148 001, Punjab, India.",Non-OADS,/arxiv_data1/oa_pdf/43/9a/JCVJS-6-12.PMC4361832.pdf
Inﬂ ammatory and degenerative sacroiliac joint disease in a primary back pain  Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/43/9a/JCVJS-6-12.PMC4361832.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 16Original Article  Upper cervical injuries: Clinical results using a new  treatment algorithm Andrei F .,Non-OADS,/arxiv_data1/oa_pdf/93/1c/JCVJS-6-16.PMC4361833.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 21Original Article Primary bone tumors of the spine revisited: A 10-year  single-center experience of the management and outcome in a neurosurgical department Christopher Munoz-Bendix, Phillip Jorg Slotty, Sebastian Alexander Ahmadi,  Richard Bostelmann, Hans-Jakob Steiger, Jan Frederick Cornelius Department of Neurosurgery, Heinrich Heine University, Duesseldorf, Germany Corresponding author: Dr. Christopher Munoz-Bendix, Department of Neurosurgery, Heinrich Heine Universität, Moorenstr - 540 225 , Düsseldorf, Germany.",Non-OADS,/arxiv_data1/oa_pdf/09/3d/JCVJS-6-21.PMC4361834.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 36Original Article  A comparison of two techniques: Open and  percutaneous biopsies of thoracolumbar vertebral body lesions Furkan Yapici, Yunus Atici, Mehmet Bülent Balioglu, Akif Albayrak, Deniz Kargin,  Yunus Emre Akman, Sinan Erdogan1, Mehmet Akif Kaygusuz Departments of Orthopedics and Traumatology, Metin Sabanci Baltaliman ı Bone Diseases Training and Research Hospital, Istanbul,  1Orthopedics and Traumatology, Gaziosmanpasa Taksim Training and Research Hospital, Istanbul, Turkey Corresponding author: Dr. Furkan Yapici, Fsm mh.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/JCVJS-6-36.PMC4361836.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 40Case Report Atlantoaxial dislocation in a patient with nonsyndromic  symmetrical dwarfism: Report of a rare case Duvuru Ram, Venkatesh S. Madhugiri1, V. R. Roopesh Kumar1, Reena Gulati2,  Gopalakrishnan M. Sasidharan1, Sudheer Kumar Gundamaneni1 Departments of General Surgery, 1Neurosurgery, 2Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research,  Gorimedu, Pondicherry, India Corresponding author: Dr. Venkatesh S. Madhugiri, Department of Neurosurgery, Jawaharlal Institute of Postgraduate Medical Educ ation and Research, Gorimedu,  Pondicherry - 605 006, India.",Non-OADS,/arxiv_data1/oa_pdf/20/35/JCVJS-6-40.PMC4361837.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK1152/.,Non-OADS,/arxiv_data1/oa_pdf/20/35/JCVJS-6-40.PMC4361837.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK1487/.,Non-OADS,/arxiv_data1/oa_pdf/20/35/JCVJS-6-40.PMC4361837.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK84550/.,Non-OADS,/arxiv_data1/oa_pdf/20/35/JCVJS-6-40.PMC4361837.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 44Case Report  Surgical treatment of cervical unilateral locked facet  in a 9-year-old boy: A case report Mutlu Cobanoglu1, Meric Enercan2, Sinan Yilar3, Azmi Hamzaoglu2 1Department of Orthopaedics and Traumatology, Adnan Menderes University School of Medicine, Ayd ın, 2Istanbul Spine Center at Florence  Nightingale Hospital, Istanbul, 3Atatürk University School of Medicine, Erzurum, Turkey Corresponding author: Assist.",Non-OADS,/arxiv_data1/oa_pdf/e5/e1/JCVJS-6-44.PMC4361838.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 6Editorial  Retro-odontoid mass: An evidence of craniovertebral  instability Atul Goel Department of Neurosurgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra, I ndia  Corresponding author: Prof. Atul Goel, Department of Neurosurgery, King Edward Memoria Hospital and Seth Gordhandas Sunderdas M edical College, Parel,  Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/23/03/JCVJS-6-6.PMC4361839.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp 8Editorial Awake craniotomies for aneurysms, arteriovenous  malformations, skull base tumors, high flow bypass, and brain stem lesions Saleem I. Abdulrauf Department of Neurosurgery, Saint Louis University, Saint Louis, Missouri, United States Corresponding author: Prof. Saleem I. Abdulrauf, 3635 Vista Avenue, Saint Louis - 63110, Missour, United States.",Non-OADS,/arxiv_data1/oa_pdf/33/4d/JCVJS-6-8.PMC4361840.pdf
"Deaths attributed to the cancer of interest are treated as events and deaths from other causes are treated as censored observation (http://seer.cancer.gov/causespecific/).Survival time was defined as the time interval between the date of RCC diagnosis and the recorded date of death or last follow-up, whichever occurred first.",Non-OADS,/arxiv_data1/oa_pdf/24/3c/srep09160.PMC4361860.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/24/3c/srep09160.PMC4361860.pdf
"http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed August 21, 2014).",Non-OADS,/arxiv_data1/oa_pdf/5f/53/cro-0008-0072.PMC4361905.pdf
http://seer.cancer.gov/statfacts/html/mulmy.html.,Non-OADS,/arxiv_data1/oa_pdf/df/7e/cro-0008-0058.PMC4361911.pdf
Available from:  http://www.rcog.org.uk/files/ rcog‑corp/21.5.13SIP1AirTravel.pdf [Last accessed on 2014 April 04].,Non-OADS,/arxiv_data1/oa_pdf/ad/e8/ABR-4-60.PMC4361953.pdf
Available from: http://www.bma.org.uk/images/shiftwork_ tcm26-196305.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/84/ABR-4-61.PMC4361954.pdf
( SEER  Fact Sheets : Pancreas: http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/07/72/EUS-4-56.PMC4362006.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/81/ff/jjm-08-02-17569.PMC4362018.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ba/e8/traumamon-20-18042.PMC4362029.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/37/bf/traumamon-20-18635.PMC4362030.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/58/c6/traumamon-20-20095.PMC4362031.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/41/86/traumamon-20-21635.PMC4362032.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7f/99/traumamon-20-21891.PMC4362033.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e5/00/traumamon-20-23325.PMC4362034.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/32/d7/traumamon-20-23846.PMC4362035.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/53/cb/traumamon-20-23862.PMC4362036.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d9/83/traumamon-20-25257.PMC4362037.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.As we all well know , the trauma surgeon is oftentimes  over-stressed because of high workload and numerous  professional responsibilities; thus, it is not surprising  that he or she unknowingly neglects the much-needed  occasional release of physical and mental stress.",Non-OADS,/arxiv_data1/oa_pdf/6e/1f/traumamon-20-25730.PMC4362038.pdf
Breath-Taking View of the Namak Abroud Cable Car Ride in the  Winter (http://fbstatus.mihanblog.com/post/599) Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/6e/1f/traumamon-20-25730.PMC4362038.pdf
The Splendid Valasht Lake (http://commons.wikimedia.org/ wiki/File:Valasht.jpg) Figure 9.,Non-OADS,/arxiv_data1/oa_pdf/6e/1f/traumamon-20-25730.PMC4362038.pdf
Mazandaran Savad Kooh Bridge (http://commons.wikimedia.,Non-OADS,/arxiv_data1/oa_pdf/6e/1f/traumamon-20-25730.PMC4362038.pdf
"City View of Masuleh (http://en.wikipedia.org/wiki/Masuleh)9- Rudkhan Castle (Also Rood-khan Castle) Rudkhan Castle is a medieval brick and stone structure  in Fuman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6e/1f/traumamon-20-25730.PMC4362038.pdf
Rood-Khan Castle Gate in Gilan Province of Northern Iran  (Mansour Nasiri-http://nasiriphotos.com and at fa.wikipedia),Non-OADS,/arxiv_data1/oa_pdf/6e/1f/traumamon-20-25730.PMC4362038.pdf
Rud-Khan Castle (http://en.wikipedia.org/wiki/Rudkhan_Castle) These popular attractions and more make the northern  provinces the editor’s second choice destination for a re - cuperating vacation.,Non-OADS,/arxiv_data1/oa_pdf/6e/1f/traumamon-20-25730.PMC4362038.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/74/be/jjm-08-02-17341.PMC4362091.pdf
"International Journal of Preventive Medicine 2015, 6:3 http://www.ijpvmjournal.net/content/6/1/3epidemiological researches.",Non-OADS,/arxiv_data1/oa_pdf/1a/cf/IJPVM-6-3.PMC4362275.pdf
"International Journal of Preventive Medicine 2015, 6:3 http://www.ijpvmjournal.net/content/6/1/3when needed.",Non-OADS,/arxiv_data1/oa_pdf/1a/cf/IJPVM-6-3.PMC4362275.pdf
"International Journal of Preventive Medicine 2015, 6:3 http://www.ijpvmjournal.net/content/6/1/3physical activity, intraclass correlation coefficient was  0.97.",OADS,/arxiv_data1/oa_pdf/1a/cf/IJPVM-6-3.PMC4362275.pdf
"International Journal of Preventive Medicine 2015, 6:3 http://www.ijpvmjournal.net/content/6/1/3Received:  05 May 12 Accepted:  01 Jan 15   Published:  15 jan 15 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/1a/cf/IJPVM-6-3.PMC4362275.pdf
"International Journal of Preventive Medicine 2015, 6:5 http://www.ijpvmjournal.net/content/6/1/5ratio (WHtR) are used to determine general and central  obesity in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/81/92/IJPVM-6-5.PMC4362276.pdf
"International Journal of Preventive Medicine 2015, 6:5 http://www.ijpvmjournal.net/content/6/1/5women.",Non-OADS,/arxiv_data1/oa_pdf/81/92/IJPVM-6-5.PMC4362276.pdf
"International Journal of Preventive Medicine 2015, 6:5 http://www.ijpvmjournal.net/content/6/1/5specificity and lower sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/81/92/IJPVM-6-5.PMC4362276.pdf
"International Journal of Preventive Medicine 2015, 6:5 http://www.ijpvmjournal.net/content/6/1/5WHtR yields higher ROC curve than BMI and greater  predictive ability for diabetes in men.",Non-OADS,/arxiv_data1/oa_pdf/81/92/IJPVM-6-5.PMC4362276.pdf
"International Journal of Preventive Medicine 2015, 6:5 http://www.ijpvmjournal.net/content/6/1/518.",Non-OADS,/arxiv_data1/oa_pdf/81/92/IJPVM-6-5.PMC4362276.pdf
"International Journal of Preventive Medicine 2015, 6:4 http://www.ijpvmjournal.net/content/6/1/4well supported with multi‑sectoral collaboration are  the crucial elements to bring about a behavioral  change among people and allow the redistribution of  resources, in order to address the rising levels of chronic  disease, the re‑emergence of infections, environmental  degradation and socially determined health inequities.",Non-OADS,/arxiv_data1/oa_pdf/61/ce/IJPVM-6-4.PMC4362277.pdf
"International Journal of Preventive Medicine 2015, 6:2 http://www.ijpvmjournal.net/content/6/1/2link between migraine without aura (MO) and vascular  events remained uncertain and so the possible role of  ED in patients affected by MO was not explored clearly  so far.",Non-OADS,/arxiv_data1/oa_pdf/c7/ce/IJPVM-6-2.PMC4362278.pdf
"International Journal of Preventive Medicine 2015, 6:2 http://www.ijpvmjournal.net/content/6/1/2the assay was <1 µg/ml.",Non-OADS,/arxiv_data1/oa_pdf/c7/ce/IJPVM-6-2.PMC4362278.pdf
"International Journal of Preventive Medicine 2015, 6:2 http://www.ijpvmjournal.net/content/6/1/2Silva et al.",Non-OADS,/arxiv_data1/oa_pdf/c7/ce/IJPVM-6-2.PMC4362278.pdf
"International Journal of Preventive Medicine 2015, 6:2 http://www.ijpvmjournal.net/content/6/1/2period.",Non-OADS,/arxiv_data1/oa_pdf/c7/ce/IJPVM-6-2.PMC4362278.pdf
"International Journal of Preventive Medicine 2015, 6:6 http://www.ijpvmjournal.net/content/6/1/6between bully and victim.",Non-OADS,/arxiv_data1/oa_pdf/70/1a/IJPVM-6-6.PMC4362279.pdf
"International Journal of Preventive Medicine 2015, 6:6 http://www.ijpvmjournal.net/content/6/1/6Table 1: Characteristics of participants according to aggressive behaviors: The CASPIAN‑IV Study Physical fight P Being bullied P Bulling to others P Agea (year) Boys 12.46 0.1 12.02 0.000 12.68 0.001 Girls 12.7 0.1 12.58 0.98 13.26 <0.001 Urban 12.87 0.32 12.53 <0.001 13.27 <0.001 Rural 11.59 0.1 11.45 0.83 11.85 0.008 Total 12.55 0.1 12.27 0.002 12.92 <0.001 Heighta (cm) Boys 148.75 0.09 146.38 0.000 150.20 0.001 Girls 146.97 0.004 146.28 0.29 150.00 <0.001 Urban 150.28 0.001 148.19 0.005 152.38 <0.001 Rural 141.37 0.011 140.53 0.42 143.29 <0.001 Total 148.07 <0.001 146.34 0.04 150.12 <0.001 Weighta (kg) Boys 43.48 0.19 41.13 <0.001 44.69 0.003 Girls 42.52 0.03 42.23 0.21 45.17 <0.001 Urban 45.33 0.014 43.50 0.002 47.20 <0.001 Rural 36.38 0.063 35.74 0.74 37.86 0.001 Total 43.11 0.005 41.63 0.01 44.88 <0.001 BMIa (kg/m2) Boys 18.85 0.069 18.44 0.002 19.09 0.006 Girls 19.12 0.116 19.19 0.04 19.67 <0.001 Urban 19.39 0.11 19.18 0.20 19.80 <0.001 Rural 17.63 0.16 17.52 0.79 17.87 0.03 Total 18.96 0.06 18.78 0.36 19.32 <0.001 WCa (cm) Boys 68.34 0.01 67.08 0.009 68.77 0.01 Girls 66.74 0.04 66.64 0.10 67.84 <0.001 Urban 69.20 <0.001 68.15 0.22 69.94 <0.001 Rural 63.27 0.05 62.89 0.51 63.71 0.03 Total 67.73 <0.001 66.88 0.47 68.40 <0.001 WHtR Boys 0.046 0.09 0.45 0.75 0.45 0.95 Girls 0.45 0.90 0.45 0.21 0.45 0.51 Urban 0.46 0.03 0.46 0.21 0.45 0.65 Rural 0.44 0.88 0.44 0.81 0.44 0.30 Total 0.45 0.10 0.45 0.22 0.45 0.87 Abdominal obesity (%) Boys 0.50 0.17 0.29 0.88 0.20 0.83 Girls 0.32 0.49 0.26 0.36 0.14 0.64 Urban 0.42 0.01 0.28 0.50 0.18 0.29 Rural 0.40 0.91 0.28 0.57 0.15 0.31 Total 0.41 0.03 0.28 0.38 0.17 0.67 Over weight (%) Boys 0.49 0.59 0.26 0.12 0.20 0.71 Girls 0.29 0.22 0.24 0.81 0.15 0.42 Urban 0.38 0.58 0.25 0.24 0.18 0.60 Rural 0.40 0.83 0.24 0.48 0.16 0.47 Total 0.39 0.51 0.25 0.18 0.17 0.89 Contd...",Non-OADS,/arxiv_data1/oa_pdf/70/1a/IJPVM-6-6.PMC4362279.pdf
"International Journal of Preventive Medicine 2015, 6:6 http://www.ijpvmjournal.net/content/6/1/6Table 1: Contd...",Non-OADS,/arxiv_data1/oa_pdf/70/1a/IJPVM-6-6.PMC4362279.pdf
"International Journal of Preventive Medicine 2015, 6:6 http://www.ijpvmjournal.net/content/6/1/6prevalence of aggressive behaviors among a nationally  representative sample of students.",Non-OADS,/arxiv_data1/oa_pdf/70/1a/IJPVM-6-6.PMC4362279.pdf
"International Journal of Preventive Medicine 2015, 6:6 http://www.ijpvmjournal.net/content/6/1/6girls are more likely to fight in the intimate relations,  whereas boys more often fight with strangers.",Non-OADS,/arxiv_data1/oa_pdf/70/1a/IJPVM-6-6.PMC4362279.pdf
"International Journal of Preventive Medicine 2015, 6:1 http://www.ijpvmjournal.net/content/6/1/1anti‑microbial agents by physicians in primary care  as the main driver of resistance.",Non-OADS,/arxiv_data1/oa_pdf/53/c9/IJPVM-6-1.PMC4362280.pdf
"International Journal of Preventive Medicine 2015, 6:1 http://www.ijpvmjournal.net/content/6/1/1Data were reported as frequency (percentage).",Non-OADS,/arxiv_data1/oa_pdf/53/c9/IJPVM-6-1.PMC4362280.pdf
"International Journal of Preventive Medicine 2015, 6:1 http://www.ijpvmjournal.net/content/6/1/1province of Iran.",Non-OADS,/arxiv_data1/oa_pdf/53/c9/IJPVM-6-1.PMC4362280.pdf
"International Journal of Preventive Medicine 2015, 6:1 http://www.ijpvmjournal.net/content/6/1/1Our results also revealed seasonal variability in antibiotic  prescribing.",Non-OADS,/arxiv_data1/oa_pdf/53/c9/IJPVM-6-1.PMC4362280.pdf
"International Journal of Preventive Medicine 2015, 6:1 http://www.ijpvmjournal.net/content/6/1/1NICE guidance.",Non-OADS,/arxiv_data1/oa_pdf/53/c9/IJPVM-6-1.PMC4362280.pdf
"International Journal of Preventive Medicine 2015, 6:15 http://www.ijpvmjournal.net/content/6/1/15are among possible risk factors for breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/20/8c/IJPVM-6-15.PMC4362281.pdf
"International Journal of Preventive Medicine 2015, 6:15 http://www.ijpvmjournal.net/content/6/1/15patients (53.2%) had positive family history for breast  cancer.",Non-OADS,/arxiv_data1/oa_pdf/20/8c/IJPVM-6-15.PMC4362281.pdf
"International Journal of Preventive Medicine 2015, 6:15 http://www.ijpvmjournal.net/content/6/1/15assess testosterone in enrolled cases, and we did not  include healthy subjects.",Non-OADS,/arxiv_data1/oa_pdf/20/8c/IJPVM-6-15.PMC4362281.pdf
"International Journal of Preventive Medicine 2015, 6:12 http://www.ijpvmjournal.net/content/6/1/12the important favorable effects of physical activity in  weigh control programs are extensively documented.",Non-OADS,/arxiv_data1/oa_pdf/7c/d7/IJPVM-6-12.PMC4362282.pdf
"International Journal of Preventive Medicine 2015, 6:12 http://www.ijpvmjournal.net/content/6/1/12rooms (e.g.",Non-OADS,/arxiv_data1/oa_pdf/7c/d7/IJPVM-6-12.PMC4362282.pdf
"International Journal of Preventive Medicine 2015, 6:12 http://www.ijpvmjournal.net/content/6/1/12Main facilities/barriers for adolescents’ daily  physical activities Almost all female participants believed that there is a  great difference in the physical activity facilities between  girls and boys.",Non-OADS,/arxiv_data1/oa_pdf/7c/d7/IJPVM-6-12.PMC4362282.pdf
"International Journal of Preventive Medicine 2015, 6:12 http://www.ijpvmjournal.net/content/6/1/12but most of the times due to some problems and  barriers, their important has been ignored.",Non-OADS,/arxiv_data1/oa_pdf/7c/d7/IJPVM-6-12.PMC4362282.pdf
"International Journal of Preventive Medicine 2015, 6:12 http://www.ijpvmjournal.net/content/6/1/124.",Non-OADS,/arxiv_data1/oa_pdf/7c/d7/IJPVM-6-12.PMC4362282.pdf
"International Journal of Preventive Medicine 2015, 6:11 http://www.ijpvmjournal.net/content/6/1/11the US and Mexico, the Mediterranean region, and  throughout Asia.",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/IJPVM-6-11.PMC4362283.pdf
"International Journal of Preventive Medicine 2015, 6:11 http://www.ijpvmjournal.net/content/6/1/11TT groups (E2) ( P = 0.011).",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/IJPVM-6-11.PMC4362283.pdf
"International Journal of Preventive Medicine 2015, 6:11 http://www.ijpvmjournal.net/content/6/1/11cortical and medullar tubular necrosis were observed  [Figures 4 and 5] with score (III) that showed significant  increased ( P ≤ 0.01) [Table 2]  and finally, total damage  score[11] was increased.",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/IJPVM-6-11.PMC4362283.pdf
"International Journal of Preventive Medicine 2015, 6:11 http://www.ijpvmjournal.net/content/6/1/11The medullary tubular necrosis was observed in E2–E4  groups with score I that showed significantly increased  against control one ( P < 0.01).",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/IJPVM-6-11.PMC4362283.pdf
"International Journal of Preventive Medicine 2015, 6:11 http://www.ijpvmjournal.net/content/6/1/11Thus, decreasing renal side effects of CIS could be  considered by diuretic effect of the plant.",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/IJPVM-6-11.PMC4362283.pdf
"International Journal of Preventive Medicine 2015, 6:11 http://www.ijpvmjournal.net/content/6/1/11by kidney weight in experimental rats.",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/IJPVM-6-11.PMC4362283.pdf
"International Journal of Preventive Medicine 2015, 6:16 http://www.ijpvmjournal.net/content/6/1/16drugs are metabolized in the liver, and hepatic injury is a  very common side‑effect of many drugs.",Non-OADS,/arxiv_data1/oa_pdf/0c/f4/IJPVM-6-16.PMC4362284.pdf
"International Journal of Preventive Medicine 2015, 6:16 http://www.ijpvmjournal.net/content/6/1/16the HepG2 cells to some extent.",Non-OADS,/arxiv_data1/oa_pdf/0c/f4/IJPVM-6-16.PMC4362284.pdf
"International Journal of Preventive Medicine 2015, 6:13 http://www.ijpvmjournal.net/content/6/1/13Measurement of weight itself is rarely possible in critical  situations, and there is often no one available who knows  the exact child’s weight.",Non-OADS,/arxiv_data1/oa_pdf/82/cf/IJPVM-6-13.PMC4362285.pdf
"International Journal of Preventive Medicine 2015, 6:13 http://www.ijpvmjournal.net/content/6/1/13In addition, Mann–Whitney U-test indicated that there  were no significant difference between weights based on  gender except by DWEM ( P = 0.01).",OADS,/arxiv_data1/oa_pdf/82/cf/IJPVM-6-13.PMC4362285.pdf
"International Journal of Preventive Medicine 2015, 6:13 http://www.ijpvmjournal.net/content/6/1/13In addition, Akaberian et al .",Non-OADS,/arxiv_data1/oa_pdf/82/cf/IJPVM-6-13.PMC4362285.pdf
"International Journal of Preventive Medicine 2015, 6:13 http://www.ijpvmjournal.net/content/6/1/13Received:  10 Jun 14 Accepted:  01 Jan 15   Published:  20  Feb 15 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/82/cf/IJPVM-6-13.PMC4362285.pdf
"International Journal of Preventive Medicine 2015, 6:18 http://www.ijpvmjournal.net/content/6/1/18METHODS Study population and sampling method This cross-sectional study was conducted on 150 clinical  faculty members of research centers and scientific  associations affiliated with Tehran University of Medical  Sciences.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
"International Journal of Preventive Medicine 2015, 6:18 http://www.ijpvmjournal.net/content/6/1/18of questions.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
"International Journal of Preventive Medicine 2015, 6:18 http://www.ijpvmjournal.net/content/6/1/18to the findings of various studies, a satisfactory level of  patient satisfaction and trust is obtained by assessing  patients’ tendency to and need for becoming informed.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
"International Journal of Preventive Medicine 2015, 6:18 http://www.ijpvmjournal.net/content/6/1/18Table 1: Description of questions about the attitude area ( n=150) Statement Mean (95% CI) (95% CI) n (%) Positive Neutral Negative The use of PDA is not cost-effective for physicians because their income  does not match the time they spend on visiting patients*2.55 (2.35-2.75) 38 (25.3) 30 (20) 82 (54.7) (18.20-32.40) (13.47-26.53) (46.57-67.83) My colleagues would welcome PDAs 3.28 (3.11-3.48) 66 (44) 52 (34.7) 32 (21.3) (35.89-52.11) (26.93-42.47) (14.61-27.99) Most people are used to not have a say in the decisions made by their  doctors.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
"International Journal of Preventive Medicine 2015, 6:18 http://www.ijpvmjournal.net/content/6/1/18important to assess service models and plan on the  employment of proper strategies for increasing the  awareness of physicians and managing the available  bedside resources.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
Available from: http://www.cfhi‑fcass.ca/migrated/pdf/mythbusters/boost9_e.,Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
"International Journal of Preventive Medicine 2015, 6:18 http://www.ijpvmjournal.net/content/6/1/18making in the consultation.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
Available from: http://www.decisionaid.,Non-OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
Available from: http://www.euro.who.int/__data/assets/ pdf_file/0011/74666/E87791.pdf.,OADS,/arxiv_data1/oa_pdf/5a/e8/IJPVM-6-18.PMC4362286.pdf
"International Journal of Preventive Medicine 2015, 6:14 http://www.ijpvmjournal.net/content/6/1/14the prognosis of MI mortality in men and women  differently.",Non-OADS,/arxiv_data1/oa_pdf/28/e2/IJPVM-6-14.PMC4362287.pdf
"International Journal of Preventive Medicine 2015, 6:14 http://www.ijpvmjournal.net/content/6/1/14with confirmed MI diagnosis are recorded and saved  in the respected software at discharge from CCU  and could be used by Cardiology Department of  Iran’s Ministry of Health and Medical Education.",OADS,/arxiv_data1/oa_pdf/28/e2/IJPVM-6-14.PMC4362287.pdf
"International Journal of Preventive Medicine 2015, 6:14 http://www.ijpvmjournal.net/content/6/1/14the prevalence of type 2 diabetes and other risk factors  including hypertension and smoking in MI patients  was lower in Iran than in India.",Non-OADS,/arxiv_data1/oa_pdf/28/e2/IJPVM-6-14.PMC4362287.pdf
"International Journal of Preventive Medicine 2015, 6:14 http://www.ijpvmjournal.net/content/6/1/14Data collection for this research was funded by the Cardiology  Department.",Non-OADS,/arxiv_data1/oa_pdf/28/e2/IJPVM-6-14.PMC4362287.pdf
"International Journal of Preventive Medicine 2015, 6:10 http://www.ijpvmjournal.net/content/6/1/10and diabetes.",Non-OADS,/arxiv_data1/oa_pdf/0c/8e/IJPVM-6-10.PMC4362288.pdf
"International Journal of Preventive Medicine 2015, 6:17 http://www.ijpvmjournal.net/content/6/1/17Perchlorate has been used industrially as oxidants  in aerospace fuels and explosives, road flares,  pyrotechnics, and solid rocket propellant.",Non-OADS,/arxiv_data1/oa_pdf/d5/8b/IJPVM-6-17.PMC4362289.pdf
"International Journal of Preventive Medicine 2015, 6:17 http://www.ijpvmjournal.net/content/6/1/17were transferred under cold chain condition to Pars  laboratory, the referral laboratory of Isfahan province for  thyroid hormone measurement.",Non-OADS,/arxiv_data1/oa_pdf/d5/8b/IJPVM-6-17.PMC4362289.pdf
"International Journal of Preventive Medicine 2015, 6:17 http://www.ijpvmjournal.net/content/6/1/17Evidences determined that the adverse effect of  perchlorate on thyroid function is more prominent in  regions or subjects with iodine deficiency.",Non-OADS,/arxiv_data1/oa_pdf/d5/8b/IJPVM-6-17.PMC4362289.pdf
Available from: http://www.mass.gov/dep/cleanup/sites/percsour.doc.,OADS,/arxiv_data1/oa_pdf/d5/8b/IJPVM-6-17.PMC4362289.pdf
"International Journal of Preventive Medicine 2015, 6:17 http://www.ijpvmjournal.net/content/6/1/17et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/8b/IJPVM-6-17.PMC4362289.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/bd/23/mtm20141.PMC4362340.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/22/41/mtm201410.PMC4362345.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/3f/11/mtm201411.PMC4362346.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/9f/83/mtm201412.PMC4362347.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mtm201423.PMC4362348.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/42/30/mtm20143.PMC4362349.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/02/f4/mtm201414.PMC4362350.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/d3/a9/mtm201424.PMC4362351.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/b2/a0/mtm201429.PMC4362352.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/0a/e3/mtm201431.PMC4362353.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/4d/5f/mtm201444.PMC4362356.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/a6/93/mtm201437.PMC4362359.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/31/11/mtm201439.PMC4362360.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/64/9d/mtm201432.PMC4362361.pdf
"35,36 Other peptides were predicted by in-silico epitope pre - diction in order to bind mouse MHC class I, H2Kb, H2Db using four algorithms  available online: Syfpeithi (http://www.syfpeithi.de/), Bimas (http://www-bimas.cit.nih.gov), NetMHCpan and SMM (http://tools.immuneepitope.org/main/).",OADS,/arxiv_data1/oa_pdf/c1/be/mtm201445.PMC4362362.pdf
J Vis Exp  45: <http://www.jove.com.gate1.inist.fr/video/2250/ antigen-specific-in-vivo-killing-assay-using-cfse-labeled-target-cells>.,Non-OADS,/arxiv_data1/oa_pdf/c1/be/mtm201445.PMC4362362.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/c1/be/mtm201445.PMC4362362.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/c4/27/mtm201447.PMC4362363.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/6a/33/mtm201435.PMC4362365.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/69/02/mtm201427.PMC4362367.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/9e/3e/mtm201440.PMC4362369.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/09/68/mtm201442.PMC4362371.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/88/2d/mtm201443.PMC4362372.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/28/ae/mtm201448.PMC4362373.pdf
Images were analyzed using AMIDE (http://amide.source - forge.net) on reconstructed images.,OADS,/arxiv_data1/oa_pdf/53/af/mtm201416a.PMC4362377.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/53/af/mtm201416a.PMC4362377.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/60/ca/mtm201415.PMC4362380.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/d8/b2/mtm201421a.PMC4362381.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/bb/e9/mtm201417.PMC4362382.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/08/2f/mtm201418.PMC4362383.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/22/62/mtm201450.PMC4362386.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/36/cf/mtm20149.PMC4362388.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/0d/cvv022.PMC4362401.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/0c/cvv046.PMC4362404.pdf
World Health Statistics (WHS) 2013. http://www.who.int.,OADS,/arxiv_data1/oa_pdf/d4/0c/cvv046.PMC4362404.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/9b/cvv049.PMC4362405.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1038/nature1332 4 Daneman, R. 2012.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1002/ana.2364 8 Daneman, R., L. Zhou, D. Agalliu, J.D.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1371/journal.pone   .001374 1 Daneman, R., L. Zhou, A.A. Kebede, and B.A.",Non-OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
468:562– 566. http://dx.doi.org/10.1038/nature0951 3Secondary Alexa Fluor–conjugated antibodies and fluorophore-conjugated  streptavidin were all purchased from Life Technologies.,OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1074/   jbc.274.19.1339 0 Yen, F.T., O. Roitel, L. Bonnard, V. Notet, D. Pratte, C. Stenger, E. Magueur,  and B.E.",Non-OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1074/jbc   .M80102720 0Dietschy, J.M., and S.D.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1097/00041433-   200104000-0000 3 Dietschy, J.M., and S.D.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1152/   physrev.00019.201 2 Higashi, T., S. Tokuda, S. Kitajiri, S. Masuda, H. Nakamura, Y. Oda, and M.  Furuse.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1242/   jcs.11644 2 Hirase, T., J.M.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1083/   jcb.20051004 3 Iwamoto, N., T. Higashi, and M. Furuse.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1247/csf   .1301 5 Kokubo, Y., G.B.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1016/S0006-8993(02)02899- 8 Liebner, S., M. Corada, T. Bangsow, J. Babbage, A. Taddei, C.J.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1083/jcb.20080602 4 Masuda, S., Y. Oda, H. Sasaki, J. Ikenouchi, T. Higashi, M. Akashi, E. Nishi,  and M. Furuse.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi   .org/10.1242/jcs.07205 8 Mesli, S., S. Javorschi, A.M. Bérard, M. Landry, H. Priddle, D. Kivlichan,  A.J.",Non-OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1111/j.1432-1033   .2004.04223. x Morita, K., H. Sasaki, M. Furuse, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1083/jcb.147.1.18 5 Nitta, T., M. Hata, S. Gotoh, Y. Seo, H. Sasaki, N. Hashimoto, M. Furuse, and S.  Tsukita.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1083/   jcb.20030207 0 Saitou, M., M. Furuse, H. Sasaki, J.D.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1091/mbc.11.12.413 1 Siegenthaler, J.A., F. Sohet, and R. Daneman.",Non-OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10.1016/j.conb.2013   .06.00 6 Sohet, F., and R. Daneman.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi.org/10   .5772/3465 7 Stenger, C., A. Pinçon, M. Hanse, L. Royer, A. Comte, V. Koziel, J.L.",Non-OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
http://dx.doi.org/10.1111/j.1471-4159.2012.07922.,Non-OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
"http://dx.doi   .org/10.1016/j.neuint.2011.10.01 3 Yen, F.T., M. Masson, N. Clossais-Besnard, P. André, J.M.",OADS,/arxiv_data1/oa_pdf/b7/6b/JCB_201410131.PMC4362448.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1242/jcs.0337 4 Pfister, K.K., E.M. Fisher, I.R.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10   .1091/mbc.10.3.69 3 Qin, H., D.T.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1016/j.cub.2005.08.04 7 Roberts, A.J., T. Kon, P.J.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1038/nrm366 7 Rompolas, P ., L.B.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi   .org/10.1242/jcs.01277 3 Rosenbaum, J.L., and G.B.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1038/nrm95 2 Schafer, J.C., C.J.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1091/mbc.E02-10-067 7 Scholey, J.M.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"19:423– 443. http://dx.doi.org/10.1146/annurev.cellbio.19.111401.09131 8 Scholey, J.M.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-101512-12233 5 Shen, Z., X. Zhang, Y. Chai, Z. Zhu, P. Yi, G. Feng, W. Li, and G. Ou.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1016/j.devcel.2014.07.01 7 Signor, D., K.P.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1083/jcb.147.3.51 9 Snow, J.J., G. Ou, A.L.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
http://dx.doi.org/10.1038/ncb118 6lists the target sequence of each gene.,OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201411041/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1242/jcs.15903 8 Blisnick, T., J. Buisson, S. Absalon, A. Marie, N. Cayet, and P. Bastin.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10   .1091/mbc.E14-05-096 1 Egan, M.J., K. Tan, and S.L.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1146/   annurev.cellbio.23.090506.12324 9 Engel, B.D., H. Ishikawa, K.A.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1371/journal.pone.002099 5 Hou, Y., G.J.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1091/mbc.E04-05-037 7 Hsu, P.D., E.S.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1016/j.cell   .2012.07.02 2 Ishikawa, H., and W.F.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1038/   nrm308 5 Kardon, J.R., and R.D.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1038/nrm280 4 Mello, C.C., J.M.",OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1038/nature0381 8 Pastrana, E. 2010.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"7:488– 489. http://dx.doi.org/10.1038/nmeth0710-488 a Patel-King, R.S., R.M.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1091/ mbc.E13-05-026 6 Pazour, G.J., C.G.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"http://dx.doi.org/10.1083/jcb.141.4.97 9 Pazour, G.J., B.L.",Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
http://dx.doi.org/10.1083/jcb.144.3.47 3,Non-OADS,/arxiv_data1/oa_pdf/57/24/JCB_201411041.PMC4362450.pdf
"Despite the challenges, developing a new tech - nology can be extremely rewarding and could lead to a  lasting impact in a given field.A short guide to technology development  in cell biology Bas van Steensel1,2 1Division of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands 2Department of Cell Biology, Erasmus Medical Centre, 3015 CE Rotterdam, Netherlands © 2015 van Steensel  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"http://dx.doi.org/10.1091/ mbc.E10­04­036 6 Brummelkamp, T.R., R. Bernards, and R. Agami.",Non-OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"http://dx.doi.org/10.1126/science.106899 9 Doudna, J.A., and E. Charpentier.",Non-OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"http://dx.doi.org/   10.1126/science.116897 8 Kind, J., L. Pagie, H. Ortabozkoyun, S. Boyle, S.S. de Vries, H. Janssen, M.  Amendola, L.D.",Non-OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"http://dx.doi.org/10.1016/j.cell.2013.02.02 8 Roux, K.J., D.I.",OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"http://dx.doi.org/10.1083/   jcb.20111209 8 Tanenbaum, M.E., L.A. Gilbert, L.S.",Non-OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"http://dx.doi.org/10.1016/   j.cell.2014.09.03 9 Ule, J., K.B.",OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
"302:1212– 1215. http://dx.doi.org/10.1126/science.109009 5 van Steensel, B., J. Delrow, and S. Henikoff.",OADS,/arxiv_data1/oa_pdf/29/9c/JCB_201502006.PMC4362452.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"The temperature-sensitive cdc25-22  allele (Thuriaux et al., 1980)  was used for fission yeast synchronization in G2 (http://www.pombase   .org/spombe/result/SPAC24H6.05).",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/j.cub   .2006.07.02 2 Clark, R.F., and S.C. Elgin.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1093/nar/20.22.606 7 Cooper, J.P., E.R.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/385744a 0 Cooper, J.P., Y. Watanabe, and P. Nurse.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/3394 7 Corbett, K.D., C.K.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.07.01 7 Courtheoux, T., G. Gay, Y. Gachet, and S. Tournier.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1083/jcb.20090209 3 de Lange, T. 2009.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1126/science.117063 3 Dheur, S., S.J.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1128/   MCB.01290-1 0 Ditchfield, C., V .L.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1083/   jcb.20020809 1 Ekwall, K., J.P. Javerzat, A. Lorentz, H. Schmidt, G. Cranston, and R. Allshire.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1126/   science.766012 6 Ekwall, K., E.R.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/S1097-2765(01)00154- X Fischer, T., B. Cui, J. Dhakshnamoorthy, M. Zhou, C. Rubin, M. Zofall, T.D.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10   .1016/j.cub.2012.08.01 9 Funabiki, H., I. Hagan, S. Uzawa, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1083/jcb.121.5.96 1 Gandhi, R., P .J.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/j.cub.2006.10.06 1 Gay, G., T. Courtheoux, C. Reyes, S. Tournier, and Y. Gachet.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1083/jcb.152.4.66 9 Giménez-Abián, J.F., I. Sumara, T. Hirota, S. Hauf, D. Gerlich, C. de la Torre, J.  Ellenberg, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/   10.1016/j.cub.2004.06.05 2 Gisselsson, D., and M. Höglund.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/j.semcancer.2004.09.00 2 Gotta, M., and S.M.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1007/   BF0195211 3 Gregan, J., C.G.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201407016/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/   10.1242/jcs.0345 7 Bähler, J., J.Q.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1002/(SICI)1097 - 0061(199807)14:10<943::AID-YEA292>3.0.CO;2- Y Beauregard, P.B., R. Guérin, C. Turcotte, S. Lindquist, and L.A. Rokeach.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1126/science.106402 7 Carmena, M., M. Wheelock, H. Funabiki, and W.C. Earnshaw.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/nrm347 4 Chang, Y.T., B.A.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1371/journal.pgen.100393 6 Chen, E.S., K. Zhang, E. Nicolas, H.P.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/nature0656 1 Chikashige, Y., and Y. Hiraoka.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
http://dx.doi   .org/10.1016/S0960-9822(01)00457- 2,OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/ncb160 6 Moreno, S., A. Klar, and P. Nurse.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/0076-6879(91)94059- L Morishita, J., T. Matsusaka, G. Goshima, T. Nakamura, H. Tatebe, and M.  Yanagida.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1046/j.1365-2443.2001   .00459. x Moser, B.A., Y .T.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10   .1038/nsmb.218 7 Motwani, T., R. Doris, S.G. Holmes, and M.R.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1128/EC.00339-0 9 Nakayama, J., J.C. Rice, B.D.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1126/   science.106011 8 Nakazawa, N., T. Nakamura, A. Kokubu, M. Ebe, K. Nagao, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"180:1115– 1131. http://dx.doi.org/10.1083/jcb.20070817 0 Nakazawa, N., R. Mehrotra, M. Ebe, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1242/jcs.07873 3 Nandakumar, J., and T.R.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/   10.1038/nrm350 5 Neurohr, G., A. Naegeli, I. Titos, D. Theler, B. Greber, J. Díez, T. Gabaldón,  M. Mendoza, and Y. Barral.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1126/science.120157 8 Nonaka, N., T. Kitajima, S. Yokobayashi, G. Xiao, M. Yamamoto, S.I.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1038/ncb73 9 Nozawa, R.S., K. Nagao, H.T.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/ncb207 5 Ono, T., Y .",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1091/mbc.E04-03-024 2 Palladino, F., T. Laroche, E. Gilson, A. Axelrod, L. Pillus, and S.M.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/0092-   8674(93)90388- 7 Pardo, M., and P. Nurse.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1242/jcs.0230 5 Petersen, J., J. Paris, M. Willer, M. Philippe, and I.M.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/ncb134 1 Poon, B.P., and K. Mekhail.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.4161/cc   .10.16.1711 3 Rumpf, C., L. Cipak, A. Schleiffer, A. Pidoux, K. Mechtler, I.M.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.4161/cc.9.19   .1323 3 Sakuno, T., K. Tada, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1038/nature0787 6 Sampath, S.C., R. Ohi, O. Leismann, A. Salic, A. Pozniakovski, and H. Funabiki.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
118:187– 202. http://dx.doi.org/10.1016/j.cell.2004.06.02 6kinetochore proteins Pcs1 and Mde4 and heterochromatin are required  to prevent merotelic orientation.,OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1016/j.cub.2007.06.04 4 Gregan, J., S. Polakova, L. Zhang, I.M.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/j.tcb.2011.01.00 3 Hall, I.M., K. Noma, and S.I.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1371/journal.pgen.100470 8 Hauf, S., A. Biswas, M. Langegger, S.A. Kawashima, T. Tsukahara, and Y.  Watanabe.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1002/yea.129 1 Hirano, T., S. Funahashi, T. Uemura, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00503- 6 Kanoh, J., M. Sadaie, T. Urano, and F. Ishikawa.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/j.cub   .2005.09.04 1 Knowlton, A.L., W. Lan, and P.T.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"16:1705– 1710. http://dx.doi.org/10.1016/j.cub.2006.07.05 7 Koch, A., K. Krug, S. Pengelley, B. Macek, and S. Hauf.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/j.cell.2006.09.04 0 Leverson, J.D., H.K.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/   10.1091/mbc.01-07-033 0 Lipp, J.J., T. Hirota, I. Poser, and J.M.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1242/jcs.0342 5 Losada, A., M. Hirano, and T. Hirano.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10   .1101/ gad.24920 2 Maillet, L., C. Boscheron, M. Gotta, S. Marcand, E. Gilson, and S.M.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1101/   gad.10.14.179 6 Miller, K.M., M.G.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/sj.emboj.760077 9 Misteli, T., and E. Soutoglou.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"10:243– 254. http://dx.doi.org/10.1038/nrm265 1 Miyoshi, T., J. Kanoh, M. Saito, and F. Ishikawa.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
http://dx.doi.org/10.1126/science.115481 9,Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/nsmb132 4 Shintomi, K., and T. Hirano.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1101/gad.184430 9 Steigemann, P., C. Wurzenberger, M.H.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.12.02 0 Sugiyama, T., H.P.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10   .1016/j.cell.2006.12.03 5 Sumara, I., E. Vorlaufer, P.T.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1101/gad.13.17.227 1 Tada, K., H. Susumu, T. Sakuno, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/nature1017 9 Tanaka, T.U., N. Rachidi, C. Janke, G. Pereira, M. Galova, E. Schiebel, M.J.  Stark, and K. Nasmyth.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1016/S0092-8674(02)00633- 5 Thuriaux, P., M. Sipiczki, and P.A.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1083/jcb.20140403 9 Tomita, K., and J.P. Cooper.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1101/gad.49860 8 Tóth, A., K.P.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)00217- 8 Tournier, S., Y. Gachet, V. Buck, J.S.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1091/mbc.E04-03-025 6 Uhlmann, F., F. Lottspeich, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1038/2183 1 Uzawa, S., and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1091/mbc   .E06-10-089 0 Vassetzky, N.S., F. Gaden, C. Brun, S.M.",Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1093/nar/27.24.468 7 Waizenegger, I.C., S. Hauf, A. Meinke, and J.M.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)00132- X Yamagishi, Y., T. Honda, Y. Tanno, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
"http://dx.doi.org/10.1126/science.119449 8 Yamazaki, H., Y. Tarumoto, and F. Ishikawa.",OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
http://dx.doi   .org/10.1101/gad.177873.11 1,Non-OADS,/arxiv_data1/oa_pdf/35/cc/JCB_201407016.PMC4362453.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1242/dev.10431 5 del Río, O.I., and A.W.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1006/jcis.1997.521 4 Djiane, A., J. Riou, M. Umbhauer, J. Boucaut, and D. Shi.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1242/dev   .0195 1 Essex, L.J., R. Mayor, and M.G.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"198:108– 122. http://dx.doi.org/10.1002/aja.100198020 5 Fagotto, F., N. Rohani, A.-S. Touret, and R. Li.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1016/j.devcel.2013.09.00 4 Farquhar, M.G., and G.E.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1083/jcb.17.2.37 5 Fujiwara, S., J.C. Corbo, and M. Levine.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00614- 6 Hammerschmidt, M., and C. Nüsslein-Volhard.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1016/S0091-679X(08)60307- 6 Holley, S.A. 2007.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1002/dvdy.2116 2 Hukriede, N.A., T.E.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1016/S1534-5807(02)00398- 2 Jiang, D., E.M. Munro, and W.C. Smith.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/j.cub.2004.12.04 1 Johnson, K.E.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/0168-   9525(94)90220- 8 Kazmierczak, P., H. Sakaguchi, J. Tokita, E.M. Wilson-Kubalek, R.A. Milligan,  U. Müller, and B. Kachar.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1038/nature0609 1 Kim, G.-H., and J.-K. Han.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/   10.1002/dvdy.2026 2 Kim, S.-H., A. Yamamoto, T. Bouwmeester, E. Agius, and E.M. Robertis.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/   10.1126/science.119118 4 Kim, S.Y., S. Yasuda, H. Tanaka, K. Yamagata, and H. Kim.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/   10.4161/cam.5.2.1437 4 Kimmel, C.B., W.W. Ballard, S.R.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1002/aja.100203030 2 Knöchel, S., A. Schuler-Metz, and W. Knöchel.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201409026/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1242/dev.0190 7 Bikkavilli, R.K., M.E.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)81226- X Bruce, A.E., C. Howley, Y. Zhou, S.L.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1242/dev.0076 3 Bucior, I., and M.M.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1016/j.sbi.2004.08.00 6 Bucior, I., S. Scheuring, A. Engel, and M.M.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1083/   jcb.20030900 5 Carreira-Barbosa, F., M.L.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1083/jcb.20060206 2 Chen, X., E. Koh, M. Yoder, and B.M.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1371/journal.pone.000841 1 Chung, H.A., T.S.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/j.cub.2007.04.03 4 Damm, E.W., and R. Winklbauer.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
http://dx.doi.org/10.1242/dev.05690 3,Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1093/emboj/19.5.101 0 Sackmann, E., and A.-S. Smith.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1039/c3sm51910 d Sargent, M.G., and M.F.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.02.01 6 Shea, S.M.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1083/jcb.51.3.61 1 Speirs, C.K., K.K.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10   .1242/dev.04597 1 Takeuchi, M., J. Nakabayashi, T. Sakaguchi, T.S.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1093/emboj/cdg08 8 Tanegashima, K., H. Zhao, and I.B.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
http://dx.doi.org/10.1038/emboj.2008.,OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1038/3504004 2 Tepass, U., D. Godt, and R. Winklbauer.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/   10.1016/S0959-437X(02)00342- 8 Thiery, J.P. 2002.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1038/nrc82 2 Veeman, M.T., D.C. Slusarski, A. Kaykas, S.H.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/   10.1016/S0960-9822(03)00240- 9 Wacker, S., K. Grimm, T. Joos, and R. Winklbauer.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"224:428– 439. http://dx.doi.org/10.1006/dbio.2000.979 4 Wallingford, J.B., S.E.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/S1534-   5807(02)00197- 1 Westerfield, M. 2000.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/S1937-6448(09)78005- 0 Winklbauer, R., and R.E.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10   .1006/dbio.1996.017 4 Winklbauer, R., A. Medina, R.K. Swain, and H. Steinbeisser.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1038/3510162 1 Witzel, S., V. Zimyanin, F. Carreira-Barbosa, M. Tada, and C.-P. Heisenberg.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1083/jcb.20070415 0Kraft, B., C.D.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1083/jcb.20111007 6 Kühl, M., and D. Wedlich.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/ 10.1002/(SICI)1097-0177(199610)207:2<121::AID-AJA1>3.0.CO;2- J Liu, W., A. Sato, D. Khadka, R. Bharti, H. Diaz, L.W.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1002/dvdy.2152 2 Luu, O., R. David, H. Ninomiya, and R. Winklbauer.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/   10.1073/pnas.100374310 7 Medina, A., W. Reintsch, and H. Steinbeisser.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1038/sj.emboj   .760032 9 Miyaguchi, K. 2000.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10   .1006/jsbi.2000.424 4 Mlodzik, M. 2002.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/S0168-9525(02)02770- 1 Montero, J.A., L. Carvalho, M. Wilsch-Bräuninger, B. Kilian, C. Mustafa, and  C.P.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1242/dev.0166 7 Nakatsuji, N. 1975.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10   .1038/ncb166 9 Ninomiya, H., R. David, E.W.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1242/jcs.09531 5 Oteiza, P., M. Köppen, M. Krieg, E. Pulgar, C. Farias, C. Melo, S. Preibisch,  D. Müller, M. Tada, S. Hartel, et al.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1242/ dev.04998 1 Panousopoulou, E., R.A. Tyson, T. Bretschneider, and J.B. Green.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1016/j.ydbio.2013.07.01 2 Park, E.C., G.S.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi   .org/10.1016/j.ydbio.2010.12.01 2 Rohani, N., L. Canty, O. Luu, F. Fagotto, and R. Winklbauer.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1371/   journal.pbio.100059 7 Rohani, N., A. Parmeggiani, R. Winklbauer, and F. Fagotto.",Non-OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/10.1371/ journal.pbio.100195 5 Roszko, I., A. Sawada, and L. Solnica-Krezel.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"http://dx.doi.org/   10.1016/j.semcdb.2009.09.00 4 Rothbächer, U., M.N.",OADS,/arxiv_data1/oa_pdf/93/46/JCB_201409026.PMC4362454.pdf
"Our re - sults suggest that the role of gp210/Nup210 in cell differ - entiation is mediated by its large luminal domain, which  can act independently of NPC association and appears  to play a pivotal role in the maintenance of nuclear enve - lope/ER homeostasis.The nucleoporin gp210/Nup210 controls muscle  differentiation by regulating nuclear envelope/ER  homeostasis J. Sebastian Gomez-Cavazos1,2 and Martin W. Hetzer1 1Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037 2Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093 © 2015 Gomez-Cavazos and Hetzer  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201410047/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1038/nrg212 2 Allen, N.P., L. Huang, A. Burlingame, and M. Rexach.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1074/jbc.M10262920 0 Alter, J., and E. Bengal.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1371/journal.pone.002949 8 Amaral, J.D., R.J. Viana, R.M.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1194/jlr.R900011-JLR20 0 Brown, C.R., and P.A.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi .org/  10.1016/j.gde.2007.02.00 5 Capelson, M., Y. Liang, R. Schulte, W. Mair, U. Wagner, and M.W.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10   .1016/j.cell.2009.12.05 4Anti-ATF6/rabbit was obtained from Santa Cruz Biotechnology, Inc. (sc- 22799).",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"Multiple se - quence alignment of Nup210 amino acid sequences was performed using  PRALINE online software (http://www.ibi.vu.nl/programs/pralinewww;  Simossis and Heringa, 2005).",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
http://dx.doi.org/   10.1046/j.1523-1755.1999.00618.,Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
9:648. http://dx.doi.org/10   .1038/msb.2013.,Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1126/science.112829 4 Rabut, G., V. Doye, and J. Ellenberg.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1038/ncb118 4 Raices, M., and M.A.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1038/nrm346 1 Raman, R., V .",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1371/journal   .pone.001437 7 Schöneich, C., E. Dremina, N. Galeva, and V. Sharov.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1007/s10495-013-0922- 7 Simossis, V.A., and J. Heringa.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/   10.1093/nar/gki39 0 Stavru, F., G. Nautrup-Pedersen, V.C.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1083/jcb.20060100 2 Wang, T., J. Zhang, X. Zhang, C. Xu, and X. Tu.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"3:1079. http://dx.doi.org/10.1038/srep0107 9 Wozniak, R.W., and G. Blobel.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1083/jcb.119.6.144 1 Wozniak, R.W., E. Bartnik, and G. Blobel.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1083/jcb.108.6.208 3 Xie, Q., V.I.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1053/jhep.2002.3544 1 Yamamoto, K., T. Sato, T. Matsui, M. Sato, T. Okada, H. Yoshida, A. Harada, and  K. Mori.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.07.01 8 Zhang, X., S. Chen, S. Yoo, S. Chakrabarti, T. Zhang, T. Ke, C. Oberti, S.L.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/j.cell.2008.10.02 2Cronshaw, J.M., A.N.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1083/jcb.20020610 6 D’Angelo, M.A., J.S.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/   j.devcel.2011.11.02 1 de las Heras, J.I., D.G.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/j.semcancer.2012.01.00 8 Deldicque, L., P. Hespel, and M. Francaux.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1097/JES.0b013e3182355e8 c Eriksson, C., C. Rustum, and E. Hallberg.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/j.febslet.2004.07.04 4 Gerace, L., Y. Ottaviano, and C. Kondor-Koch.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.08.00 8 Greber, U.F., and L. Gerace.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
http://dx.doi   .org/10.1083/jcb.128.1.,Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1091/mbc.01-11-053 8 Hoelz, A., E.W.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1146/   annurev-biochem-060109-15103 0 Huber, M.D., T. Guan, and L. Gerace.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1128/MCB.00270-0 9 Huppertz, B., D.S.",Non-OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/S0074-7696(01)05005- 7 Liang, Y., and M.W.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/   10.1016/j.ceb.2010.09.00 8 Lupu, F., A. Alves, K. Anderson, V. Doye, and E. Lacy.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1016/j.devcel   .2008.03.01 1 Mans, B.J., V. Anantharaman, L. Aravind, and E.V.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.4161/cc.3.12.131 6 Morishima, N., K. Nakanishi, H. Takenouchi, T. Shibata, and Y. Yasuhiko.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1074/ jbc.M20497320 0 Morishima, N., K. Nakanishi, and A. Nakano.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1074/ jbc.M111.23350 2 Nakagawa, T., H. Zhu, N. Morishima, E. Li, J. Xu, B.A.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/   10.1038/4751 3 Nakamura, T., D.A.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1038/ng0296-15 4 Nakanishi, K., T. Sudo, and N. Morishima.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
"http://dx.doi.org/10.1083/jcb   .20041202 4 Nakanishi, K., K. Kakiguchi, S. Yonemura, A. Nakano, and N. Morishima.",OADS,/arxiv_data1/oa_pdf/4a/13/JCB_201410047.PMC4362455.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1089/ars.2010.386 7 Bazzoni, G., O.M.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1074/jbc.M90525119 9 Benais-Pont, G., A. Punn, C. Flores-Maldonado, J. Eckert, G. Raposo, T.P.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"160:729– 740. http://dx.doi.org/10.1083/jcb.20021104 7 Birdsey, G.M., N.H. Dryden, V. Amsellem, F. Gebhardt, K. Sahnan, D.O.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1182/blood-   2007-08-10534 6 Cavallaro, U., and E. Dejana.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/   10.1038/nrm306 8 Citi, S., P. Pulimeno, and S. Paschoud.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1111/j.1749- 6632.2012.06506. x Conway, D., and M.A.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1016/j.cub.2013.04.04 9 Cooke, V.G., M.U.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/   10.1161/01.ATV.0000234923.79173.9 9 Ebnet, K., C.U.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/   10.1083/jcb.20120209 4 Fanning, A.S., and J.M.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
http://dx.doi.org/10.1111/j.1749-6632.2009.04440.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/   10.1091/mbc.E11-09-079 1 Grashoff, C., B.D.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1038/   nature0919 8 Gutwein, P ., A. Schramme, B. V oss, M.S.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1016/j.bbrc.2009.01.10 0 Haskard, D.O., J.J. Boyle, P.C.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1111/micc.1202 0 Hoffman, B.D., C. Grashoff, and M.A.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1038/nature1031 6 Huveneers, S., and J. de Rooij.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1242/   jcs.10944 7 Huveneers, S., J. Oldenburg, E. Spanjaard, G. van der Krogt, I. Grigoriev, A.  Akhmanova, H. Rehmann, and J. de Rooij.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1083/jcb.20110812 0 Itoh, M., S. Tsukita, Y. Yamazaki, and H. Sugimoto.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201404140/DC1.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10   .1038/ncb215 6 Terry, S.J., A. Elbediwy, C. Zihni, A.R.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1371/journal.pone.005018 8 Van Itallie, C.M., A.S. Fanning, A. Bridges, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/   10.1091/mbc.E09-04-032 0 Weber, C., L. Fraemohs, and E. Dejana.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1038/nri209 6 Xiao, K., D.F.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"278:19199– 19208. http://dx.doi.org/10.1074/jbc.M21174620 0 Yamamoto, M., S.H.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.2353/ajpath.2008.07007 6 Yamazaki, Y., K. Umeda, M. Wada, S. Nada, M. Okada, S. Tsukita, and S.  Tsukita.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi   .org/10.1091/mbc.E08-04-035 2 Yonemura, S. 2011.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1002/bies.20110006 4 Yonemura, S., Y. Wada, T. Watanabe, A. Nagafuchi, and M. Shibata.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1038/ncb205 5 Yoshizaki, H., Y. Ohba, K. Kurokawa, R.E.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1083/jcb.20021204 9 Zemljic-Harpf, A.E., J.C. Godoy, O. Platoshyn, E.K.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/   10.1242/jcs.14374 3Katsuno, T., K. Umeda, T. Matsui, M. Hata, A. Tamura, M. Itoh, K. Takeuchi,  T. Fujimori, Y. Nabeshima, T. Noda, et al.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1091/mbc.E07-12-121 5 Kreis, T.E.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1158/   0008-5472.CAN-04-401 2 Lampugnani, M.G.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1101/cshperspect.a00652 8 Martin, T.A.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1016/j.semcdb.2014.09.00 8 Naik, U.P., and M.U.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1006/   mvre.1995.106 1 Nie, M., M.S.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi   .org/10.1083/jcb.20030207 0 Nomme, J., A.S. Fanning, M. Caffrey, M.F.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1074/jbc   .M111.30408 9 Ohnishi, H., T. Nakahara, K. Furuse, H. Sasaki, S. Tsukita, and M. Furuse.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1074/jbc.M40261620 0 Ooshio, T., R. Kobayashi, W. Ikeda, M. Miyata, Y. Fukumoto, N. Matsuzawa,  H. Ogita, and Y. Takai.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1074/jbc   .M109.04376 0 Peddibhotla, S.S., B.F. Brinkmann, D. Kummer, H. Tuncay, M. Nakayama, R.H.  Adams, V. Gerke, and K. Ebnet.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1074/jbc   .M111.23086 2 Severson, E.A., W.Y.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1091/mbc.E08-10-101 4 Sourisseau, T., A. Georgiadis, A. Tsapara, R.R.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/   10.1128/MCB.26.6.2387-2398.200 6 Steed, E., N.T.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"10:95. http://dx.doi.org/10.1186/1471-   2121-10-9 5 Stockton, R.A., E. Schaefer, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
"http://dx.doi.org/10.1074/jbc.M40887720 0 Sun, X.T., Y.T.",OADS,/arxiv_data1/oa_pdf/0c/f7/JCB_201404140.PMC4362456.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201412024/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10   .1101/gad.13.19.257 0 Kelley, J.B., S. Datta, C.J.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/   10.1128/MCB.05087-1 1 Keminer, O., and R. Peters.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/S0006-3495(99)76883- 9 Kitakawa, M., H.-R. Graack, L. Grohmann, S. Goldschmidt-Reisin, E. Herfurth,  B. Wittmann-Liebold, T. Nishimura, and K. Isono.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
http://dx.doi   .org/10.1111/j.1432-1033.1997.t01-2-00449.,Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1111/j.1365- 2958.2001.02317. x Laurell, E., K. Beck, K. Krupina, G. Theerthagiri, B. Bodenmiller, P. Horvath, R.  Aebersold, W. Antonin, and U. Kutay.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j.cell.2011.01.01 2 Lo, W.-S., and A.M. Dranginis.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1091/mbc.9.1.16 1 López-Otín, C., M.A.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/   10.1016/j.cell.2013.05.03 9 Makio, T., D.L.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"203:187– 196. http://dx.doi.org/10.1083/jcb.20130404 7 Menendez-Benito, V., S.J.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi   .org/10.1007/s00438005069 0 Park, P.U., M. McVey, and L. Guarente.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/S0076-   6879(02)51865- 6 Rexach, M., and G. Blobel.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/0092-8674   (95)90181- 7 Rivera-Torres, J., R. Acín-Perez, P. Cabezas-Sánchez, F.G. Osorio, C. Gonzalez- Gómez, D. Megias, C. Cámara, C. López-Otín, J.A.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j.jprot.2013.08.00 8 Rotenberg, M.O., M. Moritz, and J.L.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1101/gad.2.2.16 0 Rout, M.P., G. Blobel, and J.D.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)80254- 8 Savas, J.N., B.H.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"335:942. http://dx.doi.org/10.1126/science.121742 1 Scheckhuber, C.Q., N. Erjavec, A. Tinazli, A. Hamann, T. Nyström, and H.D.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1038/ncb152 4 Schleit, J., B.M.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1074/jbc.M00196320 0 Belhumeur, P., A. Lee, R. Tam, T. DiPaolo, N. Fortin, and M.W.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j.molcel   .2007.06.03 4 Breker, M., M. Gymrek, and M. Schuldiner.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1083/jcb.20130112 0 Chaves, S.R., and G. Blobel.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1074/ jbc.M01076020 0 Colombi, P., B.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1083/   jcb.20130511 5 Corral-Debrinski, M., N. Belgareh, C. Blugeon, M.G.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1046/j.1365-2958   .1999.01295. x D’Angelo, M.A., M. Raices, S.H.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.11.03 7 Defossez, P.A., R. Prusty, M. Kaeberlein, S.J.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80472- 4 Enenkel, C., G. Blobel, and M. Rexach.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10   .1074/jbc.270.28.1649 9 Giaever, G., A.M. Chu, L. Ni, C. Connelly, L. Riles, S. Véronneau, S. Dow, A.  Lucau-Danila, K. Anderson, B. André, et al.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1093/emboj/16.11.324 3 Halfmann, R., J.R. Wright, S. Alberti, S. Lindquist, and M. Rexach.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi   .org/10.4161/pri.2019 9 Hughes, A.L., and D.E.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1038/nature1165 4 Huh, W.-K., J.V.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1038/nature0202 6 Hülsmann, B.B., A.A. Labokha, and D. Görlich.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j.cell.2012.07.01 9 Hung, N.-J., K.-Y.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1091/mbc.E07-09-096 8 Izaurralde, E., U. Kutay, C. von Kobbe, I.W.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j.febslet   .2012.07.03 8 Schlenstedt, G., E. Smirnova, R. Deane, J. Solsbacher, U. Kutay, D. Görlich, H.  Ponstingl, and F.R.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1093/emboj/16.20.623 7 Seedorf, M., and P.A.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1083/jcb.135.2.32 9 Shulga, N., N. Mosammaparast, R. Wozniak, and D.S.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1083/jcb.149.5.102 7 Sinclair, D.A., and L. Guarente.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)80493- 6 Snow, C.J., A. Dar, A. Dutta, R.H. Kehlenbach, and B.M.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10   .1083/jcb.20121211 7 Steffen, K.K., V.L.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j.cell.2008.02.03 7 Steffen, K.K., B.K.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi   .org/10.3791/120 9 Steinkraus, K.A., M. Kaeberlein, and B.K.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1083/ jcb  .20110504 2 Strawn, L.A., T. Shen, N. Shulga, D.S.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1038/ncb109 7 Terry, L.J., and S.R.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1083/jcb.20070417 4 Timney, B.L., J. Tetenbaum-Novatt, D.S.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"175:579– 593. http://dx.doi.org/10.1083/jcb.20060814 1 Tkach, J.M., A. Yimit, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1038/ncb254 9 Toyama, B.H., J.N.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j.cell.2013.07.03 7 Tran, E.J., Y. Zhou, A.H. Corbett, and S.R.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10.1016/j   .molcel.2007.09.01 9 Wente, S.R., and M.P.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"http://dx.doi.org/10   .1101/cshperspect.a00056 2 Wente, S.R., M.P.",OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
http://dx.doi.org/10   .1083/jcb.119.4.70 5,Non-OADS,/arxiv_data1/oa_pdf/7f/2a/JCB_201412024.PMC4362458.pdf
"Thus, centrin2 regulates primary ciliogenesis through con - trolling CP110 levels.Centrin2 regulates CP110 removal in primary  cilium formation Suzanna L. Prosser and Ciaran G. Morrison Centre for Chromosome Biology, School of Natural Sciences, National University of Ireland, Galway, Galway, Ireland © 2015 Prosser and Morrison  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1007/s00018-012-0961- 1 Dantas, T.J., O.M.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1371/journal.pone.006848 7 Delaval, B., L. Covassin, N.D. Lawson, and S. Doxsey.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.4161/cc.10.22.1815 0 Dingemans, K.P.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1083/   jcb.43.2.36 1 Finetti, F., S.R.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1038/ncb197 7 Goetz, S.C., and K.V.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1016/j.cell.2012.10.01 0 Graser, S., Y.D.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi   .org/10.1083/jcb.20070718 1 Griffiths, G.M., A. Tsun, and J.C. Stinchcombe.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"189:399– 406. http://dx.doi.org/10.1083/jcb.20100202 7 Guarguaglini, G., P.I.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1091/mbc   .E04-10-093 9 Inanç, B., H. Dodson, and C.G.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1091/mbc.E10-02-012 4 Ishikawa, H., and W.F.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1038/nrm308 5 Jinek, M., K. Chylinski, I. Fonfara, M. Hauer, J.A.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1126/   science.122582 9 Kleylein-Sohn, J., J. Westendorf, M. Le Clech, R. Habedanck, Y.D.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.07.00 2 Kobayashi, T., and B.D.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1083/jcb   .20110100 5 Kohlmaier, G., J. Loncarek, X. Meng, B.F. McEwen, M.M.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1016/j   .cub.2009.05.01 8 Li, J., V. D’Angiolella, E.S.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1038/nature1194 1 Mali, P., L. Yang, K.M.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1126/science.123203 3 Mikule, K., B. Delaval, P. Kaldis, A. Jurcyzk, P. Hergert, and S. Doxsey.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1038/ncb152 9 Nigg, E.A., and T. Stearns.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1038/ncb234 5 Ou, Y.Y., G.J.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/   10.1126/science.123114 3 Dammermann, A., and A. Merdes.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1083/jcb.20020402 3 D’Angiolella, V., V. Donato, S. Vijayakumar, A. Saraf, L. Florens, M.P.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1038/nature0914 0 Dantas, T.J., Y. Wang, P. Lalor, P. Dockery, and C.G.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
http://dx.doi.org/10.1083/jcb.20101209 3,Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi   .org/10.1083/jcb.20120212 6 Schmidt, T.I., J. Kleylein-Sohn, J. Westendorf, M. Le Clech, S.B.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1016/j.cub   .2009.05.01 6 Seeley, E.S., and M.V.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi   .org/10.1083/jcb.15.2.36 3 Spektor, A., W.Y.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.06.02 7 Stinchcombe, J.C., and G.M.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"369:20130463. http://dx.doi.org/10.1098/rstb.2013.046 3 Tang, C.J., R.H. Fu, K.S.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1038/ncb188 9 Tang, Z., M.G.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi   .org/10.1038/nature1260 6 Tanos, B.E., H.J.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/   10.1101/gad.207043.11 2 Tsang, W.Y., A. Spektor, D.J.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1091/mbc.E06-04-037 1 Tsang, W.Y., C. Bossard, H. Khanna, J. Peränen, A. Swaroop, V. Malhotra, and  B.D.",Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.07.00 4 Ying, G., P. Avasthi, M. Irwin, C.D.",OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0067-14.201 4,Non-OADS,/arxiv_data1/oa_pdf/57/66/JCB_201411070.PMC4362459.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201408087/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1007/978-1-62703-239-1_1 2 Aoyama, Y., J. Avruch, and X.F.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/sj.onc.120748 6 Avruch, J., D. Zhou, J. Fitamant, N. Bardeesy, F. Mou, and L.R.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1016/j.semcdb.2012.07.00 2 Beckerman, R., and C. Prives.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1101/cshperspect   .a00093 5 Bianchi-Smiraglia, A., and M.A.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.4161/cc.2258 9 Brooks, C.L., and W. Gu.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1007/s13238-   011-1063- 9 Caldwell, M.E., G.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/onc.2011.35 0 Calvisi, D.F., F. Pinna, R. Pellegrino, V. Sanna, M. Sini, L. Daino, M.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10   .1002/ijc.2372 0 Calvisi, D.F., H. Donninger, M.D.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1158/   0008-5472.CAN-08-367 2 Calzado, M.A., L. De La Vega, E. Munoz, and M.L.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.4161/cc.8.11.859 7 Campbell, P.M., and C.J.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1016/j.semcancer.2003.09.01 5 Carter, S., and K.H.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1016/j.gde   .2008.11.01 0mouse NORE1A shRNAs (#1: 5 -GGCTGCTCAAGAAGTTCATGGTTGTG - GAC-3; #2: 5-GCGACGTGAGGAGCATCTTCGAGCAGCCG-3 ) from  Origene and have been described previously (Calvisi et al., 2009).",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1016/S0960-9822(02)00683- 8 Kuilman, T., C. Michaloglou, W.J.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1101/gad   .197161 0 Lee, D., S.J.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/embor.2011.23 5 Levine, A.J.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81871- 1 Lowe, S.W., E. Cepero, and G. Evan.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/nature0309 8 Malumbres, M., and M. Barbacid.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/nrc109 7 Matallanas, D., D. Romano, F. Al-Mulla, E. O’Neill, W. Al-Ali, P. Crespo, B.  Doyle, C. Nixon, O. Sansom, M. Drosten, et al.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.10.01 6 Morton, J.P., P. Timpson, S.A. Karim, R.A. Ridgway, D. Athineos, B. Doyle,  N.B.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.2741/381 4 Park, J., S.I.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1074/jbc.M110.16550 6 Pearson, M., R. Carbone, C. Sebastiani, M. Cioce, M. Fagioli, S. Saito, Y.  Higashimoto, E. Appella, S. Minucci, P.P.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/3502100 0 Poon, C.L., X. Zhang, J.I.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10   .1016/j.cub.2012.06.07 5 Prieur, A., and D.S.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10   .1016/j.ceb.2008.01.00 7 Puca, R., L. Nardinocchi, D. Givol, and G. D’Orazi.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1038/onc.2010.18 3 Pylayeva-Gupta, Y., E. Grabocka, and D. Bar-Sagi.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1038/nrc310 6 Ramirez, R.D., S. Sheridan, L. Girard, M. Sato, Y. Kim, J. Pollack, M. Peyton,  Y. Zou, J.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-04-370 3 Rinaldo, C., A. Prodosmo, F. Siepi, A. Moncada, A. Sacchi, G. Selivanova,  and S. Soddu.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-033 7 Ringshausen, I., C.C.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1016/j   .ccr.2006.10.01 0 Schubbert, S., K. Shannon, and G. Bollag.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1038/nrc210 9 Serrano, M., A.W.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)81902- 9 Studebaker, A.W., G. Storci, J.L.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/   10.1016/S1535-6108(03)00269- 1 Chen, X., N. Mitsutake, K. LaPerle, N. Akeno, P. Zanzonico, V.A.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/nature0391 8 Collado, M., and M. Serrano.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/   nrc277 2 Collado, M., J. Gil, A. Efeyan, C. Guerra, A.J.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1016/j.ccr.2006.10.00 3 Cox, A.D., and C.J.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/sj.onc.120711 1 Dimauro, T., and G. David.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1016/j.yexcr.2003.09.03 2 Di Stefano, V ., M. Mattiussi, A. Sacchi, and G. D’Orazi.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1016/j   .febslet.2005.09.00 8 Di Stefano, V., S. Soddu, A. Sacchi, and G. D’Orazi.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/sj.onc.120871 7 Donninger, H., M.D.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1242/jcs.01038 9 D’Orazi, G., B. Cecchinelli, T. Bruno, I. Manni, Y. Higashimoto, S. Saito, M.  Gostissa, S. Coen, A. Marchetti, G. Del Sal, et al.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/ncb71 4 D’Orazi, G., C. Rinaldo, and S. Soddu.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"31:63.  http://dx.doi.org/10.1186/1756-9966-31-6 3 Ellis, C.A., M.D.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10   .1073/pnas.14219379 9 Fausti, F., S. Di Agostino, A. Sacconi, S. Strano, and G. Blandino.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10   .1016/S0960-9822(02)00787- X Ferbeyre, G., E. de Stanchina, A.W.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1128/MCB.22.10.3497-3508.200 2 Gu, B., and W.G.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/   10.7150/ijbs.428 3 Hofmann, T.G., A. Möller, H. Sirma, H. Zentgraf, Y. Taya, W. Dröge, H. Will,  and M.L.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/ncb71 5 Kennedy, A.L., J.P. Morton, I. Manoharan, D.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
http://dx.doi.org/10.1016/j.molcel.2011.02.02 0,OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi.org/10.1038/3504267 5 Vos, M.D., A. Martinez, C.A.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"http://dx.doi   .org/10.1074/jbc.M21101920 0 Watsuji, T., Y. Okamoto, N. Emi, Y. Katsuoka, and M. Hagiwara.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
"234:769– 773. http://dx.doi.org/10.1006/bbrc.1997.670 5 Xie, Q., J. Chen, H. Feng, S. Peng, U. Adams, Y. Bai, L. Huang, J. Li, J. Huang,  S. Meng, and Z. Yuan.",OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
http://dx.doi.org/10   .1158/0008-5472.CAN-12-379 3,Non-OADS,/arxiv_data1/oa_pdf/7f/d8/JCB_201408087.PMC4362463.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10   .1083/jcb.20110301 8 Arimura, S., A. Matsunaga, T. Kitamura, K. Aoki, M. Aoki, and M.M.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1053/j.gastro.2009.04.05 9 Bach, E.A., L.A. Ekas, A. Ayala-Camargo, M.S.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"7:323– 331. http://dx.doi.org/10.1016/j.modgep.2006.08.00 3 Beachy, P.A., S.S. Karhadkar, and D.M.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/   10.1038/nature0310 0 Berman, D.M., S.S. Karhadkar, A. Maitra, R. Montes De Oca, M.R.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1007/s00018-012-1152- 9 Biteau, B., and H. Jasper.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"7:1867– 1875. http://dx.doi.org/10.1016/j.celrep.2014.05.02 4 Biteau, B., C.E.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.stem.2011.10.00 4 Briscoe, J., and P.P.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1038/nrm359 8 Buchon, N., N.A.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.chom.2009.01.00 3 Buchon, N., D. Osman, F.P.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.04.00 1 Chen, Y., and G. Struhl.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/   10.1038/emboj.2012.24 8 Fendrich, V., F. Esni, M.V.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10   .1053/j.gastro.2008.04.01 1 Goulas, S., R. Conder, and J.A.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.stem.2012.06.01 7 Gu, D., Q.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1074/jbc.M112.37738 2 Guo, Z., I. Driver, and B. Ohlstein.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"201:945– 961. http://dx.doi.org/10.1083/jcb.20130204 9 Hsu, Y.C., L. Li, and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/   10.1016/j.cell.2014.02.05 7 Jiang, H., and B.A.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/   j.gde.2012.04.00 2 Jiang, H., P.H.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201409025/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
Additional  data are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201409025.d v. We thank Drs.,Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi   .org/10.1016/j.stem.2008.10.01 6 Amcheslavsky, A., N. Ito, J. Jiang, and Y.T.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1038/cr.2013.10 1 Scopelliti, A., J.B. Cordero, F. Diao, K. Strathdee, B.H.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.cub.2014.04.00 7 Shaw, R.L., A. Kohlmaier, C. Polesello, C. Veelken, B.A.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1242/dev.05250 6 Shin, K., J. Lee, N. Guo, J. Kim, A. Lim, L. Qu, I.U.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80332- 3 Staley, B.K., and K.D.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.cub.2010.07.04 1 Taipale, J., and P.A.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1038/3507721 9 Tian, A., and J. Jiang.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1038/ng130 4 Varnat, F., A. Duquet, M. Malerba, M. Zbinden, C. Mas, P. Gervaz, and A.  Ruiz i Altaba.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1002/emmm.20090003 9 Varnat, F., G. Zacchetti, and A. Ruiz i Altaba.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi   .org/10.1016/j.mod.2009.10.00 5 Wang, G., K. Amanai, B. Wang, and J. Jiang.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10   .1101/gad.84390 0 Weston, C.R., and R.J. Davis.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.ceb.2007   .02.00 1 Xu, N., S.Q.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.ydbio.2011   .03.01 8 Yauch, R.L., S.E.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/   10.1038/nature0727 5 Zeng, X., C. Chauhan, and S.X.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"48:607– 611. http://dx.doi.org/10.1002/dvg.2066 1 Zhang, W., Y. Zhao, C. Tong, G. Wang, B. Wang, J. Jia, and J. Jiang.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.01.00 1 Zhou, F., A. Rasmussen, S. Lee, and H. Agaisse.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
http://dx.doi.org/10.1016/j.ydbio.2012.10.02 3homeostasis in the Drosophila  midgut.,OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi   .org/10.1016/j.stem.2010.11.02 6 Jiang, J., and C.C.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.11.01 0 Kapuria, S., J. Karpac, B. Biteau, D. Hwangbo, and H. Jasper.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1371/journal.pgen.100304 5 Karpowicz, P., J. Perez, and N. Perrimon.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1242/dev.06048 3 Lee, T., and L. Luo.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/S0166-2236(00)01791- 4 Lee, W.C., K. Beebe, L. Sudmeier, and C.A.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1242/dev.03519 6 Li, Z., Y. Zhang, L. Han, L. Shi, and X. Lin.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1016/j.stemcr   .2013.12.01 1 Madison, B.B., K. Braunstein, E. Kuizon, K. Portman, X.T.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1242/   dev.0157 6 Marianes, A., and A.C. Spradling.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/   10.1016/S0960-9822(01)00178- 6 McGuire, S.E., Z. Mao, and R.L.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi   .org/10.1038/nature0437 1 Nakano, Y., I. Guerrero, A. Hidalgo, A. Taylor, J.R. Whittle, and P.W.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1038/341508a 0 Ochoa, B., W.K.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1002/hep.2352 5 Ohlstein, B., and A. Spradling.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi   .org/10.1038/nature0433 3 Ohlstein, B., and A. Spradling.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10.1126/science.113660 6 Peng, Y.C., C.M.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/10   .1242/dev.06529 2 Petrova, R., and A.L.",OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
"http://dx.doi.org/   10.1242/dev.08369 1 Ramalho-Santos, M., D.A.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
http://dx.doi.org/   10.1073/pnas.101275910 7,Non-OADS,/arxiv_data1/oa_pdf/fb/57/JCB_201409025.PMC4362464.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
Online supple - mental material is available at http://www.jcb.org/cgi/content/full/jcb   .201409056/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"430:111– 145. http://dx.doi.org/10.1016/S0076-6879(07)30006- 2 Adilakshmi, T., D.L.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
http://dx.doi.org/10.1038/nature0729 8demonstrate that at higher concentrations 1-NAPP1 and/or the DMSO sol - vent destabilize pre-40S ribosomes.,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/nsmb.240 3 Fiedler, D., H. Braberg, M. Mehta, G. Chechik, G. Cagney, P. Mukherjee,  A.C. Silva, M. Shales, S.R.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.cell.2008.12.03 9 Flotow, H., P.R.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/nrm210 6 Gavin, A.C., P. Aloy, P. Grandi, R. Krause, M. Boesche, M. Marzioch, C. Rau,  L.J.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/nature0453 2 Ghoshal, N., J.F.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)65219- 4 Granneman, S., and S.J.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j   .yexcr.2004.03.01 6 Grozav, A.G., K. Chikamori, T. Kozuki, D.R.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"37:382– 392. http://dx.doi.org/10.1093/nar/gkn93 4 Hage, A.E., and D. Tollervey.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.4161/rna.1.1.93 2 Held, W.A., B. Ballou, S. Mizushima, and M. Nomura.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1007/s00018-008-8027- 0 Hirner, H., C. Günes, J. Bischof, S. Wolff, A. Grothey, M. Kühl, F. Oswald, F.  Wegwitz, M.R.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1371/journal.pone.002970 9 Ho, Y., S. Mason, R. Kobayashi, M. Hoekstra, and B. Andrews.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/415180 a Hoekstra, M.F., R.M.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/nsmb71 9 Huh, W.K., J.V.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/nature0202 6 Ikeda, K., O. Zhapparova, I. Brodsky, I. Semenova, J.S.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1091/mbc.E10-09-074 1 Ito, T., T. Chiba, R. Ozawa, M. Yoshida, M. Hattori, and Y. Sakaki.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1073/pnas.06103449 8 Kafadar, K.A., H. Zhu, M. Snyder, and M.S.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1101/gad.114060 3Armistead, J., and B. Triggs-Raine.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1124/jpet.107.12284 6 Behrend, L., M. Stöter, M. Kurth, G. Rutter, J. Heukeshoven, W. Deppert, and   U. Knippschild.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1078/S0171-9335(04)70027- 8 Ben-Shem, A., N. Garreau de Loubresse, S. Melnikov, L. Jenner, G. Yusupova,  and M. Yusupov.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1126/   science.121264 2 Bhandari, D., J. Zhang, S. Menon, C. Lord, S. Chen, J.R.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1091/mbc   .E13-02-011 4 Bibian, M., R.J. Rahaim, J.Y.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.bmcl.2013.05.07 5 Bishop, A.C., J.A.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/3503014 8 Breitkreutz, A., H. Choi, J.R. Sharom, L. Boucher, V. Neduva, B. Larsen, Z.Y.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1126/science.117649 5 Breker, M., M. Gymrek, O. Moldavski, and M. Schuldiner.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1093/nar/gkt93 3 Brockschmidt, C., H. Hirner, N. Huber, T. Eismann, A. Hillenbrand, G.  Giamas, B. Radunsky, O. Ammerpohl, B. Bohm, D. Henne-Bruns, et al.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1136/   gut.2007.12369 5 Bryant, C.D., C.C.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/   10.1038/npp.2011.28 7 Butler, A.R., J.H.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1128/MCB.14.9.630 6 Campbell, M.G., and K. Karbstein.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1371/ journal.pone.001619 4 Carron, C., M.F.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1093/   nar/gkq73 4 Clatterbuck Soper, S.F., R.P.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"52:506– 516. http://dx.doi.org/10.1016/j.molcel.2013.09.02 0 Eide, E.J., H. Kang, S. Crapo, M. Gallego, and D.M.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"393:408– 418. http://dx.doi.org/10.1016/S0076-6879(05)93019- X Fasolo, J., A. Sboner, M.G.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1101/gad   .199881 1 Fassio, C.A., B.J.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
http://dx.doi.org/10.1534/genetics.11 0  .11558 4,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06811.,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/   10.1534/genetics.114.16829 4 Mizushima, S., and M. Nomura.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/   2261214a 0 Narla, A., and B.L.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1182/blood-   2009-10-17812 9 Panse, V.G.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.2533/   chimia.2011.76 5 Perez, D.I., C. Gil, and A. Martinez.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1002/med.2020 7 Perreau-Lenz, S., V. Vengeliene, H.R.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/npp.2012.6 2 Petronczki, M., J. Matos, S. Mori, J. Gregan, A. Bogdanova, M. Schwickart, K.  Mechtler, K. Shirahige, W. Zachariae, and K. Nasmyth.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.cell.2006.07.02 9 Pfaffenwimmer, T., W. Reiter, T. Brach, V. Nogellova, D. Papinski, M.  Schuschnig, C. Abert, G. Ammerer, S. Martens, and C. Kraft.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.15252/   embr.20143893 2 Price, M.A.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1101/gad.139430 6 Price, M.A., and D. Kalderon.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1016/S0092-8674(02)00664- 5 Ptacek, J., G. Devgan, G. Michaud, H. Zhu, X. Zhu, J. Fasolo, H. Guo,   G. Jona, A. Breitkreutz, R. Sopko, et al.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1038/nature0418 7 Ray, P., U. Basu, A. Ray, R. Majumdar, H. Deng, and U. Maitra.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"283:9681– 9691. http://dx.doi.org/10.1074/jbc.M71029420 0 Rieder, S.E., and S.D.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1002/emmm.20110109 4 Rodríguez-Galán, O., J.J. García-Gómez, and J. de la Cruz.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1016/j.bbagrm.2013.01.00 7 Rosenberg, L.H., M. Lafitte, W. Grant, W. Chen, M. Bibian, Y. Noguchi, M.  Fallahi, W.R. Roush, J.L.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/nrc101 5 Ruggero, D., S. Grisendi, F. Piazza, E. Rego, F. Mari, P.H.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.cbpa.2011.07.02 3 Karbstein, K. 2013.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.tcb.20 13  .01.00 4 Knippschild, U., D.M.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/sj.onc.120154 1 Knippschild, U., A. Gocht, S. Wolff, N. Huber, J. Löhler, and M. Stöter.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1016/j.cellsig.2004.12.01 1 Knippschild, U., S. Wolff, G. Giamas, C. Brockschmidt, M. Wittau, P.U.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1159/00008713 7 Knippschild, U., M. Krüger, J. Richter, P. Xu, B. García-Reyes, C. Peifer, J.  Halekotte, V. Bakulev, and J. Bischof.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"4:96. http://dx.doi.org/10.3389/fonc.2014.0009 6 Koch, B., V. Mitterer, J. Niederhauser, T. Stanborough, G. Murat, G. Rechberger,  H. Bergler, D. Kressler, and B. Pertschy.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1074/jbc.M112.36579 1 Kurihara, T., E. Sakurai, M. Toyomoto, I. Kii, D. Kawamoto, T. Asada, T.  Tanabe, M. Yoshimura, M. Hagiwara, and A. Miyata.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"10:17. http://dx.doi.org/10.1186/1744-8069-10-1 7 Lafontaine, D.L., and D. Tollervey.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/3508004 5 Lander, G.C., S.M.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.jsb.2009.01.00 2 Lebaron, S., C. Schneider, R.W.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1038/nsmb.230 8 Li, G., H. Yin, and J. Kuret.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1074/jbc.M31411620 0 Li, H., C.K.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/nature0502 0 Li, D., S. Herrera, N. Bubula, E. Nikitina, A.A. Palmer, D.A.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
http://dx.doi.org/10.1111/ j.1471-4159.2011.07308.,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1534/genetics.104.03265 6 Longtine, M.S., A. McKenzie III, D.J.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2- U Lord, C., D. Bhandari, S. Menon, M. Ghassemian, D. Nycz, J. Hay, P. Ghosh,  and S. Ferro-Novick.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1038/nature0996 9 Lövgren, J.M., G.O.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi   .org/10.1261/rna.772020 4 Ludtke, S.J., P.R.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1006/jsbi.1999.417 4 Martin, R., A.U.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
http://dx.doi   .org/10.4161/rna.2187 9,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1126/science.285.5429.90 1 Wolff, S., M. Stöter, G. Giamas, M. Piesche, D. Henne-Bruns, G. Banting, and  U. Knippschild.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1534/genetics.113.15319 7 Yasojima, K., J. Kuret, A.J.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/S0006-8993(00)02200- 9 Zemp, I., and U. Kutay.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/   j.febslet.2007.05.01 3 Zemp, I., T. Wild, M.F.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"127:1242– 1253. http://dx.doi.org/10.1242/jcs.13871 9 Zoncu, R., A. Efeyan, and D.M.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"12:21– 35. http://dx.doi.org/10.1038/nrm302 5Rumpf, C., L. Cipak, A. Dudas, Z. Benko, M. Pozgajova, C.G.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.4161/cc.9.13.1214 6 Schäfer, T., B. Maco, E. Petfalski, D. Tollervey, B. Böttcher, U. Aebi, and E.  Hurt.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1038/   nature0484 0 Scheres, S.H.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.jmb.2011.11.01 0 Schmelzle, T., and M.N.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)00117- 3 Schwab, C., A.J.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"21:503– 510. http://dx.doi.org/10.1016/S0197-4580(00)00110- X Seiser, R.M., A.E.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1534/genetics.106.06211 7 Shrum, D.C., B.W.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.jsb.2012.07.00 9 Smadja Storz, S., A. Tovin, P. Mracek, S. Alon, N.S.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1371/journal   .pone.005418 9 Sprouse, J., L. Reynolds, T.A.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1007/s00213-009-1503- x Sprouse, J., L. Reynolds, R. Kleiman, B. Tate, T.A.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1007/   s00213-010-1860- 5 Stöter, M., A.M. Bamberger, B. Aslan, M. Kurth, D. Speidel, T. Löning, H.G.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1038/sj.onc.120894 1 Strunk, B.S., and K. Karbstein.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1261/rna.179210 9 Strunk, B.S., C.R.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1126/science.120824 5 Strunk, B.S., M.N.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04   .044 Stumpf, C.R., and D. Ruggero.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1016/j.gde.2011   .03.00 7 Suloway, C., J. Pulokas, D. Fellmann, A. Cheng, F. Guerra, J. Quispe, S. Stagg,  C.S.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1016/j.jsb.2005.03.01 0 Tanaka, C., L.J.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1146/   annurev.biochem.78.070907.10304 7 Thomson, E., S. Ferreira-Cerca, and E. Hurt.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10.1242/   jcs.11194 8 Toyoshima, M., H.L.",OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
"http://dx.doi.org/10   .1073/pnas.112111910 9 Tsai, I.C., M. Woolf, D.W. Neklason, W.W. Branford, H.J.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
http://dx.doi   .org/10.1002/ijc.2236 8,Non-OADS,/arxiv_data1/oa_pdf/cb/a2/JCB_201409056.PMC4362465.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201408064/DC 1.were then thawed, resuspended in immunoprecipitation buffer (100 mM   KCl, 50 mM Tris, pH 7.5, 1 mM MgCl 2, 1 mM DTT, 5% glycerol, 0.05%  NP-40, 1 mM EDTA, and protease and phosphatase inhibitor cocktail  [Roche]), and frozen in liquid nitrogen.",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1038/nature0718 5 Nishi, Y., E. Rogers, S.M.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1242/dev   .01342 5 Noatynska, A., C. Panbianco, and M. Gotta.",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1242/dev.05529 3 O’Rourke, S.M., C. Carter, L. Carter, S.N.",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi   .org/10.1371/journal.pone.001664 4 Praitis, V., E. Casey, D. Collar, and J. Austin.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1083/jcb.20071001 8 Rothbauer, U., K. Zolghadr, S. Muyldermans, A. Schepers, M.C.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"7:282– 289. http://dx.doi.org/10.1074/mcp.M700342-MCP20 0 Sambrook, J., E.F. Fristch, and T. Maniatis.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1126/science   .115742 5 Sulston, J.E., E. Schierenberg, J.G.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1016/0012-1606(83)90201- 4 Taus, T., T. Köcher, P. Pichler, C. Paschke, A. Schmidt, C. Henrich, and K.  Mechtler.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10   .1021/pr200611 nWe thank V. Doye and P. Meraldi for critical reading of the manuscript, the  Caenorhabditis Genetics  Center (funded by the National Institutes of Health  Center for Research Resources) and the National BioResource Project C. elegans   for providing strains, and E. Nigg, T. Hyman, and B. Bowerman for strains  and reagents.",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1038/nrm265 3 Brenner, S. 1974.",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1016/j.tibs.2012.09.00 5 Budirahardja, Y., and P. Gönczy.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"135:1303– 1313. http://dx.doi.org/10.1242/dev.01907 5 Chan, E.H., A. Santamaria, H.H.",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1007/s00412-   008-0165- 5 Chase, D., C. Serafinas, N. Ashcroft, M. Kosinski, D. Longo, D.K.",Non-OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1002/(SICI)1526- 968X(200001)26:1<26::AID-GENE6>3.0.CO;2- O Decker, M., S. Jaensch, A. Pozniakovsky, A. Zinke, K.F.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1016/j.cub.2011.06.00 2 Deppe, U., E. Schierenberg, T. Cole, C. Krieg, D. Schmitt, B. Yoder, and   G. von Ehrenstein.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1126/science.107907 9 Elia, A.E., P. Rellos, L.F. Haire, J.W.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1016/   S0092-8674(03)00725- 6 Herman, R.K. 1978.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
"http://dx.doi.org/10.1016/   j.devcel.2006.06.00 2 James, P., J. Halladay, and E.A.",OADS,/arxiv_data1/oa_pdf/8f/75/JCB_201408064.PMC4362466.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"85:128– 136. http://dx.doi.org/10.1095/biolreprod.111.09120 7 Brouwers, J.F., M. Aalberts, J.W.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1002/pmic.20120034 8 Brown, T.C., S.S. Correia, C.N.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"27:13311– 13315. http://dx.doi.org/10.1523/JNEUROSCI.4258-07.200 7 Caldeira, M.V., C.V. Melo, D.B.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"35:208– 219. http://dx.doi.org/10.1016/j.mcn.2007.02.01 9 Christian, A.E., M.P.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1113/jphysiol.2010.19158 5 Deutsch, J.W., and R.B.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"279:39989– 39998. http://dx.doi.org/10.1074/jbc.M40108020 0 Frank, C., S. Rufini, V. Tancredi, R. Forcina, D. Grossi, and G. D’Arcangelo.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1016/j.expneurol.2008.04.01 9 Gähwiler, B.H., M. Capogna, D. Debanne, R.A. McKinney, and S.M.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/S0166-2236(97)01122- 3 Gamba, P., G. Testa, B. Sottero, S. Gargiulo, G. Poli, and G. Leonarduzzi.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1111/j.1749- 6632.2012.06513. x Gerges, N.Z., D.S.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1074/ jbc.M40498220 0 Goslin, K., and G. Banker.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"108:1507– 1516. http://dx.doi.org/10.1083/jcb.108.4.150 7 Granger, A.J., Y. Shi, W. Lu, M. Cerpas, and R.A. Nicoll.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1038/nature1177 5 Hansen, M.D., and W.J.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00091- 4 Hao, M., S.X.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1074/jbc.M10886120 0 Hao, M., S. Mukherjee, Y.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1074/ jbc.M30979320 0 Hayashi, Y., S.H.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"287:2262– 2267. http://dx.doi.org/10.1126/science.287.5461.226 2 Hering, H., C.C.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
Online supplemental mate - rial is available at http://www.jcb.org/cgi/content/full/jcb.201407122/ DC1.,Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201407122.d v. We thank the personnel at the fluorescence microscopy facility of the Centro  de Biología Molecular “Severo Ochoa” (Servicio de Microscopía Óptica y  Confocal) for their expert technical assistance, and members of the Esteban  laboratory for their critical reading of the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1128/MCB.06113-1 1 Aoki, K., T. Nakamura, K. Fujikawa, and M. Matsuda.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1091/mbc.E04-10-090 4 Arendt, K.L., M. Benoist, A. Lario, J.E.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1242/jcs.15655 4 Björkhem, I., and S. Meaney.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1161/01.ATV.0000120374.59826.1 b Bligh, E.G., and W.J.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10   .1139/o59-09 9 Bliss, T.V., and G.L.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1038/361031a 0 Boehm, J., M.G.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.06.01 3 Brouwers, J.F., A. Boerke, P.F.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1091/mbc.E07-09-089 7 Martin, M.G., L. Trovò, S. Perga, A. Sadowska, A. Rasola, F. Chiara, and  C.G.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.15252/emmm.20130371 1 Mayor, S., S. Sabharanjak, and F.R.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1093/emboj/17.16.462 6 Mercer, A.J., R.J. Szalewski, S.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1152/   jn.00779.201 1 Monyer, H., N. Burnashev, D.J.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1016/0896-6273(94)90210- 0 Murakoshi, H., H. Wang, and R. Yasuda.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1038/nature0982 3 Ohtani, Y., T. Irie, K. Uekama, K. Fukunaga, and J. Pitha.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
http://dx.doi.org/10.1111/j.1432-1033.1989   .tb15171.,Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1152/jn.00941.200 3 Park, M., E.C.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1126/science.110202 6 Passafaro, M., V. Piëch, and M. Sheng.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1038/nn0901-91 7 Pfrieger, F.W.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.4445-08.200 9 Rodriguez-Fraticelli, A.E., S. Vergarajauregui, D.J.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1083/jcb.20100204 7 Rouser, G., S. Fkeischer, and A. Yamamoto.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1007/BF0253131 6 Shepherd, J.D., and R.L.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.23.090506.12351 6 Shi, S., Y. Hayashi, J.A.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/S0092-   8674(01)00321- X Shimada, Y., M. Maruya, S. Iwashita, and Y. Ohno-Iwashita.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
http://dx.doi.org/10.1046/j.1432-1033.2002.03338.,Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1038/   nrm297 7 Smith, A.J., S. Sugita, and M.P.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0170-10.201 0 Sodero, A.O., L. Trovò, F. Iannilli, P. Van Veldhoven, C.G.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
http://dx.doi.org/10.1111/j.1471-4159.2010.07079.,Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1091/mbc   .E02-01-002 5 Hölttä-Vuori, M., R.L.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
http://dx.doi.org/10.1111/j.1600-0854.2008.00801.,Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/j.mcn.2008.02.01 0 Huganir, R.L., and R.A. Nicoll.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/j.neuron   .2013.10.02 5 Jaksits, S., W. Bauer, E. Kriehuber, M. Zeyda, T.M.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.4049/   jimmunol.173.3.162 8 Kennedy, M.J., and M.D.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1146/annurev.neuro.29.051605.11280 8 Kim, I.H., H. Wang, S.H.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"3:02839.  http://dx.doi.org/10.7554/eLife.0283 9 Klein, U., G. Gimpl, and F. Fahrenholz.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1021/bi00042a00 9 Kopec, C.D., B. Li, W. Wei, J. Boehm, and R. Malinow.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.3918-05.200 6 Kotti, T.J., D.M.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/j.plipres.2011.11.00 4 Linetti, A., A. Fratangeli, E. Taverna, P. Valnegri, M. Francolini, V. Cappello,  M. Matteoli, M. Passafaro, and P. Rosa.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/j.neuropharm.2014.05.02 7 Lippincott-Schwartz, J., and R.D.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1126/science.109661 5 Malinow, R., and R.C.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1146/ annurev.neuro.25.112701.14275 8 Malinow, R., Y. Hayashi, M. Maletic-Savatic, S.H.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1101/pdb.prot540 6 Mans, R.A., N. Chowdhury, D. Cao, L.L.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/j.neuroscience.2009   .12.06 2 Marks, D.L., R. Bittman, and R.E.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1007/   s00418-008-0509- 5 Martin, M.G., S. Perga, L. Trovò, A. Rasola, P. Holm, T. Rantamäki, T. Harkany,  E. Castrén, F. Chiara, and C.G.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1016/j.neurobiolaging.2010.06.00 1 Sodero, A.O., J. Vriens, D. Ghosh, D. Stegner, A. Brachet, M. Pallotto, M.  Sassoè-Pognetto, J.F.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1038/emboj.2012.3 1 Suzuki, R., H.A.",OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1371/journal.pbio.100153 2 Ullrich, O., S. Reinsch, S. Urbé, M. Zerial, and R.G.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1083/jcb.135.4.91 3 Valenza, M., D. Rigamonti, D. Goffredo, C. Zuccato, S. Fenu, L. Jamot, A.  Strand, A. Tarditi, B. Woodman, M. Racchi, et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3355-05.200 5 Valenza, M., V. Leoni, J.M.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.0917-10.201 0 Xie, C., N. Li, Z.J.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
"http://dx.doi.org/10.1074/jbc.M111.27019 9 Zidovetzki, R., and I. Levitan.",Non-OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
http://dx.doi.org/10   .1016/j.bbamem.2007.03.02 6,OADS,/arxiv_data1/oa_pdf/4b/d2/JCB_201407122.PMC4362467.pdf
This article is distributed under the terms of an Attribution–Noncommercial–  Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
Online supplemental material is available at http://www.jcb .org/cgi/content/full/jcb.201409111/DC1.,Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.4274/Jcrpe.831 Berkner, K.L., M. Harbeck, S. Lingenfelter, C. Bailey, C.M.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi  .org/10.1073/pnas.89.14.6242 Brennan-Speranza, T.C., H. Henneicke, S.J.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.3945/ajcn.111.016642 Chappard, D., S. Palle, C. Alexandre, L. Vico, and G. Riffat.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/S0065-   1281(87)80012-0culture from bone marrow according to standard protocols (Owen and Pan,  2008).",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/0006-2952(95)00202-B Hammed, A., B. Matagrin, G. Spohn, C. Prouillac, E. Benoit, and V. Lattard.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1074/jbc   .M113.457119 Hauschka, P.V., and S.A. Carr.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1021/ bi00539a038 Hauschka, P.V., J.B. Lian, D.E.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/ 10.1083/jcb.200809113 Hoang, Q.Q., F. Sicheri, A.J.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1038/nature02079 Hwang, Y.C., I.K.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1002/dmrr.1045 Ingram, B.O., J.L.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/  10.1042/BJ20130639 Kanazawa, I., T. Yamaguchi, M. Yamauchi, M. Yamamoto, S. Kurioka, S.  Yano, and T. Sugimoto.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10   .1007/s00198-010-1184-7 Karsenty, G., and M. Ferron.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1038/nature10763 Knapen, M.H., L.J.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1017/S000711451100626X Lacombe, J., G. Karsenty, and M. Ferron.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/j.molmet.2013.08.004 Lee, N.K., H. Sowa, E. Hinoi, M. Ferron, J.D.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/  10.1016/j.cell.2007.05.047 Levinger, I., R. Zebaze, G. Jerums, D.L.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1007/ s00198-010-1370-7 Li, T., C.Y.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1038/nature02254 Lu, C., K.K.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"97:4106– 4114. http://dx.doi.org/10.1210/jc.2012-2045 Malashkevich, V.N., S.C. Almo, and T.L.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi  .org/10.1021/bi4010254 Merle, B., and P.D.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/0169-6009(90)90062-K Mizokami, A., Y. Yasutake, J. Gao, M. Matsuda, I. Takahashi, H. Takeuchi, and  M. Hirata.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1371/journal.pone.0057375 Mori, K., M. Emoto, K. Motoyama, E. Lee, S. Yamada, T. Morioka, Y. Imanishi,  T. Shoji, and M. Inaba.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"4:53. http://dx.doi.org/10.1186/1758-5996-4-53 Oury, F., G. Sumara, O. Sumara, M. Ferron, H. Chang, C.E.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1002/dmrr.2509 Chomczynski, P., and N. Sacchi.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10 .1038/nprot.2006.83 Chu, P.H., T.Y.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi  .org/10.1182/blood-2013-12-545988 Dacquin, R., M. Starbuck, T. Schinke, and G. Karsenty.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/   10.1210/jc.2002-020896 Diamanti-Kandarakis, E., S. Livadas, I. Katsikis, C. Piperi, A. Mantziou, A.G.  Papavassiliou, and D. Panidis.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"29:207) http://dx.doi.org/10.1007/s00774-010-0211-2 Díaz-López, A., M. Bulló, M. Juanola-Falgarona, M.A.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1210/jc.2013-2472 Dowd, T.L., J.F.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/S0925-  4439(00)00094-6 Ducy, P., and G. Karsenty.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi   .org/10.1038/382448a0 Ferron, M., and J. Lacombe.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/j.abb.2014.05.022 Ferron, M., E. Hinoi, G. Karsenty, and P. Ducy.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/j.cell.2010.06.003 Ferron, M., J. Wei, T. Yoshizawa, P. Ducy, and G. Karsenty.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/j.bbrc.2010.06.008 Ferron, M., M.D.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10  .1016/j.bone.2011.04.017 Fulzele, K., R.C.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/  j.cell.2010.06.002 Furusyo, N., T. Ihara, T. Hayashi, H. Ikezaki, K. Toyoda, E. Ogawa, K. Okada,  M. Kainuma, M. Murata, and J. Hayashi.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1007/s12020-012-9803-z Groenen-Van Dooren, M.M., J.E.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"62:2866– 2871. http://dx.doi.org/10.1021/ja01867a066 Turner, R.C., R.R.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1172/JCI112182 Wang, Q., B. Zhang, Y. Xu, H. Xu, and N. Zhang.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"2013:842598.  http://dx.doi.org/10.1155/2013/842598 Wei, J., M. Ferron, C.J.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.2337/db13-0887 Westhofen, P., M. Watzka, M. Marinova, M. Hass, G. Kirfel, J. Müller, C.G.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1074/jbc.M110.210971 Xu, X., C. Li, L. Garrett-Beal, D. Larson, A. Wynshaw-Boris, and C.X.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1002/gene.1025 Yoshikawa, Y., A. Kode, L. Xu, I. Mosialou, B.C.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1002/jbmr.417 Zhang, M., S. Xuan, M.L.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi   .org/10.1074/jbc.M208265200 Zhou, B., H. Li, L. Xu, W. Zang, S. Wu, and H. Sun.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
http://dx.doi.org/10.1210/   en.2012-2144of male fertility by the skeleton.,Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10 .1016/j.cell.2011.02.004 Oury, F., M. Ferron, W. Huizhen, C. Confavreux, L. Xu, J. Lacombe, P. Srinivas,  A. Chamouni, F. Lugani, H. Lejeune, et al.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1172/JCI65952 Oury, F., L. Khrimian, C.A.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/j.cell.2013.08.042 Owen, T.A., and L.C.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1007/978-  1-59745-104-8_1 Pi, M., L. Chen, M.Z.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1371/journal.pone.0003858 Pi, M., Y. Wu, and L.D.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1002/jbmr.390 Polgreen, L.E., D.R.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1038/oby.2012.108 Pollock, N.K., P.J.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi  .org/10.1210/jc.2010-2731 Price, P.A., M.K.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/  10.1073/pnas.79.24.7734 Rached, M.T., A. Kode, B.C.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi .org/10.1172/JCI39901 Riddle, R.C., J.L.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/   10.1128/MCB.00075-14 Robertson, H.M. 2004.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1534/genetics.104.029744 Rost, S., A. Fregin, V. Ivaskevicius, E. Conzelmann, K. Hörtnagel, H.J.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10  .1038/nature02214 Schwenk, F., U. Baron, and K. Rajewsky.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/ 10.1093/nar/23.24.5080 Shea, M.K., C.M.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"90:1230– 1235. http://dx.doi.org/10.3945/ajcn.2009.28151 Spohn, G., A. Kleinridders, F.T.",Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1111/j.1538-7836.2005.01419.x Tie, J.K., and D.W. Stafford.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1016/  S0083-6729(07)00006-4 Tie, J.K., D.Y.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi.org/10.1111/jth.12306 Tie, J.K., D.Y.",OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
http://dx.doi.org/10.1074/jbc.M113.534446,Non-OADS,/arxiv_data1/oa_pdf/58/99/JCB_201409111.PMC4362468.pdf
"http://dx.doi   .org/10.1083/jcb.20140902 6) report a parallel path - way, mediated by Wnt signaling, Snail1, and paraxial  protocadherin (PAPC).",OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"However, there is strong evidence that this is not the  case, for example, because PAPC overexpression does not alter Balancing cell behavior at boundaries David G. Wilkinson Division of Developmental Neurobiology, Medical Research Council National Institute for Medical Research, London NW7 1AA, England, UK © 2015 Wilkinson  This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi.org/10.1101/cshperspect   .a00822 7 Blanco, M.J., A. Barrallo-Gimeno, H. Acloque, A.E.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi.org/10.1242/dev.00685 8 Cayuso, J., Q. Xu, and D.G.",OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi   .org/10.1038/nrg290 2 Fagotto, F. 2014.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"141:3303– 3318. http://dx.doi.org/10.1242/dev.09033 2 Fagotto, F., R. Winklbauer, and N. Rohani.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi   .org/10.4161/19336918.2014.97002 8 Jülich, D., R. Geisler, and S.A. Holley.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"8:575– 586. http://dx.doi.org/10.1016/j.devcel.2005.01.01 6 Jülich, D., A.P.",OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi.org/10.1242/dev   .03893 5 Kim, S.H., A. Yamamoto, T. Bouwmeester, E. Agius, and E.M. Robertis.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"8:587– 598. http://dx.doi.org/10.1016/j.devcel.2005.03.00 6 Luu, O., E.W.",OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi.org/10   .1371/journal.pbio.100059 7 Rohani, N., A. Parmeggiani, R. Winklbauer, and F. Fagotto.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi.org/10.1371/ journal.pbio.100195 5 Steinberg, M.S.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi.org/10.1002/jez.140173040 6 Tanaka, M., T. Kamo, S. Ota, and H. Sugimura.",OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
"http://dx.doi.org/10.1093/emboj/cdg08 8 Winklbauer, R., A. Medina, R.K. Swain, and H. Steinbeisser.",Non-OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
http://dx.doi.org/10.1038/3510162 1cell adhesion as measured by tissue surface tension.,OADS,/arxiv_data1/oa_pdf/0b/db/JCB_201501107.PMC4362469.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 561–568Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  561OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7956 9Factors associated with prolonged hospitalization,  readmission, and death in elderly heart failure  patients in western romania Istvan gyalai-Korpos1,2 Oana Ancusa1,2 Tiberiu Dragomir1,2 Mirela Cleopatra T omescu1,2 Iosif Marincu1,3 1University of Medicine and  Pharmacy, 2Cardiology Department,   City hospital, 3Department of  epidemiology and Infectious Diseases,    Victor Babes University of Medicine  and Pharmacy, Timisoara, romaniaPurpose:  The purpose of this prospective study was to identify factors associated with pro - longed hospitalization, readmission, and death in elderly patients presenting heart failure with  reduced ejection fraction.",Non-OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
"Keywords:  reduced ejection fraction, outcome predictors, comorbidities, acute new onset heart  failure, left ventricular ejection fraction Introduction Heart failure (HF) is the most common discharge diagnosis in patients older than 65 years  of age; it is also a common cause of hospital readmission and death, and it presents  with a significant financial burden worldwide.1,2 Although HF is primarily a disorder Correspondence: Mirela Cleopatra  Tomescu 2nd eftimie Murgu square, Timisoara  300041, romania Tel +40 72 297 9516 Fax +40 22 0636 email tomescu.mirela@umft.r oJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Gyalai-Korpos et al Running head recto: Hospitalization, readmission, and death in elderly HF patients DOI: http://dx.doi.org/10.2147/CIA.S79569",Non-OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
"Available from: https://www.idf.org/webdata/docs/WHO_ IDF_definition_diagnosis_of_diabetes.pd f. Accessed February 12,   2015.",Non-OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
Available from:  http://www.who.int/healthinfo/survey/ageingdefnolder/en /.,Non-OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
"Available from: http://dx.doi.org/10.1787/health-data-e n.  Accessed February 12, 2015.",OADS,/arxiv_data1/oa_pdf/8d/26/cia-10-561.PMC4362599.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/d4/copd-10-535.PMC4362652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 535–540International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  535OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8076 5Misidentification of airflow obstruction:  prevalence and clinical significance in an  epidemiological study Chaicharn Pothirat Warawut Chaiwong nittaya Phetsuk Chalerm liwsrisakun Division of Pulmonary, Critical Care  and allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, Chiang Mai, ThailandBackground:  The fixed threshold criterion for the ratio of forced expiratory volume in the  first second to forced vital capacity (FEV1/FVC) ,0.7 is widely applied for diagnosis of  airflow obstruction (AO).",Non-OADS,/arxiv_data1/oa_pdf/be/d4/copd-10-535.PMC4362652.pdf
"The  Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria5 defines Correspondence: Chaicharn Pothirat Division of Pulmonary, Critical Care  and allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, 110 Inthavaroros road,  sriphum, Maung Chiang Mai District,  Chiang Mai 50200, Thailand Tel +66 53 946 228 Fax +66 53 895 117 email cpothira@med.cmu.ac.t hJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pothirat et al Running head recto: Clinical significance of misidentified airflow obstruction DOI: http://dx.doi.org/10.2147/COPD.S80765",Non-OADS,/arxiv_data1/oa_pdf/be/d4/copd-10-535.PMC4362652.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/be/d4/copd-10-535.PMC4362652.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/d4/copd-10-535.PMC4362652.pdf
Available from: http://www.goldcopd .org.,OADS,/arxiv_data1/oa_pdf/be/d4/copd-10-535.PMC4362652.pdf
Available from: http://www.goldcopd .org.,OADS,/arxiv_data1/oa_pdf/be/d4/copd-10-535.PMC4362652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/e2/dddt-9-1459.PMC4362653.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1459–1467Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1459Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7498 9Design, synthesis, and antifungal activities of novel  triazole derivatives containing the benzyl group Kehan Xu1,* lei huang1,* Zheng Xu2 Yanwei Wang1,3 guojing Bai1 Qiuye Wu1 Xiaoyan Wang1 shichong Yu1 Yuanying Jiang1 1school of Pharmacy, second Military  Medical University, shanghai, 2shanghai  changzheng hospital, second Military  Medical University, shanghai, 3number  422 hospital of P la, Zhanjiang,   People’s republic of china *These authors contributed equally  to this workAbstract:  In previous studies undertaken by our group, a series of 1-(1 H-1,2,4-triazole-1-yl)-2- (2,4-diﬂuorophenyl)-3-substituted-2-propanols (1a–r), which were analogs of ﬂuconazole, was  designed and synthesized by click chemistry.",Non-OADS,/arxiv_data1/oa_pdf/ff/e2/dddt-9-1459.PMC4362653.pdf
"The CYP51 enzyme contains an iron protoporphyrin unit located in its  active site, which catalyzes the oxidative removal of the 14 α-methyl group of lanos - terol by typical monooxygenase activity.17 Azole antifungal agents bind to the iron  of the porphyrin and cause blockade of the fungal ergosterol biosynthesis pathway correspondence: shichong Yu school of Pharmacy, second Military  Medical University, 325 guohe  road, shanghai 200433, People’s  republic of china Tel +86 21 8187 1228  Fax +86 21 8187 1225 email yuscc1008@163.co m  Yuanying Jiang school of Pharmacy, second Military  Medical University, 325 guohe  road, shanghai 200433, People’s  republic of china Tel/Fax +86 21 8187 1357 email 13761571578@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Xu et al Running head recto: Novel triazole derivatives containing the benzyl group DOI: http://dx.doi.org/10.2147/DDDT.S74989",Non-OADS,/arxiv_data1/oa_pdf/ff/e2/dddt-9-1459.PMC4362653.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ff/e2/dddt-9-1459.PMC4362653.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/e2/dddt-9-1459.PMC4362653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/81/dmso-8-157.PMC4362654.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 157–162Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  157Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8090 7Factors affecting high-sensitivity cardiac troponin  T elevation in Japanese metabolic syndrome  patients Takashi hitsumoto1 Kohji Shirai2 1hitsumoto Medical clinic,  Yamaguchi, Japan; 2Department of  Vascular Function (donated), Sakura  hospital, Toho University School of  Medicine, chiba, Japan correspondence: Takashi hitsumoto   hitsumoto Medical clinic, 2-7-7,  Takezakicyou, Shimonoseki-city,  Yamaguchi 750-0025, Japan   Tel +81 83 223 0657   Fax +81 83 233 0657   email thitsu@jcom.home.ne.j pPurpose:  The blood concentration of cardiac troponin T (ie, high-sensitivity cardiac troponin T  [hs-cTnT]), measured using a highly sensitive assay, represents a useful biomarker for evaluating  the pathogenesis of heart failure or predicting cardiovascular events.",Non-OADS,/arxiv_data1/oa_pdf/5e/81/dmso-8-157.PMC4362654.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/5e/81/dmso-8-157.PMC4362654.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/81/dmso-8-157.PMC4362654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/68/copd-10-525.PMC4362655.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 525–533International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  525OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7647 5Do frequent moderate exacerbations contribute  to progression of chronic obstructive pulmonary  disease in patients who are ex-smokers?,Non-OADS,/arxiv_data1/oa_pdf/30/68/copd-10-525.PMC4362655.pdf
"It has been shown that smoking cessation decelerates the FEV1 decline in  patients with mild-to-moderate COPD.1,2 It is also widely assumed that acute exacerba - tions contribute to disease progression.3 Exacerbations increase respiratory symptoms,  impair exercise capacity, and cause a deterioration in quality of life.4,5 However, most  studies evaluating the functional and clinical changes associated with an acute exacerba - tion and its recovery have included current smokers, making it difficult to separate the Correspondence: Carmen lisboa Department of Pulmonary Diseases,  School of Medicine, Pontificia Universidad  Católica de Chile, Marcoleta 350,  santiago 8330033, Chile Tel +56 2 2633 1541 email clisboa@med.puc.c l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Dreyse et al Running head recto: Frequent exacerbations in ex-smokers with COPD DOI: http://dx.doi.org/10.2147/COPD.S76475",Non-OADS,/arxiv_data1/oa_pdf/30/68/copd-10-525.PMC4362655.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/30/68/copd-10-525.PMC4362655.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/68/copd-10-525.PMC4362655.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/71/dddt-9-1449.PMC4362656.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1449–1458Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1449Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7659 2cryo-ablation improves anti-tumor immunity  through recovering tumor educated dendritic  cells in tumor-draining lymph nodes Xiao-Zheng he1,2 Qi-Fu Wang1,2 shuai han3 hui-Qing Wang1,2 Y ong-Yi Ye1,2 Zhi-Yuan Zhu1,2 shi-Zhong Zhang1,2 1Department of neurosurgery,   Zhujiang hospital, southern Medical  University, guangzhou, People’s  republic of china; 2The national Key  clinic specialty, The neurosurgery  institute of guangdong Province,   guangdong Provincial Key laboratory  on Brain Function repair and  regeneration, southern Medical  University, guangzhou, People’s  republic of china; 3Department of  general surgery, Zhujiang hospital,   southern Medical University,   guangzhou, People’s republic of chinaBackground:  In addition to minimally invasive destruction of tumors, cryo-ablation of tumors  to some extent modulated anti-tumor immunity.",Non-OADS,/arxiv_data1/oa_pdf/ee/71/dddt-9-1449.PMC4362656.pdf
"Some studies have shown that tumor progression is associated with  the impairment of the differentiation and maturation of myeloid cells, such as DCs.2,3  Several studies have demonstrated that these tolerogenic DCs, which are recruited to  tumor-draining lymph nodes (TDLNs) and tumor sites, are responsible for escaping tumor  immunity through activating CD4+CD25+Foxp3+Tregs.2,4,5 Tumor-educated tolerogenic  DCs could eliminate anti-tumor immunity through inducing CD3 down-regulation and correspondence: shi-Zhong Zhang neurosurgery institute of guangdong,  Zhujiang hospital, southern Medical  University, 253 gongye road, 510282  guangzhou, People’s republic of china Tel/fax +86 20 6164 3267 email hizhongzhangsmu@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: He et al Running head recto: Cryo-ablation improves anti-tumor immunity DOI: http://dx.doi.org/10.2147/DDDT.S76592",Non-OADS,/arxiv_data1/oa_pdf/ee/71/dddt-9-1449.PMC4362656.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ee/71/dddt-9-1449.PMC4362656.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/71/dddt-9-1449.PMC4362656.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/02/dddt-9-1427.PMC4362657.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1427–1435Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1427Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8069 7Improved corneal bioavailability of ofloxacin:  biodegradable microsphere-loaded ion-activated  in situ gel delivery system elshaimaa g sayed1 amal K hussein1 Khaled a Khaled1 Osama aa ahmed1,2 1Department of Pharmaceutical  Technology, Faculty of Pharmacy, Minia  University, Minia, egypt; 2Department  of Pharmaceutics and industrial  Pharmacy, Faculty of Pharmacy,   King abdulaziz University, Jeddah,   saudi arabiaAbstract:  The aim of the study was to improve corneal penetration and bioavailability of  ofloxacin (OFX) eye preparations.",Non-OADS,/arxiv_data1/oa_pdf/c6/02/dddt-9-1427.PMC4362657.pdf
"correspondence: Osama aa ahmed Department of Pharmaceutics  and industrial Pharmacy, Faculty  of Pharmacy, King abdulaziz University,  PO Box 80200, 21589, Jeddah,  saudi arabia email oaahmed@kau.edu.s a;  osama712000@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sayed et al Running head recto: Improved ocular bioavailability of ofloxacin in situ gel DOI: http://dx.doi.org/10.2147/DDDT.S80697",Non-OADS,/arxiv_data1/oa_pdf/c6/02/dddt-9-1427.PMC4362657.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c6/02/dddt-9-1427.PMC4362657.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/02/dddt-9-1427.PMC4362657.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1419–1426Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1419Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7855 5single dose pharmacokinetics of the novel  transdermal donepezil patch in healthy volunteers Y o han Kim1 hee Y oun choi1 hyeong-seok lim1 shi hyang lee1 hae sun Jeon1 Donghyun hong2 seong su Kim2 Y oung Kweon choi2 Kyun-seop Bae1 1Department of clinical Pharmacology  and Therapeutics, college of Medicine,   University of Ulsan, asan Medical  center, seoul, republic of Korea;  2icure Pharmaceutical lncorporated,   anseong, gyeonggi-do, republic  of KoreaBackground:  Donepezil is an acetylcholinesterase inhibitor indicated for Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
"It is believed to inhibit the breakdown of the neurotransmitter acetylcho - line and compensate for the deficiency of acetylcholine in brain.5,6 In previous clinical  trials, it has been shown to improve cognitive function in patients for a wide range of  AD severity, from very mild to moderate-to-severe.7–11 The most common adverse events (AEs) with donepezil, as well as with other  cholinesterase inhibitors, are nausea, vomiting, diarrhea, and dizziness, all of which  are symptoms linked to cholinergic hyperstimulation.12,13 These effects are dose- related and largely depend on the plasma fluctuations.14 When donepezil is orally  administered, it is well absorbed and reaches peak plasma concentrations (Cmax) in correspondence: Kyun-seop Bae Department of clinical Pharmacology  and Therapeutics, college of Medicine,  University of Ulsan, asan Medical center,  88 Olympic-ro 43-gil, songpa-gu, seoul  138-736, republic of Korea Tel +82 2 3010 4623 Fax +82 2 3010 4622 email ksbae@amc.seoul.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kim et al Running head recto: Pharmacokinetics of transdermal donepezil patch DOI: http://dx.doi.org/10.2147/DDDT.S78555",Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
"Available from: http://www.alz.co.uk/research/ WorldAlzheimerReport2012.pd f. Accessed November 11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
"Available from: http://www.fda.gov/ ohrms/dockets/98fr/990236Gd.pd f. Accessed November 18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/nda/2010/022568orig1s000clinpharmr.pd f. Accessed  November 20, 2014.26.",Non-OADS,/arxiv_data1/oa_pdf/e6/f1/dddt-9-1419.PMC4362658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/27/copd-10-541.PMC4362659.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 541–548International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  541OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7904 1Dialectal influence on chronic pulmonary disease  assessment test: the reliability and validity study Correspondence: Chaicharn Pothirat Division of Pulmonary, Critical Care  and Allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, 110 Inthavaroros Road,  Sriphum, Maung Chiang Mai District,  Chiang Mai 50200, Thailand Tel +66 53 946 228  Fax +66 53 895 117  email cpothira@med.cmu.ac.t h;  chaicharn.p@cmu.ac.t h Chaicharn Pothirat   Warawut Chaiwong   Nittaya Phetsuk   Chalerm Liwsrisakun   Chaiwat Bumroongkit   Athavudh Deesomchok   Theerakorn Theerakittikul   Atikun Limsukon Division of Pulmonary, Critical Care  and Allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, Chiang Mai, ThailandBackground:  Chronic obstructive pulmonary disease (COPD) patients living in many countries  are familiar with local dialects rather than the official language.",Non-OADS,/arxiv_data1/oa_pdf/a1/27/copd-10-541.PMC4362659.pdf
Health status measurements such as that provided by Journal name: International Journal of COPD article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pothirat et al Running head recto: Dialectal influence on COPD assessment test DOI: http://dx.doi.org/10.2147/COPD.S79041,Non-OADS,/arxiv_data1/oa_pdf/a1/27/copd-10-541.PMC4362659.pdf
"Global  Strategy for the Diagnosis, Management and Prevention of COPD ; 2014.  available from: http://www.goldcopd.or g. accessed august 1, 2014.",OADS,/arxiv_data1/oa_pdf/a1/27/copd-10-541.PMC4362659.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lthe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a1/27/copd-10-541.PMC4362659.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/27/copd-10-541.PMC4362659.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/33/dddt-9-1437.PMC4362660.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1437–1448Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1437Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7772 7liriodenine, an aporphine alkaloid from   Enico santhellum pulchrum , inhibits proliferation  of human ovarian cancer cells through induction  of apoptosis via the mitochondrial signaling  pathway and blocking cell cycle progression noraziah nordin1 nazia abdul Majid2 najihah Mohd hashim1 Mashitoh abd rahman1 Zalila hassan3 hapipah Mohd ali3 1Department of Pharmacy, Faculty  of Medicine, 2institute of Biological  sciences, 3Department of chemistry,   Faculty of science, University  of Malaya, Kuala lumpur, MalaysiaAbstract:  Enicosanthellum pulchrum  is a tropical plant from Malaysia and belongs to the  Annonaceae family.",Non-OADS,/arxiv_data1/oa_pdf/ed/33/dddt-9-1437.PMC4362660.pdf
"Keywords:  Enicosanthellum pulchrum , liriodenine, ovarian cancer, CAOV -3, apoptosis Introduction Enicosanthellum pulchrum  (King) Heusden belongs to the family Annonaceae, which  is also known as a family of “mempisang” in Malaysia.1 This species is often found in  the middle of the highlands, and the distribution is mostly in the Cameron Highland,  Malaysia, as reported by Chua et al.2 The species is a medium-sized tree that can reach  up to 3–5 m in height.3 Phytochemical analysis of this plant has reported some known  alkaloids in the bark and roots, including (–)-asimilobine, liriodenine, (–)-anonaine, correspondence: nazia abdul Majid institute of Biological sciences,  Faculty of science, University of Malaya,  50603 Kuala lumpur, Malaysia Tel +60 3 7967 5833 Fax +60 3 7967 5833 email nazia@um.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Nordin et al Running head recto: Liriodenine inhibits proliferation of an ovarian cancer cell line DOI: http://dx.doi.org/10.2147/DDDT.S77727",Non-OADS,/arxiv_data1/oa_pdf/ed/33/dddt-9-1437.PMC4362660.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ed/33/dddt-9-1437.PMC4362660.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/33/dddt-9-1437.PMC4362660.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/45/dddt-9-1469.PMC4362661.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1469–1479Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1469Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8059 4Neuroprotective therapies for glaucoma wei Song Ping Huang Chun Zhang Department of Ophthalmology, Peking  University Third Hospital, Beijing,   People’s Republic of ChinaAbstract:  Glaucoma is the second leading cause for blindness worldwide.",Non-OADS,/arxiv_data1/oa_pdf/66/45/dddt-9-1469.PMC4362661.pdf
"Besides IOP, there may Correspondence:  Chun Zhang Department of Ophthalmology, Peking  University Third Hospital, 49 North  Garden Road, Haidian District, Beijing  100191, People’s Republic of China Tel +86 10 8226 6569 Fax +86 10 8208 9951 email zhangc1@yahoo.co mJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Song et al Running head recto: Neuroprotective therapies for glaucoma DOI: http://dx.doi.org/10.2147/DDDT.S80594",Non-OADS,/arxiv_data1/oa_pdf/66/45/dddt-9-1469.PMC4362661.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer ­ reviewed open ­access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/66/45/dddt-9-1469.PMC4362661.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/45/dddt-9-1469.PMC4362661.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/2a/ijwh-7-297.PMC4362892.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 297–303International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  297OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7425 1characterization of symptoms and edema  distribution in premenstrual syndrome Pascale Mutti Tacani1 Danielle de Oliveira  ribeiro1 Barbara evelyn Barros  guimarães1 aline Fernanda Perez  Machado2 rogério eduardo Tacani1,2 1Physical Therapy Department, são  camilo University center, 2Physical  Therapy Department, são Paulo city  University (Un IcID), são Paulo, BrazilBackground:  Premenstrual syndrome is a group of symptoms linked to the menstrual cycle,  and edema is among these symptoms.",Non-OADS,/arxiv_data1/oa_pdf/8d/2a/ijwh-7-297.PMC4362892.pdf
"Keywords:  premenstrual syndrome, menstrual cycle, edema, women’s health, affective  symptoms, body surface area Introduction Premenstrual syndrome (PMS) refers to the physical, emotional, cognitive, and  behavioral changes that often occur between 10 and 14 days prior to menstruation and  disappear with the onset of the menstrual bleeding, and can negatively affect women’s  daily activities.1 It is estimated that 70%–90% of women are affected by some type of  symptoms.2 This prevalence varies in relation to the population studied and the type of  assessment tool used: 37.5% in Arabian women,3 17.5% in Japanese women,4 25.2%,5  43.3%,6 and 97.2%7 in Brazilian women, and 41% in American women,8 with the lowest  incidence, about 10%–12%, in Europe, while Asia has the highest percentage, with  98%.9 Some factors may influence PMS, such as age, menstrual cycle characteristics,  socioeconomic and educational levels, use of hormonal contraceptives, and lifestyle,  including diet, habits, and physical activities.10,11 PMS has been considered a syndrome  of multifactorial origin, and is related to the increase of inflammatory reactions and correspondence: Pascale Mutti Tacani Physical Therapy Department,  são camilo University center,  1501 nazaré avenue, Ipiranga,  são Paulo 04263-200, Brazil Tel +55 11 0300 017 8585 email pascale.tacani@hotmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Tacani et al Running head recto: Symptoms and edema in premenstrual syndrome DOI: http://dx.doi.org/10.2147/IJWH.S74251",Non-OADS,/arxiv_data1/oa_pdf/8d/2a/ijwh-7-297.PMC4362892.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/8d/2a/ijwh-7-297.PMC4362892.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/2a/ijwh-7-297.PMC4362892.pdf
Available from: http://www.who.int/bmi/index.jsp?introPage =intro_ 3.,OADS,/arxiv_data1/oa_pdf/8d/2a/ijwh-7-297.PMC4362892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/19/ijn-10-1969.PMC4362893.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1969–1975International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1969OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7700 0Phase II trial of weekly nab-paclitaxel and  carboplatin treatment with or without  trastuzumab as nonanthracycline neoadjuvant  chemotherapy for locally advanced breast cancer liang huang1,2 sheng chen1,2 ling Yao1,2 guangyu liu1,2 Jiong Wu1,2 Zhiming shao1–3  1Department of Breast surgery, Fudan  University shanghai cancer center/ cancer Institute, 2Department of  Oncology, shanghai Medical college,   3Institutes of Biomedical science,   Fudan University, shanghai, People’s  republic of china Background:  Neoadjuvant chemotherapy has become standard treatment for women with  locally advanced breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/cb/19/ijn-10-1969.PMC4362893.pdf
"Keywords:  carboplatin, nanoparticle albumin-bound paclitaxel, neoadjuvant chemotherapy,  pathologic complete response Introduction The survival of patients with early breast cancer has improved substantially in the past  40 years.1–3 The management of locally advanced breast cancer remains challenging, correspondence: Zhiming shao Department of Breast surgery, shanghai  cancer center/cancer Institute, Fudan  University, 399 ling-ling road, shanghai,  200032, People’s republic of china   Fax +86 21 6443 4556 email zhimingshao@yahoo.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Huang et al Running head recto: Phase II neoadjuvant trial of Nab-paclitaxel and Carboplatin for LABC DOI: http://dx.doi.org/10.2147/IJN.S77000",Non-OADS,/arxiv_data1/oa_pdf/cb/19/ijn-10-1969.PMC4362893.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cb/19/ijn-10-1969.PMC4362893.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/19/ijn-10-1969.PMC4362893.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/f2/ijnrd-8-019.PMC4362894.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 19–24International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  19RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S6570 2Strategies to improve physical activity by exercise  training in patients with chronic kidney disease Y oshiyuki Morishita Daisuke Nagata Division of Nephrology, Department  of Internal Medicine, Jichi Medical  University, Tochigi, Japan Correspondence: Yoshiyuki Morishita   Division of Nephrology, Department  of Internal Medicine, Jichi Medical  University, 3311-1, Yakushiji,   Shimotsuke, Tochigi 329-0498, Japan   Tel +81 2 8558 7346   Fax +81 2 8544 4869   email ymori@jichi.ac.j pAbstract:  Decreased physical activity resulting in muscle loss is often observed in patients with  chronic kidney disease and is one of the main predictors of mortality in these patients.",Non-OADS,/arxiv_data1/oa_pdf/32/f2/ijnrd-8-019.PMC4362894.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/32/f2/ijnrd-8-019.PMC4362894.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/f2/ijnrd-8-019.PMC4362894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/f7/ijgm-8-109.PMC4362895.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 109–118International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  109OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7769 3Stimulation of proinflammatory cytokines   by volatile sulfur compounds in endodontically  treated teeth Johann lechner1 Volker von Baehr2 1Clinic for Integrative Dentistry,   Munich, Germany; 2compartment of  Immunology and Allergology, Institute  for Medical Diagnostics, Berlin,   Germany correspondence: Johann lechner   Clinic for Integrative Dentistry,  Gruenwalder Str 10A,   81547 Munich, Germany   Tel +49 89 697 0055   Fax +49 89 692 5830   email drlechner@aol.co m    Volker von Baehr   Institute for Medical Diagnostics,  Nicolaistrasse 22,   12247 Berlin, Germany   Tel +49 307 700 1220   Fax +49 307 700 1236   email vbaehr@imd-berlin.d eAbstract:  Persistent microorganisms in endodontically treated teeth produce volatile sulfur  compounds (VSC) such as methyl mercaptan, hydrogen sulfide, and thioether.",Non-OADS,/arxiv_data1/oa_pdf/5c/f7/ijgm-8-109.PMC4362895.pdf
Available from: http://www.imd-berlin.de/labor/fachbereiche/ immunologie .html.,Non-OADS,/arxiv_data1/oa_pdf/5c/f7/ijgm-8-109.PMC4362895.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/5c/f7/ijgm-8-109.PMC4362895.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/f7/ijgm-8-109.PMC4362895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/66/dddt-9-1491.PMC4362896.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1491–1498Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1491Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7995 7effect of a topical copper indomethacin gel  on inflammatory parameters in a rat model  of osteoarthritis nemat Z Yassin1 siham M el-shenawy1 rehab F abdel-rahman1 Mostafa Yakoot2 Mohamed hassan3 sherine helmy4 1Department of Pharmacology,   national research center,   cairo, egypt; 2green clinic and  research center, alexandria, egypt;   3Department of chemistry, Faculty  of science, alexandria University,   alexandria, egypt; 4european  egyptian Pharmaceutical industries,   alexandria,  egyptObjective:  We aimed to investigate the effect of topical application of a Copper indomethacin  (Cu-Indo) gel preparation on monosodium iodoacetate (MIA) induced arthritis of the knee joint  of rats and to test our hypothesis that copper complex of indomethacin could be a more potent  anti-inflammatory agent than its parent compound.",Non-OADS,/arxiv_data1/oa_pdf/e0/66/dddt-9-1491.PMC4362896.pdf
"Keywords:  osteoarthritis, copper indomethacin gel, monosodium iodoacetate, rats Introduction Osteoarthritis (OA) is a potentially debilitating disorder that can place serious limitations  on patient functionality and overall quality of life.1 Because there are no curative or  disease-modifying therapies for patients with OA at this time, current approaches to  management strive to relieve pain and increase functionality while minimizing the  potential for adverse effects.2 The nonsteroidal anti-inflammatory drugs (NSAIDs) are correspondence: Mostafa Yakoot green clinic and research center,  27 green street, alexandria 21121, egypt Tel +20 3 391 3725 email yakoot@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y assin et al Running head recto: Copper indomethacin gel and osteoarthritis DOI: http://dx.doi.org/10.2147/DDDT.S79957 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/e0/66/dddt-9-1491.PMC4362896.pdf
Or use: http://dvpr.es/1vMagt lVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/e0/66/dddt-9-1491.PMC4362896.pdf
"Available from: http://www.nice.org.uk/nicemedia/ pdf/CG59NICEguideline.pd f. Accessed March 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/e0/66/dddt-9-1491.PMC4362896.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e0/66/dddt-9-1491.PMC4362896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/66/dddt-9-1491.PMC4362896.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/63/mder-8-161.PMC4362897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 161–166Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  161CasE REpo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/MDER.S7647 4acute vertigo in an anesthesia provider   during exposure to a  3t MRI scanner andrew Gorlin1 Joseph M Hoxworth2 William pavlicek2 Christopher a thunberg1 David seamans1 1Department of anesthesiology,   2Department of Radiology, Mayo  Clinic arizona, phoenix, aZ, Usa Correspondence: andrew Gorlin   Department of anesthesiology,   Mayo Clinic arizona,  5777 E Mayo  Boulevard, phoenix, aZ  85054, Usa   tel +1 480 342 1800  Email gorlin.andrew@mayo.ed uAbstract:  Vertigo induced by exposure to the magnetic field of a magnetic resonance imaging  (MRI) scanner is a well-known phenomenon within the radiology community but is not widely  appreciated by other clinical specialists.",Non-OADS,/arxiv_data1/oa_pdf/ee/63/mder-8-161.PMC4362897.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical­devices­evidence­and­research­journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/ee/63/mder-8-161.PMC4362897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/bc/dddt-9-1585.PMC4362898.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1585–1599Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1585Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5603 8The application of click chemistry in the synthesis  of agents with anticancer activity Nan Ma1–3 Ying wang3 Bing-Xin Zhao3 wen-Cai Ye1,3 Sheng Jiang2 1Department of Natural Medicinal  Chemistry, China Pharmaceutical  University, Nanjing, 2Laboratory  of Medicinal Chemistry, Guangzhou  institute of Biomedicine and Health,   Chinese Academy of Sciences,   3institute of Traditional Chinese  Medicine and Natural Products,   College of Pharmacy, Jinan University,   Guangzhou, People’s Republic  of ChinaAbstract:  The copper(I)-catalyzed 1,3-dipolar cycloaddition between alkynes and azides (click  chemistry) to form 1,2,3-triazoles is the most popular reaction due to its reliability, specificity,  and biocompatibility.",Non-OADS,/arxiv_data1/oa_pdf/6e/bc/dddt-9-1585.PMC4362898.pdf
"They also show diverse biological activities such as Correspondence: wen-Cai Ye  Department of Natural Medicinal  Chemistry, China Pharmaceutical  University, No 24, Tongjia Lane, Nanjing,  210009, People’s Republic of China email chyewc@gmail.co m Sheng Jiang Laboratory of Medicinal Chemistry,  Guangzhou institute of Biomedicine  and Health, Chinese Academy of  Sciences, No 190, Kaiyuan Avenue,  Guangzhou 510530, People’s Republic  of China email jiang_sheng@gibh.ac.c nJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Ma et al Running head recto: Synthesis of agents with anticancer activity DOI: http://dx.doi.org/10.2147/DDDT.S56038",Non-OADS,/arxiv_data1/oa_pdf/6e/bc/dddt-9-1585.PMC4362898.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6e/bc/dddt-9-1585.PMC4362898.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/bc/dddt-9-1585.PMC4362898.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/jir-8-071.PMC4362899.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 71–77Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  71ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S7753 9Role of high-mobility group box 1 in patients with  acute obstructive suppurative cholangitis-induced  sepsis akanand singh1 Yi Feng1 nisha Mahato2 Jinzheng li1 chuanxin Wu1 Jianping gong1 1chongqing Key laboratory  of hepatobiliary surgery and  Department of hepatobiliary  surgery, The second affiliated  hospital of chongqing Medical  University, chongqing, People’s  Republic of china; 2Department of  Prosthodontics, The affiliated hospital  of stomatology, chongqing Medical  University, chongqing, People’s  Republic of china correspondence: Jianping gong   chongqing Key laboratory of  hepatobiliary surgery and Department  of hepatobiliary surgery, The second  affiliated hospital of chongqing Medical  University, no 76 linjiang Road,   Yuzhong District, chongqing 400010,   People’s Republic of china   Tel +86 139 9628 6589   Fax +86 23 6382 9191   email gongjianping11@126.co m    chuanxin Wu   chongqing Key laboratory of  hepatobiliary surgery and Department  of hepatobiliary surgery, The second  affiliated hospital of chongqing Medical  University, no 76 linjiang Road,   Yuzhong District, chongqing 40010,   People’s Republic of china   Tel +86 159 2321 8833   Fax +86 23 6382 9191   email wu_chuanxin@live.co mBackground:  High-mobility group box 1 (HMGB1) is a proinflammatory cytokine that plays  an active role during the pathogenesis of inflammatory processes.",Non-OADS,/arxiv_data1/oa_pdf/e3/c9/jir-8-071.PMC4362899.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/e3/c9/jir-8-071.PMC4362899.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/c9/jir-8-071.PMC4362899.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/dddt-9-1499.PMC4362900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1499–1510Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1499Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6664 7em08red, a dual functional antiproliferative emodin  analogue, is a downregulator of erbB2 expression   and inducer of intracellular oxidative stress Fong-Pin liang1,* Jin-cherng lien1,* Yu-hua Wu2 chien-shu chen2 shin-hun Juang1–3 1graduate institute of Pharmaceutical  chemistry, 2school of Pharmacy and  Department of Pediatrics, children’s  hospital, 3Department of Medical  research, china Medical University  hospital, Taichung, Taiwan *These authors contributed equally   to this work correspondence: shin-hun Juang   graduate institute of Pharmaceutical  chemistry, china Medical University,  91 hsueh-shih road, Taichung, 40402,  Taiwan   Tel +88 64 2205 3366 ext 5119   Fax +88 64 2205 0506   email paul@mail.cmu.edu.t wAbstract:  Expression of ErbB2 protein is inversely correlated with the prognosis in cancer  patients.",Non-OADS,/arxiv_data1/oa_pdf/e0/a7/dddt-9-1499.PMC4362900.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e0/a7/dddt-9-1499.PMC4362900.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/dddt-9-1499.PMC4362900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/68/ijn-10-1977.PMC4362901.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1977–1983International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1977OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7910 6sunroot mediated synthesis and characterization  of silver nanoparticles and evaluation of its  antibacterial and rat splenocyte cytotoxic effects adithan aravinthan1,* Muthusamy govarthanan2,3,* Kandasamy selvam4 loganathan Praburaman2,3 Thangasamy selvankumar3 rangachari Balamurugan1 seralathan Kamala-Kannan2 Jong-hoon Kim1 1college of Veterinary Medicine,   Biosafety research Institute, chonbuk  National University, Jeonju, south Korea;  2Division of Biotechnology, advanced  Institute of environment and Bioscience,   college of environmental and Bioresource  sciences, chonbuk National University,   Iksan, south Korea; 3Pg and research  Department of Biotechnology, Mahendra  arts and science college, Kalippatti,   Namakkal, Tamil Nadu, India; 4centre for  Biotechnology, Muthayammal college  of arts and science, rasipuram, Namakkal,   Tamil Nadu, India *These authors contributed equally to  this  workAbstract:  A rapid, green phytosynthesis of silver nanoparticles (AgNPs) using the aqueous  extract of Helianthus tuberosus (sunroot tuber) was reported in this study.",Non-OADS,/arxiv_data1/oa_pdf/7a/68/ijn-10-1977.PMC4362901.pdf
"Several  studies reported AgNPs synthesis using biological materials, such as microorgan - isms, plant extracts, milk, and panchakavya.7–10 Phytosynthesis of AgNPs using plant  materials has an edge over microbial mediated synthesis owing to their immediate  and large-scale production.11,12 Thus, considerable attention is given to exploit the correspondence: seralathan  Kamala-Kannan Division of Biotechnology, advanced  Institute of environment and  Bioscience, college of environmental  and Bioresource sciences, chonbuk  National University, Iksan 570-752,  south Korea Tel +82 6 3850 0842 Fax +82 6 3850 0834 email kannan@jbnu.ac.k r Jong-hoon Kim college of Veterinary Medicine, Biosafety  research Institute, chonbuk National  University, Jeonju 561-756, south Korea Tel +82 10 6207 7180 Fax +82 6378500923 email jhkim1@jbnu.ac.k rJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Aravinthan et al Running head recto: Phytosynthesis of silver nanoparticles using sunroot DOI: http://dx.doi.org/10.2147/IJN.S79106",Non-OADS,/arxiv_data1/oa_pdf/7a/68/ijn-10-1977.PMC4362901.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7a/68/ijn-10-1977.PMC4362901.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/68/ijn-10-1977.PMC4362901.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/fc/ijn-10-1985.PMC4362902.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1985–1996International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1985OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7749 8Oxcarbazepine-loaded polymeric nanoparticles:  development and permeability studies across  in vitro models of the blood–brain barrier  and human placental trophoblast antonio lopalco1–3,* hazem ali1,* Nunzio Denora3 erik rytting1,4,5 1Department of Obstretrics  and gynecology, University of Texas  Medical Branch, galveston, TX, Usa;   2Department of Pharmaceutical  chemistry, University of Kansas,   lawrence, K s, Usa; 3Department of  Pharmacy – Drug sciences, University  of Bari aldo Moro, Bari, Italy;   4center for Biomedical engineering,   University of T exas Medical Branch,   galveston, TX, Usa; 5Department  of Pharmacology and T oxicology,   University of T exas Medical Branch,   galveston, TX, Usa *These authors contributed equally  to this workAbstract:  Encapsulation of antiepileptic drugs (AEDs) into nanoparticles may offer promise  for treating pregnant women with epilepsy by improving brain delivery and limiting the trans - placental permeability of AEDs to avoid fetal exposure and its consequent undesirable adverse  effects.",Non-OADS,/arxiv_data1/oa_pdf/86/fc/ijn-10-1985.PMC4362902.pdf
"A study published in 1993 revealed no congenital malformations among  nine children born to patients exposed to oxcarbazepine during the first trimester, correspondence: erik rytting Department of Obstetrics and  gynecology, University of Texas Medical  Branch, 301 University Boulevard,  galveston, Texas 77555-0587, Usa Tel +1 409 772 2777 Fax +1 409 747 0266 email erik.rytting@utmb.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lopalco et al Running head recto: In vitro study of oxacarbazepine-loaded polymeric nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S77498",Non-OADS,/arxiv_data1/oa_pdf/86/fc/ijn-10-1985.PMC4362902.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/86/fc/ijn-10-1985.PMC4362902.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/fc/ijn-10-1985.PMC4362902.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/9a/ijgm-8-101.PMC4362903.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 101–108International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  101OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7942 3comparative seroprevalence of measles virus  immunoglobulin M antibodies in children aged   0–8 months and a control population aged   9–23 months presenting with measles-like  symptoms in selected hospitals in Kaduna state ae Olaitan ee ella JB ameh Department of Microbiology, ahmadu  Bello University, Zaria, nigeria correspondence: ee ella   Department of Microbiology, Faculty  of science, ahmadu Bello University,  samaru, Zaria, Kaduna state,   Zaria, nigeria   Tel +23 480 2363 4081   email elijahella33@yahoo.co mBackground:  Measles remains the leading cause of vaccine-preven table  childhood mortality in  developing countries, with its greatest incidence in children younger than 2 years of age.",Non-OADS,/arxiv_data1/oa_pdf/92/9a/ijgm-8-101.PMC4362903.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/92/9a/ijgm-8-101.PMC4362903.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/9a/ijgm-8-101.PMC4362903.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/41/hiv-7-075.PMC4362904.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS - Research and Palliative Care 2015:7 75–81HIV/AIDS - Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  75ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S7932 8Assessment of adherence to highly active  antiretroviral therapy and associated factors  among people living with HIV at Debrebrihan  Referral Hospital and Health Center, northeast  ethiopia: a cross-sectional study Abush Kebede Ketema1 Zewdu Shewangizaw Weret2 1Regional Monitoring and evaluation  Advisor, Management Sciences for   Health, Addis Ababa, ethiopia;   2College of Medicine and Health  Sciences, Arbaminch University,  Arbaminch, ethiopia Correspondence: Zewdu Shewangizaw  Weret   College of Medicine and Health Sciences,  Arbaminch University, Arbaminch,  ethiopia   Tel +251 91 374 9690  email hweret@gmail.co mAbstract:  Patient adherence to antiretroviral combination therapy is a critical component to  successful treatment outcome.",Non-OADS,/arxiv_data1/oa_pdf/eb/41/hiv-7-075.PMC4362904.pdf
Available from: http://data.unaids.,OADS,/arxiv_data1/oa_pdf/eb/41/hiv-7-075.PMC4362904.pdf
Available from: http://data.unaids.org/pub/Report/2010/ ethiopia_2010_country_progress_report_en.pd f. Accessed.,OADS,/arxiv_data1/oa_pdf/eb/41/hiv-7-075.PMC4362904.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids­­­research­and­palliative­care­journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/eb/41/hiv-7-075.PMC4362904.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/41/hiv-7-075.PMC4362904.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/a4/ijn-10-1961.PMC4362905.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1961–1968International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1961OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7994 4anticoccidial and antioxidant activities of zinc  oxide nanoparticles on Eimeria papillata -induced  infection in the jejunum Mohamed a Dkhil1,2 saleh al-Quraishy1 rizwan Wahab1 1Department of Zoology, college  of science, King saud University,   riyadh, saudi arabia; 2Department  of Zoology and entomology, Faculty  of science, helwan University, cairo,   egyptAbstract:  Nanomedicine has recently emerged as a better option for the treatment of various  diseases.",Non-OADS,/arxiv_data1/oa_pdf/97/a4/ijn-10-1961.PMC4362905.pdf
"The current study was designed to investigate both  the anticoccidial activity and the antioxidant role of ZNPs, using the murine Eimeria  papillata  as a model parasite for coccidiosis.correspondence: Mohamed a Dkhil Department of Zoology, college of  science, King saud University, PO Box  2455, riyadh-11451, saudi arabia Tel +966 11 467 5754 Fax +966 11 467 8514 email mohameddkhil@yahoo.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Dkhil et al Running head recto: ZNPs in Eimeria papillata -induced infection in the jejunum DOI: http://dx.doi.org/10.2147/IJN.S79944",Non-OADS,/arxiv_data1/oa_pdf/97/a4/ijn-10-1961.PMC4362905.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/97/a4/ijn-10-1961.PMC4362905.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/a4/ijn-10-1961.PMC4362905.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/14/dddt-9-1555.PMC4362906.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1555–1584Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1555Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7419 7Pro-apoptotic and pro-autophagic effects of the  aurora kinase a inhibitor alisertib (M ln8237) on  human osteosarcoma U-2 O s and M g-63 cells  through the activation of mitochondria-mediated  pathway and inhibition of p38 M aPK/Pi3K/akt/mTO r  signaling pathway ning-Kui niu,1–3 Zi-li Wang,1 shu-Ting  Pan,2,4 hui-Qiang Ding,1 giang hT au,2  Zhi-Xu he,5 Zhi-Wei Zhou,2,5 guozhi  Xiao,6 Yin-Xue Yang,7 Xueji Zhang,8  Tianxin Yang,9 Xiao-Wu chen,10   Jia-Xuan Qiu,4 shu-Feng Zhou2 1Department of spinal surgery, general hospital  of ningxia Medical University, Yinchuan, People’s  republic of china; 2Department of Pharmaceutical  sciences, college of Pharmacy, University of  south Florida, Tampa, Fl, Usa; 3Department  of Orthopedics, general hospital of Tianjin  Medical University, Tianjin, 4Department of Oral  and Maxillofacial surgery, The First affiliated  hospital of nanchang University, nanchang,   Jiangxi, 5guizhou Provincial Key laboratory for  regenerative Medicine, stem cell and Tissue  engineering research center and sino-Us   Joint laboratory for Medical sciences, guizhou  Medical University, guiyang, guizhou, People’s  republic of china; 6Department of Biochemistry,   Medical center, rush University, chicago, il, Usa;   7Department of colorectal surgery, general  hospital of ningxia Medical University, Yinchuan,   8research center for Bioengineering and sensing  T echnology, University of science and T echnology  Beijing, Beijing, People’s republic of china;   9Department of internal Medicine, University of  Utah and salt lake Veterans affairs Medical center,   salt lake city, UT, Usa; 10Department of general  surgery, The First People’s hospital of shunde  affiliated to southern Medical University, Foshan,   guangdong, People’s republic of chinaAbstract:  Osteosarcoma (OS) is the most common malignant bone tumor occurring mostly  in children and adolescents between 10 and 20 years of age with poor response to current  therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/c2/14/dddt-9-1555.PMC4362906.pdf
"Keywords:  ALS, autophagy, apoptosis, osteosarcoma, PI3K/Akt/mTOR pathway, EMT Introduction Osteosarcoma (OS) is the most common primary bone malignancy and mainly  affects children and adolescents.1,2 Although the incidence rate is 2–3/million/year correspondence:  shu-Feng Zhou Department of Pharmaceutical sciences, college of  Pharmacy, University of south Florida, 12901 Bruce B.  Downs Blvd., Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Jia-Xuan Qiu Department of Oral and Maxillofacial surgery,   The First Affiliated Hospital of Nanchang University,   17 Yongwaizheng st, nanchang 330006, Jiangxi,   People’s republic of china  Tel +86 791 8869 2531 Fax +86 791 8869 2745  email qiujiaxuan@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Niu et al Running head recto: ALS induces apoptosis and autophagy in human osteosarcoma DOI: http://dx.doi.org/10.2147/DDDT.S74197",Non-OADS,/arxiv_data1/oa_pdf/c2/14/dddt-9-1555.PMC4362906.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c2/14/dddt-9-1555.PMC4362906.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/14/dddt-9-1555.PMC4362906.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/d2/ijn-10-1909.PMC4362907.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1909–1920International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1909OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7712 5Efficient delivery of ursolic acid by poly(N- vinylpyrrolidone)-block-poly ( ε-caprolactone)  nanoparticles for inhibiting the growth of  hepatocellular carcinoma in vitro and in vivo Hao Zhang1,* Donghui Zheng2,* Jing Ding3 huae Xu4 Xiaolin li1 Weihao sun1 1Department of geriatric  Gastroenterology, First Affiliated  Hospital with Nanjing Medical  University, Nanjing, People’s  Republic of China; 2Department  of Nephrology, Huai’an Hospital  Affiliated with Xuzhou Medical  College and Huai’an Second Hospital,   Huai’an, People’s Republic of China;   3Department of Respiratory Medicine,   Affiliated Nanjing Children Hospital  with Nanjing Medical University,   4Department of Pharmacy, First  Affiliated Hospital with Nanjing  Medical University, Nanjing,   People’s Republic of China *These authors contributed equally  to this articleAbstract:  Previous reports have shown that ursolic acid (UA), a pentacyclic triterpenoid derived  from Catharanthus trichophyllus  roots, could inhibit the growth of a series of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/c5/d2/ijn-10-1909.PMC4362907.pdf
"we previously demonstrated in our lab that UA-loaded mPEG-PCL (methoxy  poly[ethylene glycol]-poly[ ε-caprolactone]) nanoparticles inhibit the proliferation of Correspondence: Weihao Sun; Xiaolin Li Department of Geriatric Gastroenterology,  First Affiliated Hospital with Nanjing  Medical University, Nanjing, 210029,  People’s Republic of China Tel +86 25 6813 5153; +86 25 6813 5151 Fax +86 25 8378 0170 email swh@njmu.edu.c n;   lxl@njmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhang et al Running head recto: Ursolic acid-loaded NP treatment for hepatocellular carcinoma DOI: http://dx.doi.org/10.2147/IJN.S77125",Non-OADS,/arxiv_data1/oa_pdf/c5/d2/ijn-10-1909.PMC4362907.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c5/d2/ijn-10-1909.PMC4362907.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/d2/ijn-10-1909.PMC4362907.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/22/opth-9-467.PMC4362972.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 467–468Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  467Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7956 1extensive superior limbic keratoconjunctivitis  in Graves’ disease: case report and mini-review  of the literature elias Chelala Hala el rami ali Dirani Henry Fakhoury ali Fadlallah Faculty of Medicine, saint-Joseph  University, Beirut, LebanonBackground:  Superior limbic keratoconjunctivitis (SLK) is characterized as an inflammation  of the superior bulbar conjunctiva with predominant involvement of the superior limbus and  adjacent epithelial keratitis.",Non-OADS,/arxiv_data1/oa_pdf/ab/22/opth-9-467.PMC4362972.pdf
"The patient was kept  on preservative-free artificial tears as needed and remained free of symptoms and  signs for the following year.Correspondence: ali Fadlallah Faculty of Medicine, saint-Joseph  University, Damascus road, Bp 17-5208  Mar Mikhaël, Beirut 1104-2020, Lebanon tel +961 71 388 893 email f adlallah2000@hotmail.co mJournal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Chelala et al Running head recto: Extensive superior limbic keratoconjunctivitis in Grave’s disease DOI: http://dx.doi.org/10.2147/OPTH.S79561",Non-OADS,/arxiv_data1/oa_pdf/ab/22/opth-9-467.PMC4362972.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ab/22/opth-9-467.PMC4362972.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/22/opth-9-467.PMC4362972.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/37/ppa-9-429.PMC4362973.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 429–433Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  429OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7702 9Desire for prenatal gender disclosure among  primigravidae in enugu, nigeria T ochukwu c Okeke1 Jamike O enwereji1 Onyemaechi s Okoro1 eric s iferikigwe1 lawrence c ikeako2 cyril c ezenyeaku2 charles O Adiri1 1Department of Obstetrics  and gynaecology, University  of nigeria T eaching hospital, enugu,   nigeria; 2Department of Obstetrics  and gynaecology, Anambra state  University T eaching hospital, Awka,   nigeriaBackground:  Prenatal gender disclosure is a nonmedical fetal ultrasonography view, which is  considered ethically unjustified but has continued to grow in demand due to pregnant women’s  requests.",Non-OADS,/arxiv_data1/oa_pdf/6c/37/ppa-9-429.PMC4362973.pdf
"Preference for male children is influenced by sociodemographic, sociocultural, reli - gious, economic, emotional, and obstetric factors.3,7 Disclosure of fetal gender to pregnant women may be associated with either a posi - tive or a negative attitude.8 Worldwide, studies have shown preference for male children  over females in Nigeria, Asian countries, India, People’s Republic of China, and South  Korea.9–12 Recurring reasons for the preference for male children are to continue with correspondence: Tochukwu c Okeke Department of Obstetrics and  gynaecology, University of nigeria  Teaching hospital, ituku-Ozalla,  enugu, nigeria email tcokeke2014@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Okeke et al Running head recto: Desire for prenatal gender disclosure among primigravidae in Enugu DOI: http://dx.doi.org/10.2147/PPA.S77029",Non-OADS,/arxiv_data1/oa_pdf/6c/37/ppa-9-429.PMC4362973.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6c/37/ppa-9-429.PMC4362973.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/2f/ndt-11-657.PMC4362974.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 657–668Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  657OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7777 8Efficacy, safety, and impact on hospitalizations  of paliperidone palmitate in recent-onset  schizophrenia Fan Zhang1 Tianmei si2,3 chiun-Fang chiou4 anthony WF harris5 chang Y oon Kim6 Padmashree Jahagirdar7 steve ascher8 1Xian Janssen Pharmaceuticals,  Beijing, People’s Republic of  china; 2Department of clinical  Psychopharmacology, Peking  University institute of Mental  Health, Beijing, People’s Republic of  china; 3Key Laboratory of Mental  Health, Ministry of Health (Peking  University), Beijing, People’s Republic  of china; 4Janssen Asia-Pacific,  singapore; 5Discipline of Psychiatry,  Sydney Medical School, University of  Sydney, Australia and Brain Dynamics  Center, Westmead Millennium  Institute for Medical Research,  Westmead, NSW, Australia; 6asan  Medical Center, University of Ulsan  College of Medicine, Seoul, South  Korea; 7Theorem Clinical Research,  Bangalore, India; 8Janssen research and  Development, LLC, Titusville, NJ, USAObjective:  To evaluate the efficacy, safety, and impact on hospitalizations of long-acting  injectable paliperidone palmitate (PP) treatment, in patients with recent-onset schizophrenia  who had not responded satisfactorily to oral antipsychotics.",Non-OADS,/arxiv_data1/oa_pdf/09/2f/ndt-11-657.PMC4362974.pdf
"Keywords:  atypical antipsychotics, long-acting injectables, open-label, paliperidone palmitate,  schizophrenia Introduction Clinical management of schizophrenia remains a major challenge due to frequent  relapses, persistence of psychotic symptoms, nonadherence to antipsychotic  medications, recurrent hospitalizations, and increased burden on healthcare  resources.1–5 Although variable, nonadherence rates among patients with schizophrenia  are estimated to range from 40% to 70%.6–8correspondence: Fan Zhang Xian Janssen Pharmaceuticals,  14F, Tower  3, China Central Place,  No 77, Jian Guo Road, Chaoyang  District,  100025 Beijing, People’s Republic of China Tel +86 10 5821 8766 email fzhang21@its.jnj.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Zhang et al Running head recto: Paliperidone palmitate in recent-onset schizophrenia  DOI: http://dx.doi.org/10.2147/NDT.S77778",Non-OADS,/arxiv_data1/oa_pdf/09/2f/ndt-11-657.PMC4362974.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/09/2f/ndt-11-657.PMC4362974.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/2f/ndt-11-657.PMC4362974.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/90/ndt-11-669.PMC4362975.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 669–674Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  669OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7694 4impact of incarceration in Nazi concentration  camps on multimorbidity of former prisoners robert K Jablonski1 Jerzy leszek2 Joanna Rosińczuk3 izabella Uchmanowicz4 Bernard Panaszek1 1Department and clinic of internal  Diseases, geriatry and allergology,   2Department of Psychiatry,   3Department of Nervous system  Diseases, Department of clinical  Nursing, 4Division of Nursing  in internal Medicine Procedures,   Department of clinical Nursing,   Wroclaw Medical University,   Wroclaw,  PolandObjective:  To show the extent to which the health of former prisoners was affected by  incarceration in extermination camps after 5 and 30 years of leaving the camp, and to determine  the etiological factors underlying particular dysfunctions.",Non-OADS,/arxiv_data1/oa_pdf/91/90/ndt-11-669.PMC4362975.pdf
"The British Empire decided to exterminate the Boer people and started Correspondence: Joanna Rosińczuk Department of Nervous system  Diseases, Department of clinical Nursing,  Wroclaw Medical University, K Bartla 5,  51-618 Wroclaw, Poland email joanna.rosinczuk@umed.wroc.p l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Jablonski et al Running head recto: Incarceration in Nazi concentration camps and multimorbidity DOI: http://dx.doi.org/10.2147/NDT.S76944",Non-OADS,/arxiv_data1/oa_pdf/91/90/ndt-11-669.PMC4362975.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/91/90/ndt-11-669.PMC4362975.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/90/ndt-11-669.PMC4362975.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/19/oajsm-6-063.PMC4362976.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 63–70Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  63OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7632 5T endinopathy of the long head of the biceps tendon:  histopathologic analysis of the extra-articular biceps  tendon and tenosynovium Jonathan J Streit1 Y ousef Shishani1 Mark rodgers2 reuben gobezie1 1The cleveland Shoulder institute,   2Department of Pathology, University  hospitals of cleveland, cleveland,   Oh, USA correspondence: reuben gobezie   The cleveland Shoulder institute,  University hospitals of cleveland,   5885 landerbrook Drive,   Monarch Center, Mayfield Heights,   Oh 44124, USA   email r euben.gobezie@uhhospitals.or gBackground:  Bicipital tendinitis is a common cause of anterior shoulder pain, but there is no  evidence that acute inflammation of the extra-articular long head of the biceps (LHB) tendon  is the root cause of this condition.",Non-OADS,/arxiv_data1/oa_pdf/1e/19/oajsm-6-063.PMC4362976.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/1e/19/oajsm-6-063.PMC4362976.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/19/oajsm-6-063.PMC4362976.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/53/ppa-9-413.PMC4362977.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 413–420Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  413OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7862 8Patients’ beliefs about adherence to oral antidiabetic  treatment: a qualitative study correspondence: line guénette chU de Québec research center,  Population health and Optimal health  Practices research Unit, hôpital du saint- sacrement, 1050 chemin sainte-Foy,  Quebec city, Qc g1s4l8, canada  Tel +1 418 682 7511 extension 4694 Fax +1 418 682 7962 email line.guenette@pha.ulaval.c a line guénette1–3 sophie lauzier1–3 laurence guillaumie2–4 gabriel giguère1 Jean-Pierre grégoire1–3 Jocelyne Moisan1–3 1Faculty of Pharmacy, laval University,   Quebec city, Qc , canada; 2chair  on Adherence to Treatments, laval  University, Quebec city, Qc , canada;  3chU de Québec research center,   Population health and Optimal  Practices research Unit, Quebec city,   Qc, canada; 4Faculty of nursing, laval  University, Quebec city, Qc , canadaPurpose:  The purpose of this study was to elicit patients’ beliefs about taking their oral  antidiabetic drugs (OADs) as prescribed to inform the development of sound adherence- enhancing interventions.",Non-OADS,/arxiv_data1/oa_pdf/2c/53/ppa-9-413.PMC4362977.pdf
"It has been suggested that interventions based on psychosocial  theories of behavior are more likely to increase the adoption of health-related  behaviors.10 Among these theories, prediction theories are used to identify the Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Guénette et al Running head recto: Patients’ beliefs about medication adherence DOI: http://dx.doi.org/10.2147/PPA.S78628",Non-OADS,/arxiv_data1/oa_pdf/2c/53/ppa-9-413.PMC4362977.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2c/53/ppa-9-413.PMC4362977.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/1e/vhrm-11-195.PMC4362978.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 195–202Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  195ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S4619 4Virtual reality simulation for the optimization of  endovascular procedures: current perspectives Nung Rudarakanchana1 isabelle Van Herzeele2 Liesbeth Desender2 Nicholas Jw Cheshire1 1Department of Surgery, imperial  College London, London, UK;   2Department of Thoracic and Vascular  Surgery, Ghent University Hospital,   Ghent, Belgium On behalf of eVeReST (european Virtual  reality endovascular ReSearch T eam) Correspondence: Nung Rudarakanchana   Department of Surgery, St Mary’s  Hospital, Room 1003, Q eQM Building,  South wharf Road, London w2 1NY, UK   Tel +44 203 312 8120   email n .rudarakanchana@imperial.ac.u kAbstract:  Endovascular technologies are rapidly evolving, often  requiring coordination and  cooperation between clinicians and technicians from diverse specialties.",Non-OADS,/arxiv_data1/oa_pdf/24/1e/vhrm-11-195.PMC4362978.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/24/1e/vhrm-11-195.PMC4362978.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/1e/vhrm-11-195.PMC4362978.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/59/2d/opth-9-469.PMC4362979.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 469–473Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  469Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8075 2nasolacrimal system aeration on computed  tomographic imaging: effects of patient  positioning and scan orientation Craig n Czyz1 Thomas s Bacon2 andrew W stacey3 eva n Cahill4 Bryan r Costin5 Boris i Karanfilov6 Kenneth V Cahill5 1section Oculofacial Plastic and  reconstructive surgery, Ohio  University/Ohio health, 2Department  of Medical education, Mount Carmel  health systems, Columbus, Oh, Usa;   3Department of Ophthalmology,   University of Michigan, ann arbor,   Mi, Usa; 4Department of Biology,   Wittenberg University, springfield,   Oh, Usa; 5Department of  Ophthalmology, William h havener  eye institute, Ohio state University  Wexner Medical Center, Columbus,   Oh, Usa; 6The sinus institute of  Ohio, Dublin, Oh, UsaPurpose:  To determine the impact of patient positioning and scan orientation on the appearance  of air in the nasolacrimal drainage system on computed tomography (CT) imaging, and the  repeatability of the observations.",Non-OADS,/arxiv_data1/oa_pdf/59/2d/opth-9-469.PMC4362979.pdf
"These  findings may allow for future correlations to pathologic states and/or be used to guide  treatment.Correspondence: Craig n Czyz 262 neil ave, suite 430, Columbus,  Oh 43201, Usa Tel +1 614 221 7464 email Dsp4000@aol.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Czyz et al Running head recto: Nasolacrimal system aeration on CT DOI: http://dx.doi.org/10.2147/OPTH.S80752",Non-OADS,/arxiv_data1/oa_pdf/59/2d/opth-9-469.PMC4362979.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/59/2d/opth-9-469.PMC4362979.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/2d/opth-9-469.PMC4362979.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/21/ppa-9-401.PMC4362980.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 401–411Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  401OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6717 1Knowledge about missed contraceptive pills  among married women at King Abdulaziz  University hospital rahila iftikhar Bahaa Abdulrahman   Aba Al Khail Family and community Medicine  Department, King Abdulaziz  University hospital, Jeddah,   saudi ArabiaBackground:  Oral contraceptive pills (OCPs) are one of the most reliable methods of  contraception.",Non-OADS,/arxiv_data1/oa_pdf/07/21/ppa-9-401.PMC4362980.pdf
"Some women do not use OCPs because of their incorrect perceptions regarding  their utilization.4 Secondly, the medications that are used for emergency contraception  are available through Gynecologist prescription in Saudi Arabia.5 OCPs are among the  most frequent form of contraception in Saudi   Arabia as well as in other Arab countries correspondence: rahila iftikhar Family and community Medicine  Department, King Abdulaziz University  hospital, PO Box 42806, Jeddah 21551,  saudi Arabia Tel +966 2 640 2114 email rahila_iftikhar@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Iftikhar and Aba Al Khail Running head recto: Knowledge about oral contraception DOI: http://dx.doi.org/10.2147/PPA.S67171",Non-OADS,/arxiv_data1/oa_pdf/07/21/ppa-9-401.PMC4362980.pdf
Available from: http://www.glowm.,Non-OADS,/arxiv_data1/oa_pdf/07/21/ppa-9-401.PMC4362980.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/07/21/ppa-9-401.PMC4362980.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/90/ppa-9-421.PMC4362981.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 421–428Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  421OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6843 2Antidepressant medication treatment patterns  in Asian patients with major depressive disorder Diego novick1 William Montgomery2 Victoria Moneta3 Xiaomei Peng4 roberto Brugnoli5 Josep Maria haro3 1eli lilly and company, Windlesham,   surrey, UK; 2eli lilly Australia Pty  ltd, West ryde, Australia; 3Parc  sanitari sant Joan de Déu, ciBersAM,   Universitat de Barcelona, Barcelona,   spain; 4eli lilly and company,   indianapolis, in, UsA; 5Department  of neuroscience, school of Medicine,   sapienza University of rome, rome,   italyPurpose:  To describe pharmacological treatment patterns in Asian patients with major depressive  disorder (MDD), including duration of treatment, reasons for medication discontinuation, rate  of medication nonadherence, factors associated with medication nonadherence, and impact of  medication nonadherence on depression outcomes.",Non-OADS,/arxiv_data1/oa_pdf/9d/90/ppa-9-421.PMC4362981.pdf
"In many patients, MDD requires  long-term antidepressant treatment to prevent relapse, making adherence with therapy  a crucial factor in relapse prevention.1 Clinical guidelines recommend several months  of antidepressant maintenance treatment for MDD; for example, 6 months of treatment  are recommended in the National Institute of Clinical Excellence (NICE) depression  guidelines.2 While clinical guidelines recommend prolonged maintenance treatment, early dis - continuation of treatment is usually high and adherence with therapy in the real-world correspondence: Diego novick lilly research centre, erl Wood Manor,  sunninghill road, Windelsham, surrey  gU20 6Ph, UK Tel +44 1276 483 832 Fax +44 1276 483 192 email novick_diego@lilly.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Novick et al Running head recto: Treatment patterns in Asian patients with depression DOI: http://dx.doi.org/10.2147/PPA.S68432",Non-OADS,/arxiv_data1/oa_pdf/9d/90/ppa-9-421.PMC4362981.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9d/90/ppa-9-421.PMC4362981.pdf
Available from:  http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/ guidelines/mdd.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9d/90/ppa-9-421.PMC4362981.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/ef/tcrm-11-407.PMC4362982.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 407–415Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  407Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7520 8Long-term safety and efficacy of tobramycin  in the management of cystic fibrosis emma vázquez-espinosa Rosa María Girón Rosa Mar Gómez-Punter elena García-Castillo Claudia valenzuela Carolina Cisneros enrique Zamora F Javier García-Pérez Julio Ancochea Pulmonology Department, La Princesa  institute for Health Research,   Hospital Universitario de La Princesa,   Madrid, SpainAbstract:  Cystic fibrosis (CF) is a fatal inherited disease caused by mutations in the CF  transmembrane conductance regulator ( CFTR ) gene whose mortality is conditioned by a pro - gressive decline in lung function.",Non-OADS,/arxiv_data1/oa_pdf/87/ef/tcrm-11-407.PMC4362982.pdf
"The most frequent antibiotic-resistant pathogens include   P. aeruginosa , Burkholderia cepacia , methicillin-resistant S. aureus , Stenotrophomo - nas maltophilia , and Achromobacter xylosoxidans .2 Chronic P. aeruginosa  infection  usually occurs during adolescence, when most patients (60%–80%) are colonized.3,4 Currently, the role of microorganisms in CF is more complex due to new noncul - ture methods, and the preferred sample is expectorated or hypertonic saline-induced  sputum; other samples are bronchoalveolar lavage fluid, as well as cough and oropha - ryngeal swabs.5 Environmental factors substantially influence the development of the  CF pediatric microbiome.6Correspondence: emma vázquez- espinosa Pulmonology Department, La Princesa  institute for Health Research, Hospital  Universitario de La Princesa, c/Diego  Leon, 62, 28006, Madrid, Spain Tel +34 91 5202277 email evazqueze@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Vázquez-Espinosa et al Running head recto: Safety and efficacy of tobramycin in cystic fibrosis DOI: http://dx.doi.org/10.2147/TCRM.S75208",Non-OADS,/arxiv_data1/oa_pdf/87/ef/tcrm-11-407.PMC4362982.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/87/ef/tcrm-11-407.PMC4362982.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/ef/tcrm-11-407.PMC4362982.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/9a/tcrm-11-417.PMC4362983.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 417–423Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  417ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7812 8Genotypic resistance profiles in Chinese patients  with chronic hepatitis B virus infection and the  efficacy of nucleoside analog rescue therapy ling-Bo liang lan-lan Chen en-Qiang Chen Juan liao hong Tang Center of infectious Disease, state  Key laboratory of Biotherapy, West  China hospital, West China school  of Medicine, sichuan University,   Chengdu, People’s Republic of ChinaBackground and aims:  The aims of this study were to explore the correlation between chronic  hepatitis B virus (HBV) drug-resistant mutation profiles and the efficacy of nucleoside analog  rescue therapy in patients with initial antiviral treatment failure.",Non-OADS,/arxiv_data1/oa_pdf/25/9a/tcrm-11-417.PMC4362983.pdf
"However, long-term nucleoside analog therapy is associated with the development of  antiviral resistance.1,2 For example, about 70%–80% of patients develop LAM resis - tance after 5-year treatment;2–4 42% of hepatitis Be antigen (HBeAg)-positive patients  and 29% of HBeAg-negative patients develop ADV resistance after 5-year treatment;5,6  and 25% of HBeAg-positive patients and 11% of HBeAg-negative patients develop  LDT resistance after 2-year treatment.2Correspondence: hong Tang Center of infectious Disease, state Key  laboratory of Biotherapy, West China  hospital, West China school of Medicine,  sichuan University, 37# guoxue lane, Chengdu 610041, People’s Republic  of China Tel +86 28 8542 3052 Fax +86 28 8542 3052 email htang6198@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Liang et al Running head recto: HBV -GR profiles and efficacy of rescue therapy DOI: http://dx.doi.org/10.2147/TCRM.S78128",Non-OADS,/arxiv_data1/oa_pdf/25/9a/tcrm-11-417.PMC4362983.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/25/9a/tcrm-11-417.PMC4362983.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/9a/tcrm-11-417.PMC4362983.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/73/opth-9-475.PMC4362984.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 475–482Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  475Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7968 0Efficiency, safety, and patient preference of  switching from dorzolamide 1%/timolol 0.5%   to brinzolamide 1%/timolol 0.5% while  maintaining the prostaglandin F2 α analog Y oshie shimizu1 shunsuke nakakura1 Makiko nishiyama1 hitoshi Tabuchi1 Y oshiaki Kiuchi2 1Department of Ophthalmology,   Saneikai Tsukazaki Hospital, Himeji,   2Department of Ophthalmology  and Visual Sciences, Graduate School  of Biomedical Sciences, Hiroshima  University, Hiroshima, JapanBackground:  We investigated the efficiency, safety and patient preference of switching from  dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the pros - taglandin F2 α analog.",Non-OADS,/arxiv_data1/oa_pdf/63/73/opth-9-475.PMC4362984.pdf
"Keywords:  glaucoma, prostaglandin F2 α, brinzolamide, dorzolamide, fixed combination,  timolol Introduction Fixed combination therapy has an advantage with respect to patient adherence in  subjects with glaucoma by decreasing the number of eye bottles required.1,2 The  effectiveness of this treatment has been shown to be equal to or greater than that of  combination therapy.3–8 Carbonic anhydrase inhibitor and beta-blocker fixed com - bination therapies are now available in two types: dorzolamide 2% or 1%/timolol Correspondence: Yoshie shimizu Department of Ophthalmology, Saneikai  Tsukazaki Hospital, 68-1 Aboshi Waku,  Himeji 671-1227, Japan Tel +817 9272 8555 Fax +817 9272 8550 email yo.shimizu@tsukazaki-eye.ne t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Shimizu et al Running head recto: Dorzolamide 1%/timolol 0.5% versus brinzolamide 1%/timolol 0.5% DOI: http://dx.doi.org/10.2147/OPTH.S79680",Non-OADS,/arxiv_data1/oa_pdf/63/73/opth-9-475.PMC4362984.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/63/73/opth-9-475.PMC4362984.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/73/opth-9-475.PMC4362984.pdf
"( Imaging Sci Dent 2015; 45: 1-5 ) KEY WORDS : Pterygoid Muscles; Temporomandibular Joint Disorders; Migraine Disorders; Magnetic Resonance Imaging Received April 18, 2014; Revised January 1, 2015; Accepted January 3, 2015 *Correspondence to : Dr. Isadora Luana FloresDepartment of Oral Diagnosis, School of Dentistry, UNICAMP, Avenida Limeira,901, PO Box 52, Piracicaba, SP 13414-903, Brazil Tel) 55-19-2106-5327, Fax) 55-19-2106-5327, E-mail) isadoraluanaflores@gmail.comImaging Science in Dentistry 2015; 45: 1-5 http://dx.doi.org/10.5624/isd.2015.45.1.1 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/29/isd-45-1.PMC4362986.pdf
"( Imaging Sci Dent 2015; 45: 15 -22) KEY WORDS : Cephalometry; Cone -Beam Computed Tomography; Orthodontics; Sella Turcica; Imaging, Three -Dimensional *This work was supported by a doctoral scholarship in the framework of the Inter- faculty Council for Development Co-operation (IRO).Received August 4, 2014; Revised October 16, 2014; Accepted November 3, 2014*Correspondence to : Dr. Pisha PittayapatOIC, OMFS-IMPATH Research Group, Department of Imaging and Pathology,Faculty of Medicine, University of Leuven and Oral and Maxillofacial Surgery,University Hospitals Leuven, Kapucijnenvoer 7, Leuven 3000-Belgium Tel) 32-16-34-1975 , Fax) 32-16-33-2410 , E-mail) p.pittayapat@gmail.comImaging Science in Dentistry 2015; 45: 15-22 http://dx.doi.org/10.5624/isd.2015.45.1.15 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/11/isd-45-15.PMC4362987.pdf
"Prof. K ıvanç Kamburo ˘glu Department of Dentomaxillofacial Radiology, Faculty of Dentistry, AnkaraUniversity, 06500, Bes ¸evler, Ankara, Turkey Tel) 90-312-2965632, Fax) 90-312-2123954, E-mail) dtkivo@yahoo.comImaging Science in Dentistry 2015; 45: 23-9 http://dx.doi.org/10.5624/isd.2015.45.1.23 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/d9/isd-45-23.PMC4362988.pdf
"5-11CBCT can potentially result in images with a sub-millimeter spatial resolution and soft -tissue contrast detection.12,13 Since the imaging quality a diagnostic tool must be ade- quate for the diagnosis of lesions in the oral and maxillo-facial region, it is desirable to acquire images with a highimage quality, showing adequate contrast -to-noise ratio performance and soft -tissue discrimination, while minimiz- ─31─Received  April 13, 2014; Revised June 2, 2014; Accepted June 9, 2014 *Correspondence to : Prof.  Eui-Hwan HwangDepartment of Oral and Maxillofacial Radiology, School of Dentistry, Kyung HeeUniversity, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Korea Tel) 82-2-958-9406 , Fax) 82-2-965-1256 , E-mail) hehan@khu.ac.krImaging Science in Dentistry 2015; 45: 31-9 http://dx.doi.org/10.5624/isd.2015.45.1.31 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/f0/isd-45-31.PMC4362989.pdf
"Revised September 30, 2014; Revised November 25, 2014; Accepted December 31, 2014 *Correspondence to : Dr. Swati AhujaDepartment of Prosthodontics, University of Tennessee Health Science Center, 875Union Ave, Memphis, TN 38163, USA Tel) 1-901-448-6230, Fax) 1-901-448-1294, E-mail) sahuja@uthsc.eduImaging Science in Dentistry 2015; 45: 41-7 http://dx.doi.org/10.5624/isd.2015.45.1.41 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/0d/isd-45-41.PMC4362990.pdf
"( Imaging Sci Dent 2015; 45: 49-54 ) KEY WORDS : Odontoma; Mandible; Odontogenic Tumors; Facial Asymmetry Received June 28, 2014; Revised September 25, 2014; Accepted October 4, 2014 *Correspondence to : Prof. Shivanand B. BagewadiB-1, Staff quarters, ITS Centre for Dental Studies and Research Campus, MuradNagar, Delhi-Meerut Road NH-58, Ghaziabad 201206, Uttar Pradesh, India Tel) 91-953-6158247 , Fax) 91-01232-225382 , E-mail) drshivanandb@yahoo.comImaging Science in Dentistry 2015; 45: 49-54 http://dx.doi.org/10.5624/isd.2015.45.1.49 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/c6/isd-45-49.PMC4362991.pdf
"( Imaging Sci Dent 2015; 45: 55-60 ) KEY WORDS : Multiple Myeloma; Maxilla; Plasma Cells; Plasmacytoma Received July 29, 2014; Revised October 21, 2014; Accepted October 27, 2014 *Correspondence to : Dr. Kiran Kumar Kotagudda RamaiahDepartment of Oral Medicine and Radiology, Navodaya Dental College andHospital, Raichur, Karnataka PIN -584103, India Tel) 91-948-0407682 , Fax) 91-85-32-223070 , E-mail) krksmile@gmail.comImaging Science in Dentistry 2015; 45: 55-60 http://dx.doi.org/10.5624/isd.2015.45.1.55 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/f8/isd-45-55.PMC4362992.pdf
"470, Pituba, Salvador, BA, CEP 41830 -480, Brazil  Tel) 55 -71-33550917, Fax) 55 -71-21084300, E -mail) torresmarianna@hotmail.comImaging Science in Dentistry 2015; 45: 61-5 http://dx.doi.org/10.5624/isd.2015.45.1.61 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/fc/isd-45-61.PMC4362993.pdf
"( Imaging Sci Dent 2015; 45: 67-72 ) KEY WORDS : Pneumatization; Sphenoid Sinus; Cone -Beam Computed Tomography; Skull Base Received September 8, 2014; Revised October 10, 2014; Accepted October 20, 2014 *Correspondence to: Dr. Aditya TadinadaDepartment of Oral and Maxillofacial Radiology, University of Connecticut, Schoolof Dental Medicine, 263 Farmington Ave., Farmington, CT 06030, USATel) 1-869- 679- 2719, Fax) 1-860-679-4760, E-mail) tadinada@uchc.eduImaging Science in Dentistry 2015; 45: 67-72 http://dx.doi.org/10.5624/isd.2015.45.1.67 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/98/isd-45-67.PMC4362994.pdf
"*Correspondence to : Prof. Won-Jin Yi Department of Oral and Maxillofacial Radiology, School of Dentistry, SeoulNational University, Seoul, KoreaTel) 8-22-2072-3049, Fax) 8-22-744-3919, E-mail) wjyi@snu.ac.kr*Correspondence to : Prof. Tae-Il KimDepartment of Periodontology, School of Dentistry, Seoul National University,Seoul, KoreaTel) 82-2-2072-2642, Fax) 82-2-744-0051, E-mail) periopf@snu.ac.krImaging Science in Dentistry 2015; 45: 7-13 http://dx.doi.org/10.5624/isd.2015.45.1.7 Copyright ⓒ2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://cr eativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/37/isd-45-7.PMC4362995.pdf
e-mail: folashadeakanmu@yahoo.com ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jvms-77-133.PMC4363013.pdf
©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b4/17/jvms-77-139.PMC4363014.pdf
e-mail: kyoshi@obihiro.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/jvms-77-147.PMC4363015.pdf
e-mail:	seiya-m@rakuno.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the creative  commons Attribution Non-commercial No derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/71/4c/jvms-77-155.PMC4363016.pdf
e-mail: etakahashi@brain.riken.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4f/4b/jvms-77-161.PMC4363017.pdf
"The polymerase chain reaction (PCR) protocols and primers  of microsatellite markers were reported in the Mouse Mic- rosatellite Data Base of Japan (MMDBJ, http://www.shigen.",OADS,/arxiv_data1/oa_pdf/4f/4b/jvms-77-161.PMC4363017.pdf
e-mail: ysyoon@snu.ac.kr ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/eb/80/jvms-77-167.PMC4363018.pdf
e-mail: muehara@muses.tottori-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c2/0a/jvms-77-175.PMC4363019.pdf
©2015	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5f/d0/jvms-77-181.PMC4363020.pdf
©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b7/19/jvms-77-187.PMC4363021.pdf
e-mail: h.takano@cardiovets.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5f/8b/jvms-77-193.PMC4363022.pdf
e-mail: jsuto@affrc.go.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d0/da/jvms-77-203.PMC4363023.pdf
e-mail: takehara@cc.tuat.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1c/18/jvms-77-211.PMC4363024.pdf
e-mail: ircpmi@obihiro.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/eb/45/jvms-77-217.PMC4363025.pdf
data were analyzed using Graphpad (http://graphpad.com/quickcalcs/).,OADS,/arxiv_data1/oa_pdf/eb/45/jvms-77-217.PMC4363025.pdf
e-mail: sugiyama@ gifu-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e3/b8/jvms-77-221.PMC4363026.pdf
e-mail: shiroki@gifu-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/jvms-77-225.PMC4363027.pdf
e-mail: mcchoi@snu.ac.kr ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5e/a7/jvms-77-229.PMC4363028.pdf
e-mail: KanreuthaiW@gmail.com ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/37/55/jvms-77-233.PMC4363029.pdf
Amplified PCR products  of cps-positive strains were sequenced and compared with  the GenBank database using the BLAST software main-tained by the National Center for Biotechnology Information  (NCBI) (http://www.ncbi.nlm.nih.gov/BLAST).,OADS,/arxiv_data1/oa_pdf/37/55/jvms-77-233.PMC4363029.pdf
e-mail: rei@u-a-h.com ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d3/8a/jvms-77-237.PMC4363030.pdf
e-mail: nakamuta@iwate-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/af/db/jvms-77-241.PMC4363031.pdf
"e-mail:	jku0623@korea.kr **Co-Corresponden Ce to:	park, S.C., e-mail:	parksec@snu.ac.kr ©2015	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/b2/f7/jvms-77-247.PMC4363032.pdf
e-mail: masuda@aacl.co.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b3/93/jvms-77-251.PMC4363033.pdf
e-mail: furuhama@iwate-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f9/4f/jvms-77-261.PMC4363034.pdf
‘‘Pediatric/VFC Vaccine Price List.’’ Available at: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/25/88/10.1177_0960327113512340.PMC4363126.pdf
Available at: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/25/88/10.1177_0960327113512340.PMC4363126.pdf
Available at: http://webarchive.nationa larchives.gov.uk/20130107 105354/http://www.dh.gov.,Non-OADS,/arxiv_data1/oa_pdf/25/88/10.1177_0960327113512340.PMC4363126.pdf
Immunization summary: a statistical reference containing data through 2011.Available from: http://www.unicef.org/videoaudio/ PDFs/EN-ImmSumm-2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d8/dd/40121_2015_Article_59.PMC4363213.pdf
http://mhlw-grants.niph.go.jp .,Non-OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
"Minutes of pneumococcal sub-committee meeting on Wednesday, May 30, 2012. http://webarchive.nationalarchives.gov.uk/2013040 2145952/http:/transparency.dh.gov.uk/2012/07/27/jcvi-pneumococcal-sub- committee-meeting-may- 2012/ .",Non-OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
2013. http://www.e-stat.go.jp/ .,OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
2012. http://www.e-stat.go.jp/ .,OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
http://mhlw-grants.niph.go.jp .,Non-OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
2012. http://www.e-stat.go.jp/ .,OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
2013. http://www.e-stat.go.jp/ .,OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
2013. http://www.e-stat.go.jp/ .,OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
Guidelines for evaluating the cost-effectiveness of vaccination.http://www.mhlw.go.jp/stf/shingi/2r98520000014 ryv-att/2r98520000014sdi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
2012. http://www.e-stat.go.jp/ .,OADS,/arxiv_data1/oa_pdf/23/db/40121_2014_Article_53.PMC4363214.pdf
2010. http://www.uroweb.,Non-OADS,/arxiv_data1/oa_pdf/03/91/40121_2014_Article_54.PMC4363217.pdf
European Association of Urology guidelines onurological infections 2014 (limited update of 2013).http://www.uroweb.org .,Non-OADS,/arxiv_data1/oa_pdf/03/91/40121_2014_Article_54.PMC4363217.pdf
http://kdigo.org/home/ .,Non-OADS,/arxiv_data1/oa_pdf/bf/85/40121_2014_Article_56.PMC4363218.pdf
http://www.cebm.net/ index.aspx?o=1025 .,Non-OADS,/arxiv_data1/oa_pdf/bf/85/40121_2014_Article_56.PMC4363218.pdf
In: Presented at the CROI 2013. http://clinicaltrials.gov/ct2/ show/NCT00089505?term=ACTG ?A5208&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/bf/85/40121_2014_Article_56.PMC4363218.pdf
http://www.natap.,Non-OADS,/arxiv_data1/oa_pdf/bf/85/40121_2014_Article_56.PMC4363218.pdf
http://www.iasociety.org/Default.aspx?pageId= 12&abstractId=200746721 .,OADS,/arxiv_data1/oa_pdf/bf/85/40121_2014_Article_56.PMC4363218.pdf
http://archives.who.int/eml/ expcom/expcom15/applications/newmed/emtri/ REF_emtricitabine/Molina_ABT418_IAS2005_Poster WePe123C12.pdf .,OADS,/arxiv_data1/oa_pdf/bf/85/40121_2014_Article_56.PMC4363218.pdf
Available from: http://biostat.hitchcock.org/Measurement Error/Analytics/PowerCalculationsforLogisticRegres sion.asp .,OADS,/arxiv_data1/oa_pdf/27/f8/40121_2015_Article_57.PMC4363219.pdf
Available from: http://aidsinfo.nih.gov/guidelines .,Non-OADS,/arxiv_data1/oa_pdf/27/f8/40121_2015_Article_57.PMC4363219.pdf
Available from: http://www.aidsmeds.com/list.,Non-OADS,/arxiv_data1/oa_pdf/27/f8/40121_2015_Article_57.PMC4363219.pdf
http://www.hcvguidelines.org/full-report-view .,Non-OADS,/arxiv_data1/oa_pdf/bf/01/40121_2015_Article_58.PMC4363220.pdf
"Surveillance for Viral Hepatitis—United States, 2011. http://www.cdc.gov/hepatitis/ Statistics/2011Surveillance/index.htm .",Non-OADS,/arxiv_data1/oa_pdf/bf/01/40121_2015_Article_58.PMC4363220.pdf
Available from http://www.uptodate.com/crlsql/interact/ frameset.jsp .,OADS,/arxiv_data1/oa_pdf/bf/01/40121_2015_Article_58.PMC4363220.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Gennuso KP, Gangnon RE, Matthews CE, et al.",Non-OADS,/arxiv_data1/oa_pdf/29/ca/bjsports-2014-093514.PMC4363289.pdf
"Shynrye Lee and Hyung-Jun Kim * Korea Brain Research Institute, Research Division, Daegu 700-010, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.1 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
"Key words:  ALS (Amyotrophic lateral sclerosis), SOD1, TDP-43, FUS, Plion-like phenomena, Misfolded protein aggregates Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
"2 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.1Shynrye Lee and Hyung-Jun Kim PFN1, TAF15, ATXN2, C9ORF72, UBQLN2, OPTN, VCP ,  FUS  and TARDBP  genes [4,7].",OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
"3 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.1Prion-like Mechanism in ALS related FALS patients [22,23].",Non-OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
4 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.1Shynrye Lee and Hyung-Jun Kim very well accepted that secreted toxic factors produced by glial cells  expressing ALS-causing mutant SOD1 induce the loss of motor  neurons in the FALS SOD1 mouse model [20].,Non-OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
"5 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.1Prion-like Mechanism in ALS are found in the C-terminal region, and C-terminal truncated  fragments of TDP-43 show significantly enhanced aggregation  properties in vitro  and in cells [20].",OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
"6 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.1Shynrye Lee and Hyung-Jun Kim Foundation of Korea (NRF) funded by the Ministry of Science,  ICT & Future Planning (NRF-2013R1A1A1076124).",Non-OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
7 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.1Prion-like Mechanism in ALS Other Motor Neuron Disord 1:163-184.,OADS,/arxiv_data1/oa_pdf/95/f2/en-24-1.PMC4363329.pdf
"All of these  mechanisms appear to require Ca2+ increase in the cytoplasm, but  it is still not clear whether the source of Ca2+ is Ca2+ entry or Ca2+ Ca2+ Entry is Required for Mechanical   Stimulation-induced ATP Release from Astrocyte Jaekwang Lee1, Y e-Eun Chun1,2, Kyung-Seok Han1, Jungmoo Lee1,3,   Dong Ho Woo1 and C. Justin Lee1,2,3* 1Center for Functional Connectomics, and Center for Neural Science, Korea Institute of Science and Technology (KIST),   Seoul 136-791, 2Neuroscience Program, University of Science and Technology (UST), Daejeon 305-350,   3KU-KIST Graduate School of Converging Science and Technology, Seoul 136-701, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.17 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
"Key words:  Astrocytes, ATP , Mechanical stimulation, Ca2+ Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
"18 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.17Jaekwang Lee, et al.",OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
19 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.17Ca2+ Influx is Critical for Mechanical Stimulation Induced ATP Release in Astrocyte W orkbench was synchronized with pClamp 9.2.,OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
"20 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.17Jaekwang Lee, et al.",OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
21 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.17Ca2+ Influx is Critical for Mechanical Stimulation Induced ATP Release in Astrocyte from sensor cell nearby a single astrocyte and Fura-2 ratiometric  imaging (Fig.,OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
"22 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.17Jaekwang Lee, et al.",OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
"23 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.17Ca2+ Influx is Critical for Mechanical Stimulation Induced ATP Release in Astrocyte Nistri A, Pryazhnikov E, Khiroug L, Giniatullin R, Zorec R  (2007) Exocytotic release of ATP from cultured astrocytes.",OADS,/arxiv_data1/oa_pdf/84/d5/en-24-17.PMC4363330.pdf
"Furthermore, Koenig and  Cho [15] showed that hypothalamic KA receptor mRNA levels  are elevated in insulin-induced hypoglycemic rats, suggesting that Intracerebroventricular Kainic Acid-Induced  Damage Affects Blood Glucose Level in   d-glucose-fed Mouse Model Chea-Ha Kim1 and Jae-Seung Hong2* 1Department of Pharmacology, Institute of Natural Medicine, College of Medicine,   2Department of Physical Education, College of Natural Science, Hallym University, Chuncheon 200-702, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.24 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
"Key words:  kainic acid, neuronal cell death, blood glucose, D-glucose-fed model Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
25 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.24Intracerebroventricular Kainic Acid-Induced Damage Affects the Blood Glucose Level KA receptor expression may be dynamically regulated depending  on the level of blood glucose.,Non-OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
"26 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.24Chea-Ha Kim and Jae-Seung Hong San Diego, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
27 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.24Intracerebroventricular Kainic Acid-Induced Damage Affects the Blood Glucose Level to 2 h after D-glucose feeding in the control group.,Non-OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
"28 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.24Chea-Ha Kim and Jae-Seung Hong located in the hippocampal formation plays an important role  in synaptic physiology and plasticity [18, 19].",OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
"29 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.24Intracerebroventricular Kainic Acid-Induced Damage Affects the Blood Glucose Level Foundation of Korea (NRF) funded by the Ministry of Education,  Science and T echnology.",Non-OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
30 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.24Chea-Ha Kim and Jae-Seung Hong patterns of neuronal damage following systemic or intra- cere  bral injections of kainic acid: a histological study.,OADS,/arxiv_data1/oa_pdf/95/f5/en-24-24.PMC4363331.pdf
"Therefore, there is an urgency Amelioration of Cerebral Ischemic Injury by a  Synthetic Seco-nucleoside LMT497 Sangwoo Ryu1#, Joonha Kwon1#, Hyeon Park1, In-Y oung Choi1, Sunyoung Hwang1,  Veeraswamy Gajulapati2, Joo Y oung Lee2, Y ongseok Choi2, Katia Varani3,   Pier Andrea Borea3, Chung Ju1 and Won-Ki Kim1* 1Department of Neuroscience, School of Medicine, Korea University, Seoul 136-705, 2Department of Biotechnology, School  of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea, 3Dipartimento di Scienze Farmaceutiche and  Dipartimento di Medicina Clinica e Sperimentale-Sezione di Farmacologia, Università, di Ferrara, 44100 Ferrara, Italyhttp://dx.doi.org/10.5607/en.2015.24.1.31 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"Key words:  cerebral ischemia, MCAO, oxidative stress, inflammation, LMT497, Cl-IB-MECA Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"32 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Sangwoo Ryu, et al.",OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
33 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Anti-ischemic Effect of Seco-Cl-IB-MECA or 10 h/18 h after the onset of MCAO.,Non-OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"34 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Sangwoo Ryu, et al.",OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
35 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Anti-ischemic Effect of Seco-Cl-IB-MECA for multiple comparisons.,OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"36 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Sangwoo Ryu, et al.",OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"37 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Anti-ischemic Effect of Seco-Cl-IB-MECA of LMT497 (2 mg/kg, i.v., twice) significantly reduced ischemic  infarction volume, edema and neurological score in two different  time windows (3 h/8 h; 10 h/18 h) ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"38 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Sangwoo Ryu, et al.",OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
39 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Anti-ischemic Effect of Seco-Cl-IB-MECA REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"40 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.31Sangwoo Ryu, et al.",OADS,/arxiv_data1/oa_pdf/15/a5/en-24-31.PMC4363332.pdf
"T o reduce  the brain damage caused by cerebral ischemia, the solution for Dehydroascorbic Acid Attenuates Ischemic Brain  Edema and Neurotoxicity in Cerebral Ischemia:  An in vivo  Study Juhyun Song1,#, Joohyun Park1,2,#, Jae Hwan Kim1, Ja Y ong Choi1,2,   Jae Y oung Kim1,2, Kyoung Min Lee3 and Jong Eun Lee1,2,* 1Department of Anatomy, 2BK21 Plus Project for Medical Sciences, and Brain Research Institute, Yonsei University College of  Medicine, Seoul 120-752, 3Department of Neurology, Seoul National University College of Medicine, Seoul 120-752, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.41 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"Key words:  Dehydroascorbic acid (DHA), Cerebral ischemia, Edema, Blood-brain barrier (BBB), Neurotoxicity, Synaptic  dysfunction Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"42 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
43 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Dehydroascorbic Acid Improves Brain Damage Following Cerebral Ischemia (PVDF) membrane.,Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"44 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
45 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Dehydroascorbic Acid Improves Brain Damage Following Cerebral Ischemia preserve the expression of Claudin 5 in ischemic brain and also  protect the BBB disruption.,Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"46 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
47 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Dehydroascorbic Acid Improves Brain Damage Following Cerebral Ischemia we conducted immunohistochemistry using Bax antibody at  reperfusion 24 hr after MCAO injury to examine whether DHA  influences on the alteration of marker that affects mitochondrial  cell death both in cortex (Fig.,Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"48 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"49 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Dehydroascorbic Acid Improves Brain Damage Following Cerebral Ischemia DHA treatment group, iNOS expression was decreased in both  cortex (Fig.",Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"50 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
51 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Dehydroascorbic Acid Improves Brain Damage Following Cerebral Ischemia 9.,Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"52 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
53 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Dehydroascorbic Acid Improves Brain Damage Following Cerebral Ischemia Am J Emerg Med (in press).,Non-OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"54 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.41Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/3b/c7/en-24-41.PMC4363333.pdf
"COMP-Ang1 Potentiates EPC Treatment of  Ischemic Brain Injury by Enhancing Angiogenesis  Through Activating AKT-mTOR Pathway and  Promoting Vascular Migration Through Activating  Tie2-FAK Pathway Hyo Eun Moon1,2,3#, Kyunghee Byun4,5#, Hyung Woo Park1,2,3, Jin Hyun Kim6, Jin Hur7,  Joong Shin Park8, Jong Kwan Jun8, Hyo-Soo Kim7, Seung Leal Paek1,2,3,9,   In Keyoung Kim1, Jae Ha Hwang1, Jin Wook Kim1, Dong Gyu Kim1, Y oung Chul Sung10,  Gou-Y oung Koh11, Chang W Song12, Bonghee Lee4,5* and Sun Ha Paek1,2,3* 1Department of Neurosurgery, 2Cancer Research Institute, 3Ischemic/Hypoxic Disease Institute, Seoul National University  College of Medicine, Seoul 110-744, 4Center for Regenerative Medicine, Lee Gil Ya Cancer and Diabetes Institute,   Gachon University, 5Department of Anatomy and Cell Biology, Gachon University Medical School, Incheon 406-840,   6Clinical Research Institute, Gyeongsang National University Hospital, Jinju 660-702, 7Innovative Research Institute for Cell  Therapy (IRICT), Seoul National University Hospital, 8Department of Obstetrics & Gynecology, Seoul National University  Hospital, Seoul 110-744, Korea, 9Department of Neurosurgery, Mayo Clinic, USA, 10Division of Molecular and Life Science,  Integrative Bioscience & Biotechnology, Pohang University of Science and Technology, Pohang 790-784, 11Laboratory for  Vascular Biology and Stem Cell, Department of Biological Sciences, Korea Advanced Institute of Science and Technology,  Daejeon 305-338, Korea, 12Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota Medical  School, Minneapolis, USAhttp://dx.doi.org/10.5607/en.2015.24.1.55 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"Molecular studies revealed that COMP-Ang1 induced an interaction between Tie2 and FAK, but  Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"56 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
57 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55COMP-Ang1 Promotes Angiogenesis by hCB-EPC Isolation of mononuclear cells (MNCs) derived from human  umbilical cord blood (HUCB)  All human aspects of this study were approved by the institu - tional review board of Seoul National University Hospital (IRB No.,OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
The length of capillary tube  formed was determined with ImageJ v1.38 (http://rsb.info.nih.gov/ ij/).,OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"58 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
59 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55COMP-Ang1 Promotes Angiogenesis by hCB-EPC NaCl (heparin included) followed by ~50 ml of ice-cold (4oC) 4%  paraformaldehyde.,Non-OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"60 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
61 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55COMP-Ang1 Promotes Angiogenesis by hCB-EPC location of AKT remained the same in cytoplasm and nucleus  after COMP-Ang1 treatment (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"62 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
63 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55COMP-Ang1 Promotes Angiogenesis by hCB-EPC Fig.,Non-OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"64 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
65 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55COMP-Ang1 Promotes Angiogenesis by hCB-EPC W e also analyzed the MAPK molecules to determine whether  the AKT/mTOR interaction induced angiogenesis via MAPK  pathway in EPCs in rat brain.,OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"66 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"67 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55COMP-Ang1 Promotes Angiogenesis by hCB-EPC Relative HIF-1α mRNA expression level was also investigated  before and after COMP-Ang1 treatment with or without Tie2, FAK,  or AKT silencing or mTOR inhibition in EPCs in vitro  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"68 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
69 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55COMP-Ang1 Promotes Angiogenesis by hCB-EPC blood-derived endothelial precursor cells augment postnatal  neovascularization.,Non-OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"70 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.55Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/e0/84/en-24-55.PMC4363334.pdf
"Conversely, increased serum estradiol, specifically, has been Long-term Treatment with Oriental Medicinal  Herb Artemisia princeps  Alters Neuroplasticity in  a Rat Model of Ovarian Hormone Deficiency Hyun-Bum Kim1, Byeong-Jae Kwon1, Hyun-Ji Cho2, Ji-Won Kim2, Jeong-Woo Chon2,  Moon-Ho Do4, Sang-Y ong Park5, Sun-Y eou Kim4, Sung-Ho Maeng3,   Y oo-Kyoung Park2,6 and Ji-Ho Park3,6* Departments of 1East-West Medical Science, 2Medical Nutrition, 3East-West Medicine, Graduate School of East-West Medical  Science, Kyung Hee University, Yongin 446-701, 4College of Pharmacy, Gachon University, Incheon 406-799 ,   5Department of Oriental Medicinal Materials and Processing, College of Life Science,   6Research Institute of Medical Nutrition, Kyung Hee University, Yongin 446-701, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.71 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"Key words:  Artemisia princeps , Oriental medicine, ovariectomy, long-term depression (LTD), hippocampal synaptic plasticity Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"72 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71Hyun-Bum Kim, et al.",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"73 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71LTD Attenuation by AP in OVX Rat carried out on a W aters system (Milford, MA, USA) consisting  of a separation module (e2695) with integrated column heater,  as well as an autosampler and photodiode array detector (2998).",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"74 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71Hyun-Bum Kim, et al.",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
75 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71LTD Attenuation by AP in OVX Rat was set at p=0.05.,OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"76 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71Hyun-Bum Kim, et al.",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"77 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71LTD Attenuation by AP in OVX Rat (17.93±0.47% versus 54.40±5.26%; mean difference -36.47%,  p<0.01), ALEN (20.81±4.41%; mean difference -33.59%, p<0.01),  and AP (18.38±1.84%; mean difference -36.02%, p<0.01) but  no differences among the three treatment groups.",Non-OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"78 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71Hyun-Bum Kim, et al.",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"79 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71LTD Attenuation by AP in OVX Rat pulse stimulation in 17β estradiol-treated ovariectomized adult  rats [34, 56].",Non-OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"80 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71Hyun-Bum Kim, et al.",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
81 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71LTD Attenuation by AP in OVX Rat 13.,Non-OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"82 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71Hyun-Bum Kim, et al.",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"83 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.71LTD Attenuation by AP in OVX Rat M, Munkhzaya M, Altankhuu T , Kuwahara A, Y asui T , Irahara  M (2014) Changes in central and peripheral inflammatory  responses to lipopolysaccharide in ovariectomized female  rats.",OADS,/arxiv_data1/oa_pdf/be/35/en-24-71.PMC4363335.pdf
"T aken together, GIT1 regulates both  excitatory and inhibitory synaptic transmission, which is critical  for excitatory and inhibitory balance.A Critical Role of GIT1 in Vertebrate and  Invertebrate Brain Development Sung-Tae Hong1 and Won Mah1,2* 1Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon,   2Department of Anatomy and Neurobiology, School of Dentistry, Kyungpook National University, Daegu, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.8 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
"Key words:  GIT1, dGit, Microcephaly, Brain Development Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
9 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Role of GIT1 in Brain Development The importance of the GIT1-βPIX-RAC1-PAK3 signaling  complex in brain development has been supported by a series of  studies.,Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
10 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Sung-Tae Hong and Won Mah Statistics Student’ s t test was done using Microsoft Excel 2007 (Microsoft).,Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
Result of rotarod assay was analyzed by repeated ANOV A using R  (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
11 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Role of GIT1 in Brain Development Fig.,Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
12 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Sung-Tae Hong and Won Mah changed (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
"13 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Role of GIT1 in Brain Development DISCUSSION Here, we report a microcephaly-like brain size reduction,  decreased neuronal cell body size, and behavioral deficits such as  impaired motor coordination and learning in Git1–/– mice.",Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
14 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Sung-Tae Hong and Won Mah dGit  deletion mutation.,OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
"15 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Role of GIT1 in Brain Development Garner CC, Gundelfinger ED, Premont RT , Kaang BK, Kim  E (2003) The GIT family of proteins forms multimers and  associates with the presynaptic cytomatrix protein Piccolo.",OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
16 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.8Sung-Tae Hong and Won Mah 29.,Non-OADS,/arxiv_data1/oa_pdf/a3/c9/en-24-8.PMC4363336.pdf
"Unfortunately, a touch-screen system for the working Development of a Touch-Screen-Based Paradigm  for Assessing Working Memory in the Mouse Chuljung Kwak, Chae-Seok Lim and Bong-Kiun Kaang * Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul 151-747, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.84 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/25/8f/en-24-84.PMC4363337.pdf
"Key words:  touch screen, working memory, mouse cognition, delayed match to position Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/8f/en-24-84.PMC4363337.pdf
85 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.84Working Memory Test in Touch Screen memory test paradigm for mice is not available yet [7].,Non-OADS,/arxiv_data1/oa_pdf/25/8f/en-24-84.PMC4363337.pdf
"86 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.84Chuljung Kwak, et al.",OADS,/arxiv_data1/oa_pdf/25/8f/en-24-84.PMC4363337.pdf
87 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.84Working Memory Test in Touch Screen rate of correct choice to matched position (Fig.,Non-OADS,/arxiv_data1/oa_pdf/25/8f/en-24-84.PMC4363337.pdf
"88 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.84Chuljung Kwak, et al.",OADS,/arxiv_data1/oa_pdf/25/8f/en-24-84.PMC4363337.pdf
89 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.84Working Memory Test in Touch Screen 12.,Non-OADS,/arxiv_data1/oa_pdf/25/8f/en-24-84.PMC4363337.pdf
"Anatomical, functional, and metabolic asymmetries between  the hemispheres in the healthy brain have been widely accepted Asymmetry of Dopamine D2/3 Receptor  Availability in Dorsal Putamen and   Body Mass Index in Non-obese Healthy Males Sang Soo Cho1, Eun Jin Y oon1 and Sang Eun Kim1,2,3* 1Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University   College of Medicine, Seongnam 463-707, 2Department of Transdisciplinary Studies,   Graduate School of Convergence Science and Technology, Seoul National University, Seoul 151-742,   3Advanced Institutes of Convergence Technology, Suwon 443-270, Koreahttp://dx.doi.org/10.5607/en.2015.24.1.90 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/50/4e/en-24-90.PMC4363338.pdf
"Key words:  Dopamine, striatum, body mass index, asymmetry Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/4e/en-24-90.PMC4363338.pdf
"91 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.90Dopamine and Body Mass Index [8,9].",Non-OADS,/arxiv_data1/oa_pdf/50/4e/en-24-90.PMC4363338.pdf
"92 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.90Sang Soo Cho, et al.",OADS,/arxiv_data1/oa_pdf/50/4e/en-24-90.PMC4363338.pdf
"93 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.90Dopamine and Body Mass Index receptor availability [20], DA transporter density [21], and  DA synthesis capacity [22].",OADS,/arxiv_data1/oa_pdf/50/4e/en-24-90.PMC4363338.pdf
"94 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.1.90Sang Soo Cho, et al.",OADS,/arxiv_data1/oa_pdf/50/4e/en-24-90.PMC4363338.pdf
The test is currently beingevaluated ( http://clinicaltrials.gov/show/NCT01865032 ).,Non-OADS,/arxiv_data1/oa_pdf/86/c5/40257_2015_Article_114.PMC4363483.pdf
http://ctep.cancer.gov/protocolDevelopment/electronic_ applications/docs/ctcaev3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/da/d1/11523_2014_Article_307.PMC4363524.pdf
Pfizer Inc. http://labeling.pfizer.com/ShowLabeling.aspx?id=759 .,Non-OADS,/arxiv_data1/oa_pdf/da/d1/11523_2014_Article_307.PMC4363524.pdf
http://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf .,OADS,/arxiv_data1/oa_pdf/da/d1/11523_2014_Article_307.PMC4363524.pdf
http://www.nhlbi.nih.gov/ guidelines/hypertension/express.pdf .,Non-OADS,/arxiv_data1/oa_pdf/da/d1/11523_2014_Article_307.PMC4363524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/4b/main.PMC4363578.pdf
1944-7124/15 http://dx.doi.org/10.1016/j.tranon.2014.12.001,Non-OADS,/arxiv_data1/oa_pdf/76/4b/main.PMC4363578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/23/rjv025.PMC4363684.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/64/rjv021.PMC4363686.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/37/rjv023.PMC4363691.pdf
Cells 2015; 38(3): 195-201  http://dx.doi.org/10.14348/molcells.2015.2331                     Life of T Follicular Helper Cells     Woong-Kyung Suh*      Antibodies are powerful defense tools against pathogens  but may cause autoimmune diseases when erroneously directed toward self-antigens.,Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
CD4 T cells harboring high affinity  TCR appear to preferentially  undergo pre-Tfh differentiation over  other effector T helper cellsMolecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
Cells http://molcells.org      A                          B                         Fig.,Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
Life of T Follicular Helper Cells  Woong-Kyung Suh      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
Cells http://molcells.org     kine synthesis for targeted delivery to cognate B cells.,Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
Life of T Follicular Helper Cells  Woong-Kyung Suh      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
Cells http://molcells.org     Tracing B cell development in human germinal centres by  molecular analysis of single cells picked from histological  sections.,OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
Life of T Follicular Helper Cells  Woong-Kyung Suh      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ae/fd/molcell-38-3-195.PMC4363718.pdf
"Cells 2015; 38(3): 202-209  http://dx.doi.org/10.14348/molcells.2015.2356                    Turning Hepatic Cancer Stem Cells Inside Out –  A Deeper Understanding through Multiple  Perspectives     Lok-Hei Chan1, Steve T. Luk1, and Stephanie Ma1,2,*      Hepatocellular carcinoma (HCC), a highly malignant disease  and the third leading cause of all cancer mortalities world-wide, often responses poorly to current treatments and re- sults in dismal outcomes due to frequent chemoresistance  and tumor relapse.",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
"Cells http://molcells.org     ports revealed high clonogenic capacity, which was associated  with increased abundance of CD133, CD44, CXCR4 and en-hanced transcriptions of OCT4  and NANOG.",OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
"Cells http://molcells.org                                                        on HCC growing subcutaneously or multifocally in the peritone- al cavity of nude mice (Bach et al., 2013).",OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
Cells http://molcells.org     progression depends on autocrine IL-6 signaling.,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e7/1e/molcell-38-3-202.PMC4363719.pdf
"Cells 2015; 38(3): 210-220  http://dx.doi.org/10.14348/molcells.2015.2138                     Genome-Wide Analysis of DNA Methylation before-  and after Exercise in the Thoroughbred Horse with MeDIP-Seq     Jeong-An Gim1,14, Chang Pyo Hong2,14, Dae-Soo Kim3, Jae-Woo Moon2, Yuri Choi1, Jungwoo Eo1, Yun- Jeong Kwon1, Ja-Rang Lee1, Yi-Deun Jung1, Jin-Han Bae1, Bong-Hwan Choi4, Junsu Ko2, Sanghoon  Song2, Kung Ahn2, Hong-Seok Ha5, Young Mok Yang6, Hak-Kyo Lee7, Kyung-Do Park7, Kyoung-Tag Do8,  Kyudong Han9, Joo Mi Yi10, Hee-Jae Cha11, Selvam Ayarpadikannan1, Byung-Wook Cho12, Jong Bhak2,13,*,  and Heui-Soo Kim1,*      Athletic performance is an important criteria used for the  selection of superior horses .",Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
How-Molecules and Cells http://molcells.org   Established in 1990   eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
Cells http://molcells.org                                         Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
Cells http://molcells.org                            Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
Cells http://molcells.org     changes occurring in the horse that are induced by exercise.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
Cells http://molcells.org     Biol.,OADS,/arxiv_data1/oa_pdf/c4/e4/molcell-38-3-210.PMC4363720.pdf
"Cells 2015; 38(3): 221-228  http://dx.doi.org/10.14348/molcells.2015.2170                    A Fibrin Matrix Promotes the Differentiation of  EMSCs Isolated from Nasal Respiratory Mucosa to Myelinating Phenotypical Schwann-Like Cells     Qian Chen1, Zhijian Zhang1,*, Jinbo Liu2, Qinghua He3, Yuepeng Zhou1, Genbao Shao1, Xianglan Sun1,  Xudong Cao4, Aihua Gong1, and Ping Jiang1      Because Schwann cells perform the triple tasks of mye-lination, axon guidance and neurotrophin synthesis, they  are candidates for cell transplantation that might cure  some types of nervous-system degenerative diseases or injuries.",Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
"Because the neural crest is regarded as  the forth germ layer and its cells mainly develop into peripheral nervous-system components, its direct descendants, the Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
"Cells http://molcells.org     EMSCs, naturally have the propensity to differentiate into SCs  (Hall, 2008).",Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
Cells http://molcells.org      A              B              C              D                E              F              G              H                   A            B             C                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
"Cells http://molcells.org      A                     B                    C                  D                     E                    F                  G                     H                    I                       A                      B                              compliant matrix environment is reported to be lower than that  on a stiff matrix (Hadjipanayi et al., 2009).",OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
"Cells http://molcells.org     34, 6112-6122.",Non-OADS,/arxiv_data1/oa_pdf/e2/e1/molcell-38-3-221.PMC4363721.pdf
"Cells 2015; 38 (3): 229-235  http://dx.doi.org/10.14348/molcells.2015.2253                  Nicotinamide Exerts Antioxidative Effects on  Senescent Cells     Ju Yeon Kwak, Hyun Joo Ham, Cheol Min Kim1, and Eun Seong Hwang*      Nicotinamide (NAM) has been shown to suppress reactive   oxygen species (ROS) production in primary human fibro- blasts, thereby extending their replicative lifespan when   added to the medium during long-term cultivation.",Non-OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
In both sense- Molecules and Cells http://molcells.org   Established in 1990   eISSN: 0219-1032 The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
"Cells http://molcells.org  cence models, NAM treatment substantially reduced ROS le- vels and the majority of the assessed senescence phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
"Cells http://molcells.org  A                     B                  C                     D                     E                       A                                    B                                              ides in various cell types at doses ranging from 1-5 mM (Spag- nuolo et al., 2006; So-Young Jang, data not shown).",OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
Cells http://molcells.org arrested at the G2/M phase in response to Adriamycin treatment  somehow escaped the effects of NAM treatment and progressed through the cell cycle until they became arrested in the G1 phase.,Non-OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/40/e6/molcell-38-3-229.PMC4363722.pdf
"Cells 2015; 38(3): 236-242  http://dx.doi.org/10.14348/molcells.2015.2282                    Caffeine Induces High Expression of cyp-35A  Family   Genes and Inhibits the Early Larval Development in  Caenorhabditis elegans    Hyemin Min1,3, Ichiro Kawasaki1,3, Joomi Gong1, and Yhong-Hee Shim1,2,*      Intake of caffeine during pregnancy can cause retardation  of fetal development.",Non-OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
"Besides detoxification effect of cyp-35A  genes, it  was reported that CYPs could convert non-toxic chemicals to Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
"Cells http://molcells.org      responding L4440 vector feeding RNAi clones using T7 primer,  5-GTAATACGACTCACTATAGGGC-3 , and L4440 T7 primer,  5-ATTAATACGACTCACTATAGGGA-3 .",Non-OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
Cells http://molcells.org      Table 3.,OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
"Cells http://molcells.org     not completely blocked in this condition, although slow pumping  rate might have affected growth rate of worms.",Non-OADS,/arxiv_data1/oa_pdf/d3/58/molcell-38-3-236.PMC4363723.pdf
"Cells 2015; 38(3): 243-250  http://dx.doi.org/10.14348/molcells.2015.2297                     Comparative Analysis of the Conserved Functions  of Arabidopsis DRL1 and Yeast KTI12    Sang Eun Jun1,6, Kiu-Hyung Cho1,5,6, Ji-Young Hwang1, Wael Abdel-Fattah3, Alexander Hammermeister3,  Raffael Schaffrath2,3, John L. Bowman4, and Gyung-Tae Kim1,*      Patterning of the polar axis dur ing the early leaf developmen- tal stage is established by cell-to-cell communication between  the shoot apical meristem (SAM) and the leaf primordia.",OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
"In addition, CENTER CITY  (CCT)Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
"Cells http://molcells.org     and GRAND CENTRAL  (GCT) are identified as the Arabidop- sis orthologs of MEDIATOR12  (MED12 ) and MED13 , respec- tively and are involved in the regulation of KAN expression  independently of PHB in peripheral-abaxial identity (Gillmor et  al., 2010).",Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
"Amino acid sequence alignment  DRL1 and homologs  nucleotide and amino acid sequences  from various organisms were retrieved from NCBI GenBank database (http://www.ncbi.nlm.nih.gov/""www.",OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
Cells http://molcells.org      A                          B                      Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
Cells http://molcells.org      A                     B                   C                     D                     E                     F                   G                     H                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
"Cells http://molcells.org     frath, R. (2001).",OADS,/arxiv_data1/oa_pdf/c5/57/molcell-38-3-243.PMC4363724.pdf
"Cells 2015; 38(3): 251-258  http://dx.doi.org/10.14348/molcells.2015.2302                    Brca2 Deficiency Leads to T Cell Loss and   Immune Dysfunction     Jun-hyeon Jeong3, Areum Jo1,2, Pilgu Park3, Hyunsook Lee3, and Hae-Ock Lee1,2,*      Germline mutations in the breast cancer type 2 suscepti- bility gene ( BRCA2 ) are linked to familial breast cancer and  the progressive bone marrow failure syndrome Fanconi  anaemia.",Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
MATERIALS AND METHODS   Mice and preparation of tissues  Brca2 F11/F11 and lck-Cre  mice were kind gifts from Dr. Anton Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
"Cells http://molcells.org     Berns (The Netherland Cancer Institute, The Netherlands).",Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
"Cells http://molcells.org      A                     B                    C                              D                       al., 1997), whereas the mouse equivalent pSer18 has been  implicated in the pro-apoptotic function of p53 (Sluss  et al.,  2004).",Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
Cells http://molcells.org      A                B                         A                      B                      C                      Fig.,Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
Cells http://molcells.org     646.,Non-OADS,/arxiv_data1/oa_pdf/3f/f6/molcell-38-3-251.PMC4363725.pdf
"Cells 2015; 38(3): 259-266  http://dx.doi.org/10.14348/molcells.2015.2311                    Expression of the Floral Repressor miRNA156 is  Positively Regulated by the AGAMOUS-like  Proteins AGL15 and AGL18     Phanu Serivichyaswat, Hak-Seung Ryu, Wanhui Kim, Soonkap Kim, Kyung Sook Chung, Jae Joon Kim,  and Ji Hoon Ahn*      The regulation of flowering time has crucial implications for plant fitness.",OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
The SRFMolecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
"Cells http://molcells.org     core DNA-binding domain selectively binds to a consensus  DNA sequence, the C-A/T rich-G (CArG) motif (West et al., 1997) to either activate or repress the expression of target  genes.",Non-OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
Electrophoretic mobility shift assay   Prediction of putative CArG motifs in MIR156a  and MIR156c  was  done using AthaMap (http://www.athamap.de) and PLACE  (http://www.dna.affrc.,OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
"Cells http://molcells.org        A                  B                        C                                   D               E                             Higo et al., 1998), we identified eight putative CArG motifs in  the upstream regions of MIR156a  and MIR156c  (Figs.",OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
Cells http://molcells.org      A                 C                      D    B                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
"Cells http://molcells.org     REFERENCES     Adamczyk, B.J., Lehti-Shiu, M.D., and Fernandez, D. E. (2007).",OADS,/arxiv_data1/oa_pdf/c9/97/molcell-38-3-259.PMC4363726.pdf
"Cells 2015; 38(3): 267-272  http://dx.doi.org/10.14348/molcells.2015.2315                    Osteogenic Potency of Nacre on Human   Mesenchymal Stem Cells     David W. Green1,4, Hyuk-Jae Kwon2,4, and Han-Sung Jung1,3,*      Nacre seashell is a natural osteoinductive biomaterial with  strong effects on osteoprogenitors, osteoblasts, and osteo-clasts during bone tissue fo rmation and morphogenesis.",Non-OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
Particular individual fractions have been shown to Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
Cells http://molcells.org     give rise to specific responses from cultured osteoblast cells.,Non-OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
Cells http://molcells.org                                                                         were run in triplicate and read at 540 nm.,OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
Cells http://molcells.org     ing nacre in rabbit.,Non-OADS,/arxiv_data1/oa_pdf/9b/c3/molcell-38-3-267.PMC4363727.pdf
"Cells 2015; 38 (3): 273-278  http://dx.doi.org/10.14348/molcells.2015.2320                    Antiangiogenic Activi ty of the Lipophilic  Antimicrobial Peptides from an Endophytic Bacterial Strain Isolated from Red Pepper Leaf    Hye Jin Jung1,2,5, Yonghyo Kim1,5, Hyang Burm Lee3, and Ho Jeong Kwon1,4,*      The induction of angiogenesis is a crucial step in tumor  progression, and therefore, efficient inhibition of angio-genesis is considered a powerful strategy for the treat- ment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
AMPs could thus be considered  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
"Cells http://molcells.org     interesting and promising therapeu tic lead molecules with elevat- ed pharmacological action, lower cytotoxicity, and decreased  resistance in a wide range of infectious and malignant diseases.",Non-OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
Cells http://molcells.org                                                                     neovascularized zones were visualized under a microscope.,OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
"Cells http://molcells.org     target gene, VEGF .",Non-OADS,/arxiv_data1/oa_pdf/ac/0b/molcell-38-3-273.PMC4363728.pdf
"Cells 2015; 38(3): 279-284  http://dx.doi.org/10.14348/molcells.2015.2340                    Obatoclax Regulates the Proliferation and Fusion  of Osteoclast Precursors through the Inhibition of ERK Activation by RANKL    Ju Hee Oh1,2, Jae Yoon Lee1,2, Jin Hyeong Park1, Jeong Hyeon No1, and Na Kyung Lee1,*      Obatoclax, a pan-Bcl2 inhibitor, shows antitumor activities  in various solid malignancies.",Non-OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
"Dendritic cell-specific transmembrane protein (DC-STAMP)  and the d2 isoform of vacuolar (H +) ATPase (v-ATPase) Vo  domain (Atp6v0d2) are known to be key regulators for osteo- clast maturation, and the deficiency of DC-STAMP or Atp6v0d2 leads to osteopetrosis in mice (Kim et al., 2008; Kukita et al.,Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
"Cells http://molcells.org     2004; Lee et al., 2006).",OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
Cells http://molcells.org      A                            B                C                 D                            E                F                      A                   B            precursors were pretreated with 10 μM of PD98059 (PD) for 30 min then treated with RANKL (R) for 3 days.,Non-OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
"Cells http://molcells.org     30, 827-832.",Non-OADS,/arxiv_data1/oa_pdf/59/d3/molcell-38-3-279.PMC4363729.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/4d/main.PMC4363734.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.02.0032211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/4d/main.PMC4363734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/4d/main.PMC4363734.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/bf/4d/main.PMC4363734.pdf
"Available at, http://www.diabetes.org/assets/pdfs/at-risk/risk-test-paper-version.pdf (Accessed July 10, 2014).",Non-OADS,/arxiv_data1/oa_pdf/bf/4d/main.PMC4363734.pdf
DiabetMed http://dx.doi.org/10.1111/dme.12500 .,Non-OADS,/arxiv_data1/oa_pdf/bf/4d/main.PMC4363734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2015.02.001 2352-2895/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 1 (2015) 184 e194,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1016/j.neubiorev.2005.05.007 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1093/scan/nsm029 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1523/JNEUR- OSCI.4812-10.2010 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"125 (1),20e28.http://dx.doi.org/10.1037/a0022008 .",Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1002/neu.20025 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1037/1528-3542.7.2.227 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2007.12.010 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3446-12.2013 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1002/ dev.21157 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2233-09.2010 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1016/S0006-3223(02)01786-9 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1038/nn1965 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1037/a0032671 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1210/edrv-12-2-118 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1159/000216540 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1056/ NEJMsa043266 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1111/j.1365-2826.2009.01837.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1097/ 01.wnr.0000101520.44335.20 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1093/cercor/bhq116 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1001/archpsyc.60.7.709 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.1184-06.2006 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1038/nrn2639 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1073/ pnas.1105371108 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1016/ j.neuroscience.2013.01.023 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1038/ npp.2010.92 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1146/annurev.neuro.22.1.105 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1073/pnas.1 121254109 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1073/pnas.0504011102 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"20 (Special Issue 04), 1231 e 1250. http://dx.doi.org/10.1017/S095457940800059X .",Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1002/ dev.20482 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1016/j.neuroscience.2008.07.078 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1001/archpsyc.61.9.933 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1016/ j.biopsych.2004.12.024 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1073/ pnas.1206834109 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"Psychopharmacology 214 (1), 55 e70.http://dx.doi.org/10.1007/s00213-010-2009-2 .",Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1111/j.1467-8721.2008.00608.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.4297-06.2006 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1523/JNEUR- OSCI.5843-11.2012 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1210/en.2008-0633 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"5, 33. http://dx.doi.org/10.3389/fendo.2014.00033 .",Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1002/dev.20437 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4765-06.2007 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1111/ desc.12087 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1176/appi.ajp.163.6.993 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"1200, 58 e65.http://dx.doi.org/10.1016/j.brainres.2008.01.057 .D.G.",OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1002/dev.20531 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"3, 68. http://dx.doi.org/10.3389/neuro.09.068.2009 .",Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"13 (1), 46e61.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1111/j.1467-7687.2010.00971.x .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1126/science.1150516 .,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/10.1016/ j.neuroscience.2004.07.013 .,OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
http://dx.doi.org/ 10.1176/appi.ajp.2009.08091438 .D.G.,Non-OADS,/arxiv_data1/oa_pdf/8e/27/main.PMC4363736.pdf
"This is an open-access article distributed under the terms of the Creative Com- mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e3/4e/aapm-05-01-21943.PMC4363737.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cd/57/aapm-05-01-27470.PMC4363738.pdf
"This is an open-access article distributed under the terms of the Creative Com- mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/31/aapm-05-01-24837.PMC4363739.pdf
Available from: http://mohfw.nic.in/index1.php?lan g=1&level=1&sublinkid=4883&lid=3013.,OADS,/arxiv_data1/oa_pdf/8b/72/IJMPO-36-1.PMC4363844.pdf
Available from: http://www.biospecimens.cancer.gov/ resources/sops/library.asp.,Non-OADS,/arxiv_data1/oa_pdf/8b/72/IJMPO-36-1.PMC4363844.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/8b/72/IJMPO-36-1.PMC4363844.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8b/72/IJMPO-36-1.PMC4363844.pdf
The UK biobank project (http://www.ukbiobank.ac.uk/)  is a good example of  such an endeavor.,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
"[25] The North German Tumor Bank of  Colorectal Cancer  (ColoNet) (http://www.northgermantumorbank-crc.de/ North_German_Tumor_Bank_-_CRC/Home.html) is  a disease-specific project funded by the German Cancer  Aid Foundation involving universities and university clinics  in Lübeck, Rostock and Hamburg in Germany.",Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
"[30] The Estonian Genome Centre, University of  Tartu  (EGCUT - http://www.geenivaramu.ee/en) is a prime  example of  the above.",Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
"[13,16] The International HapMap Project  (http://hapmap.ncbi.nlm.nih.gov/thehapmap.html.en) is  one such multi-national effort to identify and catalogue,  genetic similarities and differences in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.training.cancer.gov/ includingclinicaltrials/util/print/includingclinicaltrials.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.technopolis-group.,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.framinghamheartstudy.org/ participants/pr/09_1115.html.,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.ukbiobank.ac.uk/ [Last accessed  on 2013 Apr].,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.biospecimens.cancer.gov/ practices/ [Last accessed on 2013 Jun].,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.geenivaramu.ee/en/ [Last  accessed on 2013 Jun].,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.ukcrc.org/infrastructure/expmed/ fundersvisionforhumantissuesresources/ [Last accessed on  2013 Jun].,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.dddmagcom/ articles/2007/09/cost-clinical-trials.,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.public.ukcrn.org.uk/search/ [Last  accessed on 2013 Jun].,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.ukcrcorg/ indexaspx?o=1502.,Non-OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from: http://www.gen2phen.org/groups/brif-bio- resource-impact-factor.,OADS,/arxiv_data1/oa_pdf/b1/5d/IJMPO-36-17.PMC4363845.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs339/en.,Non-OADS,/arxiv_data1/oa_pdf/80/32/IJMPO-36-24.PMC4363846.pdf
Available  from: http://www.who.int/fctc/about/en.,OADS,/arxiv_data1/oa_pdf/80/32/IJMPO-36-24.PMC4363846.pdf
Available from: http://megapib.nic.,Non-OADS,/arxiv_data1/oa_pdf/80/32/IJMPO-36-24.PMC4363846.pdf
Available from:  http://www.cdc.gov/niosh/idlh/54115.html.,OADS,/arxiv_data1/oa_pdf/80/32/IJMPO-36-24.PMC4363846.pdf
Available from: http://www.samhsa.gov/data/2k12/  MHUS2010/MHUS-2010.pdf.,OADS,/arxiv_data1/oa_pdf/80/32/IJMPO-36-24.PMC4363846.pdf
Available	 from:	http://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/be/16/IJMPO-36-3.PMC4363847.pdf
Available from:  http://www.searo.who.int/LinkFiles/Regional_Tobacco_ Surveillance_System_GATS_India.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/27/IJMPO-36-32.PMC4363848.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/09/27/IJMPO-36-32.PMC4363848.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/90/45/num-07-02-24427.PMC4363907.pdf
Available from: http://www.whonamedit.com/doctor.cfm.,Non-OADS,/arxiv_data1/oa_pdf/d0/e3/IJO-63-1.PMC4363949.pdf
"Eigenfactor Metrics, comprising  the Eigenfactor Score  ( http://eigenfactor.org/) and Article  Influence Score,  are designed to reflect the prestige and citation  influence of journals by considering scholarly literature as a  network of journal‑to‑journal relationships.",Non-OADS,/arxiv_data1/oa_pdf/c4/0c/IJO-63-54.PMC4363959.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/42/bbt074.PMC4364064.pdf
"Ta b l e 2 : Overview of popular frequent itemset mining algorithms and implementations Algorithm Itemsets, subgraphs or rules Context License Publication Additional information or implementations Anets All (apriori), various threshold measures Annotation mining GNU GPL 16 http://sourceforge.net/projects/anets AGM All (apriori) Subgraph mining / 57 / Apriori (Borgelt) All / GNU GPL 6, 94 http://www .borgelt.net/apriori.html Apriori (Goethals) All / Research only 6 http://adrem.ua.ac.be/ /C24goethals/software/ ARIA All (apriori), various verifications Annotation mining / 15 http://pedant.gsf.de/ARIA/index.htmCarpenter Closed Quantitative omics profiles GNU GPL 29 http://www .borgelt.net/carpenter .html CBA All (apriori) Classifiers / 67 / CMAR All (FP-growth) Classifiers / 68 /Cobbler Closed Quantitative omics profiles / 40 / CODENSE Coherent dense subgraphs Subgraph mining Research only 62 http://zhoulab.usc.edu/CODENSE/ COLL All (apriori), chi-squared threshold pruning Annotation mining Open source 3 http://datadryad.org/resource/doi:10.5061/dryad.nr353COPS All (FP-tree), score threshold Biclustering Contact authors 18 http://www .cos.uni-heidelberg.de/index.php/n.haCPAR All Classifiers / 69 / CPMine All (eclat), machine learning Structural patterns / 22 / DeBi Maximal Biclustering Creative Commons 2.0 29 http://www .molgen.mpg.de/ /C24serin/debi/main.html Distiller Closed Quantitative omics profiles Academic use only 49 http://homes.esat.kuleuven.be/ /C24kmarchal/Supplementary _ Information _Lemmens _2008/startPage.html Eclat (Borgelt) All / GNU GPL 13, 94 http://www .borgelt.net/eclat.html FESP Emerging patterns Classifiers / 92, 93 /Farmer Closed Quantitative omics profiles Research only 41 http://www.sgi.com/tech/mlc/ FSG / Subgraph mining / 58 / FPGrowth All / GNU GPL 14 /GenMax Maximal Quantitative omics profiles Research only 36 http://www.cs.rpi.edu/ /C24zaki/www-new/pmwiki.php/ Software/Software GenMiner Closed Quantitative omics profiles Research only 46 http://keia.i3s.unice.fr/?Logiciels_et_Imple ¤mentations___GenMiner gSpan All Subgraph mining Internal research only 59 http://www .cs.ucsb.edu/ /C24xyan/software/gSpan.htm KRIMP Minimal descriptive length Future work 83 http://adrem.ua.ac.be/ /C24jvreeken/prj/krimp/ MAFIA Maximal / Contact authors 95 http://sourceforge.net/projects/himalaya-tools/files/ MAGO Multilevel association rules Quantitative omics profiles / 47 / MaxConf Closed Quantitative omics profiles Research only 96 https://bitbucket.org/tara/fpm/src/581 3e782542b?at ¼default MaxMiner Maximal Quantitative omics profiles / 35 /Min-Ex d-free itemsets Quantitative omics profiles / 32 / MULE Maximal frequent connected subgraph Subgraph mining Research only 4 http://compbio.case.edu/koyuturk/software/mule/ NetCAR Maximal frequent connected subgraph Classifiers Research only 77 http://bioinformatics.oxfordjournals.org/content/24/1 3/1523.longPathFinder Large Subgraph mining / 64 / REMMAR Shortest distance thresholding Quantitative omics profiles Research only 48 http://websystem.csie.ncku.edu.tw/REMMAR_Program.rar TD-Close Closed Quantitative omics profiles / 42 /T opKRGs T op-k Quantitative omics profiles / 43 /A primer to frequent itemset mining for bioinformatics 22 1",Non-OADS,/arxiv_data1/oa_pdf/c5/42/bbt074.PMC4364064.pdf
"However, algorithms such asTa b l e 3 : Overview of software frameworks for frequent itemset mining Application nameDescription License Publication Available from Arules FIM toolbox in R GNU GPL-2 84 http://cran.r-project.org/web/packages/arules/index.html ARtool FIM toolbox for binary databases GNU GPL 97 http://www .cs.umb.edu/ /C24laur/ARtool/ KNIME Desktop Data analytics platform GNU GPL 98 http://www .knime.org/ MIME Interactive FIM toolbox Research only 99 http://adrem.ua.ac.be/mime Orange Data analytics platform GNU GPL-3 100 http://orange.biolab.si/PyFIM Python library GNU LPL 94 http://www .borgelt.net/pyfim.htmlRapidminer Data analytics platform AGPL-3 101 http://rapid-i.com/ SPMF FIM toolbox GNU GPL-3 / http://www.philippe-fournier-viger.com/spmf/index.php Weka Machine learning library GNU GPL 102 http://www .cs.waikato.ac.nz/ml/weka/222 Naulaerts et al.",Non-OADS,/arxiv_data1/oa_pdf/c5/42/bbt074.PMC4364064.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/d9/ijn-10-1899.PMC4364153.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1899–1908International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1899OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7834 5In vitro percutaneous penetration and  characterization of silver from silver-containing  textiles carlotta Bianco1 sanja Kezic2 Matteo crosera1 Vesna Svetličić3 suzana Šegota3 giovanni Maina4 canzio romano5 Francesca larese6,7 gianpiero adami1 1Department of chemical and  Pharmaceutical sciences, University  of Trieste, Trieste, Italy; 2academic  Medical center, coronel Institute,   University of amsterdam, amsterdam,   the Netherlands; 3laboratory for  Bioelectrochemistry and surface  Imaging, Division for Marine and  Environmental Research, Ruđer  Bošković Institute, Zagreb, Croatia;   4Department of clinical and Biological  sciences, University of T urin, T urin,   Italy; 5Department of  Public and  Pediatric health sciences, University  of T urin, T urin, Italy; 6Unit of  Occupational Medicine, University of  Trieste, Trieste, Italy; 7Department of  Medical sciences, University of Trieste,   Trieste, ItalyAbstract:  The objective of this study was to determine the in vitro percutaneous penetration  of silver and characterize the silver species released from textiles in different layers of full  thickness human skin.",Non-OADS,/arxiv_data1/oa_pdf/16/d9/ijn-10-1899.PMC4364153.pdf
"correspondence: carlotta Bianco Department of chemical and  Pharmaceutical sciences, University  of Trieste, Via giorgeri 1, Trieste   I-34127, Italy Tel +39 04 0558 3944 email carlotta_bianco@yahoo.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Bianco et al Running head recto: In vitro percutaneous penetration of silver DOI: http://dx.doi.org/10.2147/IJN.S78345",Non-OADS,/arxiv_data1/oa_pdf/16/d9/ijn-10-1899.PMC4364153.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/16/d9/ijn-10-1899.PMC4364153.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/d9/ijn-10-1899.PMC4364153.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/f0/ijn-10-1941.PMC4364157.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1941–1952International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1941OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7854 7Preparation of poly( β-l-malic acid)-based charge- conversional nanoconjugates for tumor-specific  uptake and cellular delivery correspondence: hong Wu Department of Pharmaceutical analysis,  school of Pharmacy, Fourth Military  Medical University, 169 West changle  street, Xi’an 710032, People’s republic  of china Tel +86 29 8477 6823 Fax +86 29 8477 6823 email wuhong@fmmu.edu.c n Qing Zhou1,* Tiehong Yang1,* Y oubei Qiao1 songyan guo1 lin Zhu2 hong  Wu1 1Department of Pharmaceutical  analysis, school of Pharmacy,  Fourth Military Medical University,  Xi’an, People’s republic of china;  2Department of Pharmaceutical  sciences, Irma lerma rangel college of  Pharmacy, Texas a&M University health  science center, Kingsville, T exas, Usa *These authors contributed equally  to this workAbstract:  In this study, a multifunctional poly( β-L-malic acid)-based nanoconjugate with  a pH-dependent charge conversional characteristic was developed for tumor-specific drug  delivery.",Non-OADS,/arxiv_data1/oa_pdf/4e/f0/ijn-10-1941.PMC4364157.pdf
"Its efficacy, therefore,  is intrinsically limited by cellular heterogeneity, which mainly results from intrinsic  genetic instability, epigenetic diversity, and stochastic noise in phenotype expression  of cancer cells that exists both within and among tumors.11–13 Nanocarriers have been  successfully used to decrease drawbacks of conventional chemotherapeutics such as  nonspecific cytotoxicity, poor pharmacokinetics, and chemical instability to improve  drug efficacy.14 Drug delivery nanocarriers with positive charge can easily implement endocytosis  through the electrostatic interaction with the negatively charged cell membrane.15,16 Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhou et al Running head recto: Poly( β-L-malic acid) nanoconjugates for tumor-specific uptake DOI: http://dx.doi.org/10.2147/IJN.S78547 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/4e/f0/ijn-10-1941.PMC4364157.pdf
Or use: http://dvpr.es/1E2IlK zVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/4e/f0/ijn-10-1941.PMC4364157.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4e/f0/ijn-10-1941.PMC4364157.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/f0/ijn-10-1941.PMC4364157.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ijn-10-1921.PMC4364158.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1921–1930International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1921OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7420 4Therapeutic antitumor efficacy of tumor-derived  autophagosome (Dribble) vaccine on head  and neck cancer hang su1,* Qiong luo2,* hao Xie3 Xiaofeng huang1 Yanhong Ni1 Y ongbin Mou1 Qingang hu1,4 1Center Laboratory of Stomatology,   stomatological hospital affiliated  Medical school, 2State Key Laboratory  of Pharmaceutical Biotechnology,   school of life sciences, Nanjing  University, 3Institute of life sciences,   Key Laboratory of Developmental  genes and human Disease, southeast  University, Nanjing, People’s Republic  of china; 4leeds Dental Institute,   Faculty of Medicine and Health,   University of Leeds, Leeds, UK *These authors contributed equally  to this workPurpose:  Vaccines play important roles in antitumor biotherapy.",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ijn-10-1921.PMC4364158.pdf
"These data indicate that targeting cross-presentation may be a unique approach  for immunotherapy for cancer.4 Therefore, the first critical component of successful  therapeutic cancer vaccines is to maximize the efficiency of cross-presentation.5 Autophagy is a basic cellular process in which unnecessary or dysfunctional cel - lular components are sequestered by autophagosomes and delivered to lysosomes for  degradation.6,7 As we know, autophagy in tumor-targeted therapy is thought to be a  “double-edged sword”, which plays a prodeath or prosurvival role.8–10 On the other  hand, it has been reported that autophagy can be induced by metabolic stress and antitu - mor therapies.11,12 Although the role of autophagy in tumor therapy is complicated and correspondence: Qingang hu/Yongbin  Mou Center Laboratory of Stomatology,  Stomatological Hospital Affiliated Medical  School, Nanjing University, 30 Zhongyang  Road, Nanjing, Jiangsu 210008, People’s  republic of china Tel +86 25 8362 0101 Fax +86 25 8362 0101 email qghu@nju.edu.c n; yongbinmou@ gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Su et al Running head recto: DRibble vaccine for head and neck cancer DOI: http://dx.doi.org/10.2147/IJN.S74204",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ijn-10-1921.PMC4364158.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ijn-10-1921.PMC4364158.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ijn-10-1921.PMC4364158.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/6c/ijn-10-1931.PMC4364160.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1931–1939International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1931OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7737 2Magnetic thermoablation stimuli alter Bcl2  and FGF-R1 but not HSP70 expression profiles  in BT474 breast tumors Marcus stapf Nadine Pömpner Melanie Kettering Ingrid hilger Institute of Diagnostic  and Interventional radiology, Jena  University hospital, Jena, germanyAbstract:  Magnetically induced heating of magnetic nanoparticles (MNP) in an alternating  magnetic field (AMF) is a promising minimal invasive tool for localized tumor treatment that  eradicates tumor cells by applying thermal stress.",Non-OADS,/arxiv_data1/oa_pdf/24/6c/ijn-10-1931.PMC4364160.pdf
"Ablative temperatures above 50 °C for a treatment  duration of 4–6  minutes induce irreversible damages in tumor cells and cause necrosis  (thermoablation).1,2 Whereas different heating sources (eg, water bath, infrared light,  etc) for heat generation have been suggested, the administration of magnetic nanopar - ticles (MNP) in the tumor area will induce local heating when an alternating magnetic  field (AMF) is applied.3,4 Therefore, MNP act as internal heating sources and allow a  highly selective inactivation of tumors with very low side effects.5 On the pathobiological level, hyperthermia treatments are known to be associated  with immune modulatory effects.6 Furthermore, hyperthermia has been shown to hinder  the function of cell surface receptors and transmembrane transport proteins and affect correspondence: Ingrid hilger Institute of Diagnostic and  Interventional radiology, Jena University  hospital, Forschungszentrum lobeda, erlanger allee 101, D-07747 Jena,  germany Tel +49 3641 9 32 59 21 Fax +49 3641 9 32 59 22 email ingrid.hilger@med.uni-jena.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Stapf et al Running head recto: Magnetic thermoablation stimuli alter protein expression in tumors DOI: http://dx.doi.org/10.2147/IJN.S77372",Non-OADS,/arxiv_data1/oa_pdf/24/6c/ijn-10-1931.PMC4364160.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/6c/ijn-10-1931.PMC4364160.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/6c/ijn-10-1931.PMC4364160.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/bd/ijn-10-1885.PMC4364164.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1885–1898International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1885OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7773 4Peptide gh625 enters into neuron and astrocyte  cell lines and crosses the blood–brain barrier  in rats salvatore Valiante1,* annarita Falanga2,3,* luisa cigliano1 giuseppina Iachetta1 rosa anna Busiello1 Valeria la Marca1 Massimiliano galdiero4 assunta lombardi1 stefania galdiero1,2 1Department of Biology, 2Department  of Pharmacy, 3DFM scarl, University  of Naples Federico II, 4Department of  experimental Medicine, II University  of Naples, Naples, Italy *These authors contributed equally  to this paper and are considered  joint first authorsAbstract:  Peptide gH625, derived from glycoprotein H of herpes simplex virus type 1, can  enter cells efficiently and deliver a cargo.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/ijn-10-1885.PMC4364164.pdf
"Their advantages as deliv - ery enhancers are their relatively small molecular weight, ease of synthesis, relatively  low cytotoxicity and immunogenicity, and degradation in vivo to naturally occurring correspondence: stefania galdiero Department of Biology, University of  Naples Federico II, Via Mezzocannone 8,  Naples 80134, Italy email stefania.galdiero@unina.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Valiante et al Running head recto: Peptide gH625 crosses the BBB DOI: http://dx.doi.org/10.2147/IJN.S77734",Non-OADS,/arxiv_data1/oa_pdf/01/bd/ijn-10-1885.PMC4364164.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/ijn-10-1885.PMC4364164.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/bd/ijn-10-1885.PMC4364164.pdf
"E-mail: graduate@csmu.edu.tw  Th is is an open-access article distributed under the te rms of the http://creativecommons.org/licenses/by-nc-nd/3.0/ CC-BY-NC-ND 3.0 License which  permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and  provided the original source is credited .",Non-OADS,/arxiv_data1/oa_pdf/7b/9b/cjog35_60.PMC4364270.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/03/19/10.1177_2047981614555141.PMC4364381.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e51719 | Page 1 of 8Video Article Massively Parallel Reporter Assays in Cultured Mammalian Cells Alexandre Melnikov1, Xiaolan Zhang1, Peter Rogov1, Li Wang1, Tarjei S. Mikkelsen1 1Broad Institute Correspondence to: Tarjei S. Mikkelsen at tarjei@broadinstitute.org URL: http://www.jove.com/video/51719 DOI: doi:10.3791/51719 Keywords: Genetics, Issue 90, gene regulation, transcriptional regulation, sequence-activity mapping, reporter assay, library cloning, transfection, tag sequencing, mammalian cells Date Published: 8/17/2014 Citation: Melnikov, A., Zhang, X., Rogov, P., Wang, L., Mikkelsen, T.S.",Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jove-90-51719.PMC4364389.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51719/ Introduction Massively Parallel Reporter Assays (MPRA) allow multiplexed measurement of the transcriptional regulatory activities of thousands to hundreds of thousands of DNA sequences1-7.,Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jove-90-51719.PMC4364389.pdf
"This protocol describes construction of a library of promoter variants using OLS and the pMPRA1 and pMPRAdonor1 vectors (Addgene IDs 49349 and 49352, respectively; http://www.addgene.org), transient transfection of this library into cultured mammalian cells and subsequent quantitation of the promoter activities by deep sequencing of their associated tags (Tag-Seq).",Non-OADS,/arxiv_data1/oa_pdf/cf/b4/jove-90-51719.PMC4364389.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/2a/33/10.1177_2047981614546795.PMC4364398.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/1c/e9/10.1177_2047981614552217.PMC4364399.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/3f/70/10.1177_2047981614561285.PMC4364400.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/8f/90/10.1177_2047981614560076.PMC4364401.pdf
"ACR-SPR practice parameter for performing FDG-PET/CT in oncology.Reston, VA: American College of Radiology; 2014.Available at: http://www.acr.org/ /C24/media/ACR/ Documents/PGTS/guidelines/FDG_PET_CT.pdf.",Non-OADS,/arxiv_data1/oa_pdf/8f/90/10.1177_2047981614560076.PMC4364401.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/8f/90/10.1177_2047981614560076.PMC4364401.pdf
was from http://www.graphitestore.com.,Non-OADS,/arxiv_data1/oa_pdf/3f/38/SC-006-C4SC03401E.PMC4364445.pdf
13 (a) http://www.insphero.com; ( b) http:// www.solidusbiosciences.com.,Non-OADS,/arxiv_data1/oa_pdf/3f/38/SC-006-C4SC03401E.PMC4364445.pdf
"20 (a) E. Gyor ﬀy, L. Anna, K. Kov ´acs, P. Rudnai and B. Schoket, Mutagenesis , 2008, 23,1–18; ( b)International Conference on Harmonization, Guidance on Genotoxicity Testing and DataInterpretation for Pharmaceuticals Intended for Human Use , 2011, http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html.",Non-OADS,/arxiv_data1/oa_pdf/3f/38/SC-006-C4SC03401E.PMC4364445.pdf
55 http://www.fda.gov/downloads/Drugs/Guidances/ucm074931.,Non-OADS,/arxiv_data1/oa_pdf/3f/38/SC-006-C4SC03401E.PMC4364445.pdf
"64 U.S. Department of Health and Human Services, ToxGuideTM for Styrene, Sept., 2011, http://www.atsdr.cdc.gov/toxguides/toxguide-53.pdf.",OADS,/arxiv_data1/oa_pdf/3f/38/SC-006-C4SC03401E.PMC4364445.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/8f/ndt-11-675.PMC4364589.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 675–683Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  675OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7176 8association between pain severity, depression  severity, and use of health care services in Japan:  results of a nationwide survey Jeffrey Vietri1 T empei Otsubo2 William Montgomery3 T oshinaga Tsuji4 eiji harada5 1health Outcomes Practice, Kantar  health, Milan, italy; 2Tokyo shinjuku  Medical center, T okyo, Japan; 3eli  lilly australia Pty ltd., West ryde,   australia; 4Medical affairs, shionogi  & co., ltd., Osaka, Japan; 5eli lilly  Japan KK, Kobe, JapanBackground:  Depression is often associated with painful physical symptoms.",Non-OADS,/arxiv_data1/oa_pdf/21/8f/ndt-11-675.PMC4364589.pdf
"MDD is  one of the most common mood disorders, and the impact of MDD and other forms of  depression on the patient and society is considerable.1–3 The reported prevalence of  mood disorders is far lower in Japan than in many Western countries; the 12-month  prevalence of MDD is approximately 3% among Japanese adults according to the  World Health Organization Composite International Diagnostic Interview.4 Cohort  differences in susceptibility to mood disorders have been noted that may result in a correspondence: Jeffrey Vietri Kantar health, Via Paleocapa 7,  Milan 20121, italy Tel +39 02 3035 0416 Fax +39 02 3035 0415 email jeffrey.vietri@kantarhealth.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Vietri et al Running head recto: Pain severity and depression in Japan DOI: http://dx.doi.org/10.2147/NDT.S71768",Non-OADS,/arxiv_data1/oa_pdf/21/8f/ndt-11-675.PMC4364589.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/21/8f/ndt-11-675.PMC4364589.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/8f/ndt-11-675.PMC4364589.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ijnrd-8-025.PMC4364590.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 25–28International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  25RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S7596 0A fresh look into the pathophysiology of  ischemia-induced complications in patients with  chronic kidney disease undergoing hemodialysis Patrick M Honore1 Rita Jacobs1 elisabeth De waele1 viola van Gorp1 Jouke De Regt1 Olivier Joannes-Boyau2 willem Boer3 Herbert D Spapen1 1Intensive Care Department,   Universitair Ziekenhuis Brussel, vrije  Universiteit Brussel, Brussels, Belgium;   2Intensive Care Unit, Haut Leveque  University Hospital of Bordeaux,   University of Bordeaux 2, Pessac,   France; 3Intensive Care Department,   Ziekenhuis Oost Limburg, Genk,   Belgium Correspondence: Patrick Honore   Intensive Care Department, UZ Brussels   vUB University  101, Laarbeeklaan,   Jette 1090, Brussels, Belgium   Tel +32 2474 9097  Fax +32 2477 5253  email p atrick.",Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ijnrd-8-025.PMC4364590.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ijnrd-8-025.PMC4364590.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/e9/ijnrd-8-025.PMC4364590.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/79/amep-6-171.PMC4364591.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 171–175Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  171OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7215 9Web-based teaching in point-of-care ultrasound:  an alternative to the classroom?,Non-OADS,/arxiv_data1/oa_pdf/0b/79/amep-6-171.PMC4364591.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/0b/79/amep-6-171.PMC4364591.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/79/amep-6-171.PMC4364591.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/99/ndt-11-685.PMC4364593.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 685–693Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  685OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8092 5effects of switching from olanzapine to aripiprazole  on the metabolic profiles of patients with  schizophrenia and metabolic syndrome: a double- blind, randomized, open-label study rayees ahmad Wani Mansoor ahmad Dar rajesh Kumar chandel Yasir hassan rather inaamul haq arshad hussain altaf ahmad Malla Department of Psychiatry,   government Medical college,   srinagar, Jammu and Kashmir, indiaBackground:  Patients with schizophrenia suffer high rates of metabolic derangements on  some antipsychotic medications that predispose them to cardiovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/6f/99/ndt-11-685.PMC4364593.pdf
"Studies show that metabolic syndrome is associ - ated with twofold to threefold increased risk of cardiovascular morbidity.2correspondence: rayees ahmad Wani Department of Psychiatry, government  Medical college, srinagar, Jammu and  Kashmir 190003, india Tel +91 96 2242 7577 email rayeeswani92@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Wani et al Running head recto: Metabolic effects of switching from olanzapine to aripiprazole DOI: http://dx.doi.org/10.2147/NDT.S80925 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/6f/99/ndt-11-685.PMC4364593.pdf
Or use: http://dvpr.es/1wHthD pVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/6f/99/ndt-11-685.PMC4364593.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6f/99/ndt-11-685.PMC4364593.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/99/ndt-11-685.PMC4364593.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/b3/ppa-9-435.PMC4364594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 435–448Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  435OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7705 3impact of patient programs on adherence and  persistence in inflammatory and immunologic  diseases: a meta-analysis Objectives:  Patient adherence and persistence is important to improve outcomes in chronic  conditions, including inflammatory and immunologic (I&I) diseases.",Non-OADS,/arxiv_data1/oa_pdf/54/b3/ppa-9-435.PMC4364594.pdf
"Adherence refers to the act of  conforming to recommendations made by the provider with respect to timing, dose,  and frequency of administration.1 Persistence is defined as the duration of time from  initiation to discontinuation of therapy.1 Significant evidence suggests that nonad - herence is highly prevalent in medical care2 and is a rising concern to health care  providers and payers because it increases the cost of care and results in poor patient  outcomes.3 Patients are nonadherent to treatment due to various self-identified reasons, Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Burudpakdee et al Running head recto: Adherence and persistence in inflammation and immunology (I&I) DOI: http://dx.doi.org/10.2147/PPA.S77053 chakkarin Burudpakdee1,2 Zeba M Khan3 smeet gala1 Merena Nanavaty1 Satyin Kaura3 1Market Access solutions, llc,   raritan, nJ, UsA; 2University of North  carolina at charlotte, charlotte, nc,   UsA; 3celgene corporation, summit,   nJ, UsA correspondence: chakkarin  Burudpakdee iMs health, 8280 Willow Oaks  corporate Drive, sTe 775 Fairfax, VA  22031, UsA Tel +1 703 992 1028 email cburudpakdee@us.imshealth.co m",Non-OADS,/arxiv_data1/oa_pdf/54/b3/ppa-9-435.PMC4364594.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/54/b3/ppa-9-435.PMC4364594.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/d0/ijn-10-2033.PMC4364595.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2033–2049International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2033OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7440 4New findings about iron oxide nanoparticles  and their different effects on murine primary  brain cells Jenni Neubert1 Susanne Wagner2 Jürgen Kiwit3 anja U Bräuer1,* Jana glumm1,3,* 1Institute of Cell Biology and  Neurobiology, Center for Anatomy,   2Institute for Radiology, Charité- Universitaetsmedizin Berlin, 3clinic  for Neurosurgery, HELIOS Klinikum  Berlin-Buch, Berlin, Germany *These authors contributed equally  to this workAbstract:  The physicochemical properties of superparamagnetic iron oxide nanoparticles  (SPIOs) enable their application in the diagnostics and therapy of central nervous system dis - eases.",Non-OADS,/arxiv_data1/oa_pdf/f3/d0/ijn-10-2033.PMC4364595.pdf
Available from: http://www.ich.org/products/guidelines/ safety/article/safety-guidelines.html.,Non-OADS,/arxiv_data1/oa_pdf/f3/d0/ijn-10-2033.PMC4364595.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f3/d0/ijn-10-2033.PMC4364595.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/d0/ijn-10-2033.PMC4364595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/33/ijn-10-1997.PMC4364596.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1997–2019International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1997OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7441 8Optimizing stem cell functions and antibacterial  properties of TiO2 nanotubes incorporated with  ZnO nanoparticles: experiments and modeling Wenwen liu,1–3 Penglei su,2  arthur gonzales III,3 su chen,1  Na Wang,1 Jinshu Wang,2  hongyi li,2,4 Zhenting Zhang,1   Thomas J Webster3,5 1laboratory of Biomaterials  and Biomechanics, Beijing Key  laboratory of Tooth regeneration  and Function reconstruction, school  of stomatology, capital Medical  University, 2Photoelectrochemical  research group, Key laboratory of  advanced Functional Materials, school  of Materials science and engineering,   Beijing University of T echnology,   Beijing, People’s republic of china;   3chemical engineering Department,   Northeastern University, Boston, M a,   Usa; 4guangxi research Institute  of chemical Industry, Nanning,   People’s republic of china; 5center  of excellence for advanced Materials  research, King abdulaziz University,   Jeddah, saudi arabiaAbstract:  To optimize mesenchymal stem cell differentiation and antibacterial properties of  titanium (Ti), nano-sized zinc oxide (ZnO) particles with tunable concentrations were incorpo - rated into TiO2 nanotubes (TNTs) using a facile hydrothermal strategy.",Non-OADS,/arxiv_data1/oa_pdf/50/33/ijn-10-1997.PMC4364596.pdf
"Specifically, nanotopographical features on Ti can  provide a similar structure with bone’s natural hierarchical nanostructure.4 In fact,  our previous studies suggest that TiO2 nanotubes (TNTs) with a diameter of 70 nm  (fabricated by electrochemical anodization) can promote bone regeneration in vivo.5   To further improve the osteogenic properties of TiO2, bioactive molecules (such as correspondence: su chen laboratory of Biomaterials and  Biomechanics, Beijing Key laboratory  of Tooth regeneration and Function  reconstruction, school of stomatology,  capital Medical University, Tian Tan  Xi li No 4, Beijing 100050,  People’s republic of china Tel +86 10 5125 1700   Fax +86 10 5125 1700   email dentistchensu@yahoo.com.c n  hongyi li  Photoelectrochemical research group,  Key laboratory of advanced Functional  Materials, school of Materials science  and engineering, Beijing University  of Technology, Beijing 100124,  People’s republic of china Tel +86 10 6739 1101 Fax +86 10 6739 1101  email lhy06@bjut.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Liu et al Running head recto: TiO2 nanotubes incorporated with ZnO nanoparticles  DOI: http://dx.doi.org/10.2147/IJN.S74418",Non-OADS,/arxiv_data1/oa_pdf/50/33/ijn-10-1997.PMC4364596.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/50/33/ijn-10-1997.PMC4364596.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/33/ijn-10-1997.PMC4364596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/24/opth-9-483.PMC4364668.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 483–492Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  483Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7485 3A comparative study of a modified filtering  trabeculotomy and conventional trabeculectomy Juliane Matlach1,* Matthias hipp1,* Martin Wagner2,3 Peter U heuschmann2,3 Thomas Klink1 Franz grehn1 1Department of Ophthalmology,   2institute of Clinical epidemiology  and Biometry, 3Comprehensive  heart Failure Center, University  of Würzburg, Würzburg, germany *These authors contributed equally  to this workPurpose:  The objective of the study reported here was to evaluate the outcome of a modified  filtering trabeculotomy (FTO) without iridectomy in open-angle glaucoma compared with that  of conventional trabeculectomy (trab).",Non-OADS,/arxiv_data1/oa_pdf/72/24/opth-9-483.PMC4364668.pdf
"Augmentation with  antimetabolites such as mitomycin C (MMC) or 5-fluorouracil (5-FU) has been one  of the major advances in glaucoma filtering surgery to reduce bleb failure.2 How - ever, serious ocular complications such as hypotony, hypotony-related choroidal  detachment, maculopathy, blebitis, or endophthalmitis are associated with the use of   antimetabolites.3 Therefore, several modifications, combinations, and new techniques  of trab have been described.4–23 Peripheral iridectomy (PI) is a part of filtration Correspondence: Juliane Matlach Department of Ophthalmology,  University of Würzburg, Josef-schneider- straße 11, 97080 Würzburg, germany Tel +49 931 2012 0600 Fax +49 931 2012 0490 email juliane.matlach@outlook.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Matlach et al Running head recto: Modified filtering trabeculotomy versus trabeculectomy DOI: http://dx.doi.org/10.2147/OPTH.S74853",Non-OADS,/arxiv_data1/oa_pdf/72/24/opth-9-483.PMC4364668.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/72/24/opth-9-483.PMC4364668.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/24/opth-9-483.PMC4364668.pdf
"At the age of 15, he was referred to the pediatric pulmonology outpatient clinic for evaluation and This case report is an illustration of an invited review available in Respirology : http://dx.doi.org/10.1111/resp.12480.",Non-OADS,/arxiv_data1/oa_pdf/c2/e4/rcr20003-0025.PMC4364795.pdf
Available from: http://www.google.com.au/ url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1 &sqi=2&ved=0CCEQFjAA&url=http%3A%2F%2Fwww.,OADS,/arxiv_data1/oa_pdf/83/59/jmrs0062-0015.PMC4364802.pdf
Available from: http://www.acr.org/SecondaryMain MenuCategories/quality_safety/BIRADSAtlas/BIRADSAtlas excerptedtext/BIRADSMammographyFourthEdition.aspx (accessed 4 February 2010).,Non-OADS,/arxiv_data1/oa_pdf/83/59/jmrs0062-0015.PMC4364802.pdf
Available from: http://www.air.asn.au/cms_ﬁles/09_AdvancedPractice/APWG_Final_Report_260609.pdf (accessed 2 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/83/59/jmrs0062-0015.PMC4364802.pdf
Available from: http://www.acr.org/Secondary MainMenuCategories/quality_safety/BIRADSAtlas/BIRADS Atlasexcerptedtext/BIRADSMammographyFourthEdition.,OADS,/arxiv_data1/oa_pdf/d7/dd/jmrs0062-0023.PMC4364803.pdf
Available from: http://www.sydney.edu.au/health_sciences/ breastaustralia.,Non-OADS,/arxiv_data1/oa_pdf/d7/dd/jmrs0062-0023.PMC4364803.pdf
Available from: http://seer.cancer.gov/csr/1975; 2005.,Non-OADS,/arxiv_data1/oa_pdf/5e/de/jmrs0062-0032.PMC4364804.pdf
Available from: http://www.bcna.org.au/about-breast- cancer.,Non-OADS,/arxiv_data1/oa_pdf/c2/a7/jmrs0062-0040.PMC4364805.pdf
45Using MRI as a guide for whom radiotherapy may be safely omitted is the subject of thePROSPECT trial (https://www.anzbctg.org/clinical-trials/anz1002/prospect).,Non-OADS,/arxiv_data1/oa_pdf/51/82/jmrs0062-0047.PMC4364806.pdf
Available from: http://health.gov.au/internet/main/ publishing.nsf/Content/pathol-di-mri-breastmriqa.,Non-OADS,/arxiv_data1/oa_pdf/51/82/jmrs0062-0047.PMC4364806.pdf
Available from: http://www.globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed 8 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/42/40/jmrs0062-0054.PMC4364807.pdf
Available from: http://www.imvinfo.,Non-OADS,/arxiv_data1/oa_pdf/42/40/jmrs0062-0054.PMC4364807.pdf
Available from: http://www.aihw.gov.au/p ublication-detail/?id=10737423008 2.,Non-OADS,/arxiv_data1/oa_pdf/37/41/jmrs0062-0074.PMC4364809.pdf
Available from: http://www.air.asn.au//cms_ﬁles/09_AdvancedPractice/ ipat_ﬁnal_report21april2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/5b/jmrs0062-0082.PMC4364810.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/48/e6/jdi0006-0109.PMC4364843.pdf
Available from: http://www.idf.org [accessed 13 October2014].,Non-OADS,/arxiv_data1/oa_pdf/48/e6/jdi0006-0109.PMC4364843.pdf
2 March 2015 111EDITORIAL http://onlinelibrary.wiley.com/journal/jdi Editorial,Non-OADS,/arxiv_data1/oa_pdf/48/e6/jdi0006-0109.PMC4364843.pdf
2 March 2015 113REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Testosterone in men with type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
2 March 2015 115REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Testosterone in men with type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
2 March 2015 117REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Testosterone in men with type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
2 March 2015 119REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Testosterone in men with type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
2 March 2015 121REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Testosterone in men with type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
2 March 2015 123REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Testosterone in men with type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/2f/8d/jdi0006-0112.PMC4364844.pdf
2 March 2015 125REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Glucokinase activators,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Nakamura and Terauchi http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
2 March 2015 127REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Glucokinase activators,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Nakamura and Terauchi http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
2 March 2015 129REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Glucokinase activators,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Nakamura and Terauchi http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
2 March 2015 131REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Glucokinase activators,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Nakamura and Terauchi http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/0b/be/jdi0006-0124.PMC4364845.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/48/4b/jdi0006-0133.PMC4364846.pdf
2 March 2015 135COMMENTARY http://onlinelibrary.wiley.com/journal/jdi b-Cell speci ﬁc desnutrin/ATGL knockout,Non-OADS,/arxiv_data1/oa_pdf/48/4b/jdi0006-0133.PMC4364846.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/48/4b/jdi0006-0133.PMC4364846.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5a/1a/jdi0006-0137.PMC4364847.pdf
2 March 2015 139COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Mitochondrial ROS in early DN,Non-OADS,/arxiv_data1/oa_pdf/5a/1a/jdi0006-0137.PMC4364847.pdf
2 March 2015 141ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi BM-MNCs from young rats ameliorate DPN,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
2 March 2015 143ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi BM-MNCs from young rats ameliorate DPN,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
2 March 2015 145ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi BM-MNCs from young rats ameliorate DPN,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
2 March 2015 147ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi BM-MNCs from young rats ameliorate DPN,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
2 March 2015 149ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi BM-MNCs from young rats ameliorate DPN,Non-OADS,/arxiv_data1/oa_pdf/81/49/jdi0006-0140.PMC4364848.pdf
2 March 2015 151ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle and bone strength in men,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
2 March 2015 153ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle and bone strength in men,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
2 March 2015 155ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle and bone strength in men,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
Available at:http://www.data.kishou.go.jp/obs-env/radiation/data_rad.html.,OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
Available at: http://www.mext.go.jp/b_menu/shingi/gijyutu/gijyu tu3/houkoku/1298713.htm.,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
Available at: http://www.mhlw.go .jp/bunya/kenkou/eiyou/dl/ h23-houkoku.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
2 March 2015 157ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Lifestyle and bone strength in men,Non-OADS,/arxiv_data1/oa_pdf/b1/7f/jdi0006-0150.PMC4364849.pdf
2 March 2015 159ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin resistance in fatty liver,Non-OADS,/arxiv_data1/oa_pdf/80/72/jdi0006-0158.PMC4364850.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/80/72/jdi0006-0158.PMC4364850.pdf
2 March 2015 161ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin resistance in fatty liver,Non-OADS,/arxiv_data1/oa_pdf/80/72/jdi0006-0158.PMC4364850.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/80/72/jdi0006-0158.PMC4364850.pdf
2 March 2015 163ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin resistance in fatty liver,Non-OADS,/arxiv_data1/oa_pdf/80/72/jdi0006-0158.PMC4364850.pdf
2 March 2015 165CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Effect of sitagliptin on liver,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
2 March 2015 167CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Effect of sitagliptin on liver,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
2 March 2015 169CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Effect of sitagliptin on liver,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
2 March 2015 171CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Effect of sitagliptin on liver,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c1/20/jdi0006-0164.PMC4364851.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
2 March 2015 175ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi IL-6 SNPs and DPP-4 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
2 March 2015 177ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi IL-6 SNPs and DPP-4 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
2 March 2015 179ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi IL-6 SNPs and DPP-4 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
2 March 2015 181ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi IL-6 SNPs and DPP-4 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/fa/dd/jdi0006-0173.PMC4364852.pdf
2 March 2015 183CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with sitagliptin,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
2 March 2015 185CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with sitagliptin,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
2 March 2015 187CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with sitagliptin,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
2 March 2015 189CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with sitagliptin,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
2 March 2015 191CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with sitagliptin,Non-OADS,/arxiv_data1/oa_pdf/d8/69/jdi0006-0182.PMC4364853.pdf
2 March 2015 193CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin vs liraglutide,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
2 March 2015 195CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin vs liraglutide,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
2 March 2015 197CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin vs liraglutide,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
2 March 2015 199CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin vs liraglutide,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/jdi0006-0192.PMC4364854.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
2 March 2015 203ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GetGoal-S Japan subanalysis,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
2 March 2015 205ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GetGoal-S Japan subanalysis,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
2 March 2015 207ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GetGoal-S Japan subanalysis,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
2 March 2015 209ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi GetGoal-S Japan subanalysis,Non-OADS,/arxiv_data1/oa_pdf/60/70/jdi0006-0201.PMC4364855.pdf
2 March 2015 211CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi 52-Week canagli ﬂozin open-label study,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
2 March 2015 213CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi 52-Week canagli ﬂozin open-label study,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
2 March 2015 215CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi 52-Week canagli ﬂozin open-label study,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
2 March 2015 217CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi 52-Week canagli ﬂozin open-label study,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
"Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202293s000lbl.pdf (last accessed April 30, 2014).",Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d9/62/jdi0006-0210.PMC4364856.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/be/20/jdi0006-0219.PMC4364857.pdf
2 March 2015 221ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Combined use of insulin and acarbose,Non-OADS,/arxiv_data1/oa_pdf/be/20/jdi0006-0219.PMC4364857.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/be/20/jdi0006-0219.PMC4364857.pdf
2 March 2015 223ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Combined use of insulin and acarbose,Non-OADS,/arxiv_data1/oa_pdf/be/20/jdi0006-0219.PMC4364857.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/be/20/jdi0006-0219.PMC4364857.pdf
2 March 2015 225ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Combined use of insulin and acarbose,Non-OADS,/arxiv_data1/oa_pdf/be/20/jdi0006-0219.PMC4364857.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/be/20/jdi0006-0219.PMC4364857.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
2 March 2015 229ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi ApEn and CAN of diabetes,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
2 March 2015 231ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi ApEn and CAN of diabetes,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
2 March 2015 233ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi ApEn and CAN of diabetes,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
2 March 2015 235ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi ApEn and CAN of diabetes,Non-OADS,/arxiv_data1/oa_pdf/85/60/jdi0006-0227.PMC4364858.pdf
2 March 2015 237ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Behavioral risk factors for diabetes,Non-OADS,/arxiv_data1/oa_pdf/b0/26/jdi0006-0236.PMC4364859.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b0/26/jdi0006-0236.PMC4364859.pdf
2 March 2015 239ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Behavioral risk factors for diabetes,Non-OADS,/arxiv_data1/oa_pdf/b0/26/jdi0006-0236.PMC4364859.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b0/26/jdi0006-0236.PMC4364859.pdf
2 March 2015 241ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Behavioral risk factors for diabetes,Non-OADS,/arxiv_data1/oa_pdf/b0/26/jdi0006-0236.PMC4364859.pdf
"DEVELOPMENT OF THE 2014 CLASSIFICATION (REVISED CLASSIFICATION) Prior to revising the Classi ﬁcation, as part of a MHLW-subsi- dized project on kidney disease, entitled ‘Diabetic Nephropathy Research, from the Ministry of Health, Labor and Welfare ofJapan, ’a‘historical cohort study ’was conducted by the Research Group of Diabetic Nephropathy, MHLW, involving a total of 4,355 subjects with type 2 diabetes from 10 participating health- care facilities with the aim of evaluating renal events (i.e., adecrease in eGFR to half the baseline level and/or the need fordialysis), cardiovascular events and all-cause mortality 10,11.S u m - marized below are the major ﬁndings of that study (for detailed information, please access the MHLW website http://www.mhlw.go.jp/ or refer to the literature cited above).",Non-OADS,/arxiv_data1/oa_pdf/81/80/jdi0006-0242.PMC4364860.pdf
2 March 2015 243SPECIAL REPORT http://onlinelibrary.wiley.com/journal/jdi Classi ﬁcation of Diabetic Nephropathy 2014,Non-OADS,/arxiv_data1/oa_pdf/81/80/jdi0006-0242.PMC4364860.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/81/80/jdi0006-0242.PMC4364860.pdf
"Current state of dialysis therapy in Japan, 2013 illustrate d. Available at: http://docs.jsdt.or.jp/ overview/index.html.",Non-OADS,/arxiv_data1/oa_pdf/81/80/jdi0006-0242.PMC4364860.pdf
http://mhlw-grants.niph.,Non-OADS,/arxiv_data1/oa_pdf/81/80/jdi0006-0242.PMC4364860.pdf
2 March 2015 245SPECIAL REPORT http://onlinelibrary.wiley.com/journal/jdi Classi ﬁcation of Diabetic Nephropathy 2014,Non-OADS,/arxiv_data1/oa_pdf/81/80/jdi0006-0242.PMC4364860.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/81/80/jdi0006-0242.PMC4364860.pdf
"Supplementary information for this article is available online: http://embor.embopress.org Acknowledgements We thank N. Tapon for stocks, plasmids and insightful suggestions, J. Bernuésfor plasmids and GAF antibody, KD.",Non-OADS,/arxiv_data1/oa_pdf/a5/d8/embr0016-0362.PMC4364875.pdf
"Bioinformatic analysis Analyses were performed with the Perseus software (version 1.4.2.23), part of the MaxQuant environment (http://www.perseus-framework.org).",OADS,/arxiv_data1/oa_pdf/13/5d/embr0016-0387.PMC4364878.pdf
"Supplementary information for this article is available online: http://embor.embopress.org Acknowledgements We thank Korbinian Mayr, Igor Paron and Gabriele Sowa for their assistancewith MS; Stefano Ciciliot for the pictures of muscle sections; Francesca Fornerfor performing pilot experiments; Nils Kulak, Stefka Tyanova, Tikira Temu,Marco Hein and Markus Raeschle for critical discussions; and the PRIDE Teamfor the data deposition.",Non-OADS,/arxiv_data1/oa_pdf/13/5d/embr0016-0387.PMC4364878.pdf
"Supplementary information for this article is available online: http://emboj.embopress.org Acknowledgements This work was supported by the German Federal Ministry of Education andResearch BMBF within its joint research project SyStaR (KLR, MK, HAK), by theEU (ERC to KLR: 323136—Stem Cell Geronto Genes) and by the International Graduate School in Molecular Medicine Ulm, funded by the Excellence Initia-tive of the German Federal and State Governments (GSC 270).Author contributions ST and DT performed and analyzed majority of all experiments, including crypt isolation and culture, LGR 5hiand LGR 5locell purification, RNA isolation and qPCR, flow cytometry, intestinal tissue staining and counting, irradiation, andWestern blot.",Non-OADS,/arxiv_data1/oa_pdf/ff/c3/embj0034-0624.PMC4365032.pdf
Supplementary information for this article is available online: http://emboj.embopress.org Acknowledgements We thank B.,Non-OADS,/arxiv_data1/oa_pdf/14/08/embj0034-0669.PMC4365035.pdf
Laboratoryinvestigations revealed a markedly elevated alpha-fetoprotein levelFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/9e/c9/tre-05-298-6601-1.PMC4365056.pdf
"The finger-following test demonstrated not only action myoclonus, but alsosymmetric overshoot dysmetria.Termsarasab P, Yang AC Myoclonus in Ataxia–Telangiectasia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/9e/c9/tre-05-298-6601-1.PMC4365056.pdf
"62013 1 46 Myoclonus and dystonia Head (myoclonus), truncal extensor muscles (dystonia) Me`neret et al.22014 12 (out of 14 patients)Unknown Myoclonus with dystonia in 10 patients; multifocal myoclonus without dystonia in 2Neck, trunk, upper limbs Nakayama et al.72014 1 8 Myoclonic/dystonic jerks Neck and truncal extensor muscles Current cases 2014 2 11 and 12 Myoclonus One in neck, face, trunk and extremities; the otherin the limbs and trunk The authors, years the cases were published, number of the patients with myoclonus, the phenomenology described in the literature (note that some als o described dystonia), and the body regions involved are shown in each column.Myoclonus in Ataxia–Telangiectasia Termsarasab P, Yang AC Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/9e/c9/tre-05-298-6601-1.PMC4365056.pdf
"Handb Clin Neurol 2012;103:307–332, doi: http://dx.doi.org/10.1016/B978-0- 444-51892-7.00019-X 2.Meneret A, Ahmar-Beaugendre Y, Rieunier G, et al.",OADS,/arxiv_data1/oa_pdf/9e/c9/tre-05-298-6601-1.PMC4365056.pdf
